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2 Abstract 
 
The hematopoietic system is the best understood stem cell system in mammals. It is easy 
accessible and many decision steps need to take place during differentiation of multipotent 
hematopoietic stem cells into numerous mature blood cell types. Prospective isolation, in vitro 
differentiation experiments and in vivo transplantations have significantly contributed to the 
phenotypic definition of intermediate hematopoietic progenitor cells with restricted lineage 
potential. Lineage decisions at various branching points of hematopoiesis are commonly 
believed to be regulated by stochastically fluctuating transcription factor networks. The 
paradigmatic transcription factor pair PU.1 and Gata1 has specifically contributed to that 
hypothesis: PU.1 and Gata1 have been described as master regulators driving granulocytic-
monocytic versus megakaryocytic-erythroid lineage choice, respectively. Lineage priming, 
reprogramming experiments, positive autoregulation and mutual cross-antagonism of PU.1 
and Gata1   have   led   to   the   hypothesis   that   random   ‘noisy’   fluctuations in PU.1 and Gata1 
expression  will   allow  one   factor   ‘defeating’   the  other   and   thus   to   lineage  choice.  However,  
this hypothesis is based on limited expression data. So far, transcription factor expression 
mostly was measured at the mRNA level in discontinuous snapshot analysis. For a 
comprehensive understanding, quantification of protein levels before, during and after lineage 
choice would be required. Therefore, a knock-in of the fluorescent protein mCHERRY into 
the endogenous Gata1 locus was performed and the mouse line was bred with an existing 
PU.1eYFP knock-in mouse line. Phenotypic analysis of the double knock-in line did not 
reveal any defects in the function of the transcription factors. The double knock-in line 
allowed the measurement of endogenous expression levels at any time in individual primary 
hematopoietic stem and progenitor cells. Flow cytometric analysis of double knock-in mice 
led to the identification and prospective isolation of several new myeloid hematopoietic 
subpopulations. Continuous long-term time-lapse imaging and tracking at the single-cell level 
allowed the generation of cell genealogy trees and continuous live quantification of PU.1 and 
Gata1 protein expression. Continuous single-cell data showed that future lineage choice does 
not correlate with an interdependent fluctuating network of PU.1 and Gata1. It is therefore not 
compulsory for, and likely not involved in, granulocytic-monocytic versus megakaryocytic-
erythroid lineage choice. This corrects a central paradigm about the regulation of 
hematopoietic stem and progenitor cell lineage choice. In addition, the novel 
PU.1eYFP/Gata1mCHERRY double knock-in mouse line and the developed technology of 
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continuous quantification of transcription factor levels in living primary cells will be 
invaluable to further investigate what regulates hematopoiesis. 
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3 Introduction 
3.1 Hematopoiesis 
 
Hematopoiesis is the lifelong process of blood generation from hematopoietic stem cells 
(HSCs) which are both able to self-renew and differentiate into more than 10 different mature 
blood cell types. Among those are cells with basic function like oxygen supply, carbon 
dioxide removal or blood clotting and cells of the innate as well as the adaptive immune 
system.   Every   day   of   an   adult   human’s   life   1011 – 1012 cells are produced de novo 
(Kaushansky and Williams, 2010). After massive blood loss due to injury the blood system is 
able to rebuild itself within a relatively short period of time. As an easy accessible liquid 
organ, the blood system is the best investigated stem cell system in higher organisms and 
often serves as a model for other stem cell types. Therapeutic HSC transplantations are 
reliably performed in humans for more than 50 years. Despite of the clinical application there 
are still many open questions in HSC research. Due to experimental reasons like the easy and 
reproducible access to primary cells for basic research and the possibility of targeted genetic 
manipulations, the murine blood system is much better understood than the human. For 
therapeutic reasons, there is a huge interest of understanding how the highly complex and 
dynamic process of hematopoiesis is controlled. This includes both the developmental origin 
of hematopoietic cells and the regulation of adult hematopoiesis.  
 
3.1.1 Embryonic Hematopoiesis 
 
Embryonic hematopoiesis during development in mice occurs in different waves at different 
places (reviewed in Orkin and Zon, 2008). One distinguishes between primitive and definitive 
hematopoiesis. Primitive blood cells originate in the yolk sac and show unique morphological 
and molecular features compared to definitive blood cells. Their main function is the oxygen 
supply of the rapidly growing embryo. After the transient primitive phase definitive 
hematopoiesis takes place and generates blood types of adult phenotypes already. The sites of 
hematopoiesis then change during development from the AGM (aorta-gonads-mesonephros) 
region to the placenta, fetal liver, thymus, spleen and finally bone marrow, where 
hematopoiesis is maintained throughout the whole live of the organism. It is assumed that the 
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four latter sites only provide niches for maintenance and expansion for hematopoietic stem 
and progenitor cells (HSPCs) that have migrated there, instead of producing new cells de 
novo. To what extent HSCs arise at the other sites of embryonic hematopoiesis is not well 
understood. Endothelial cells are the definite immediate cellular precursor of blood cells 
which has been demonstrated recently (Eilken et al., 2009; Bertrand et al., 2010; Kissa and 
Herbomel, 2010).  
   
3.1.2 Adult Hematopoiesis  
 
Adult hematopoiesis is entirely maintained by HSCs that mainly reside in the bone marrow. 
After single cell transplants one individual HSC is defined as a cell that is able to reconstitute 
the whole blood system of a lethally irradiated recipient mouse over at least 16 weeks 
(reviewed in Ema et al., 2006). Only 1 out of about 100000 cells of unfractionated bone 
marrow is a HSC. Protocols for prospective isolation of HSCs have increased significantly 
during the past years (reviewed in Warr et al., 2011). Most current protocols include the 
marker   combination   ‘Lineage’, c-Kit and Sca-1 (Spangrude et al., 1988), where   ‘Lineage’  
resembles a cocktail of antibodies that are directed against antigens only expressed by mature 
cells  (‘lineage-positive’).  HSCs  are  both  positive  for  c-Kit, the receptor for the cytokine stem 
cell factor (SCF), and Sca-1 (stem cell antigen 1). Additional negative markers for better 
purification were described and included Thy-1.1 (Spangrude et al., 1988), CD34 (Osawa et 
al., 1996) and Flt3 (Adolfsson et al., 2001; Christensen and Weissman, 2001). A more recent 
protocol described the SLAM markers CD150 and CD48 that proved to be less strain and age 
dependent than Thy-1.1 and CD34 (Kiel et al., 2005).  
Classically, the hematopoietic system has been divided into the lymphoid and myeloid system 
(Figure 3-1). This classical discrimination was confirmed by the discovery of the common-
lymphoid progenitor (CLP) that is only able to give rise to B-, T- and natural killer (NK) cell 
lineages in vivo (Kondo et al., 1997), and the discovery of the presumptive common myeloid 
progenitor (CMP) that only exhibits lineage potential for the granulocytic-monocytic (GM) 
and megakaryocytic-erythroid (MegE) lineages, respectively (Akashi et al., 2000). From 
which cell type the CLP and CMP directly originate is an open question. Cells that do not 
have long-term reconstitution potential, but still can give to all mature blood lineages have 
been described as multipotent progenitors (MPPs). Due to the amount of available markers  
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and significant overlaps between their expressions, the hierarchical order of different MPP 
populations is not entirely clear. On a population level different MPP phenotypes show 
different proportions of cell-cycle stages in vivo that let them appear more immature (Wilson 
et al., 2008). Besides a shorter reconstitution potential of more mature MPPs the different 
lineage potential of those has to be taken into account: The upregulation of Flt3 among the 
Lin-c-Kit+Sca-1+ cells has led to the description of the lymphoid-primed multipotent 
Figure 3-1: Hematopoietic lineage tree                   
Classically, the hematopoietic system is divided into the lymphoid and the myeloid system with the 
first branching points being the common lymphoid progenitor (CLP) and common myeloid progenitor 
(CMP). CLPs are able to give rise to T-cells, B-cells and natural killer (NK) cells. CMPs are further able 
to give rise to granulocyte-macrophage progenitors (GMPs) and megakaryocyte-erythrocyte 
progenitors (MEPs). GMPs then give rise to neutrophil, basophil and eosinophil granulocytes, 
osteoclasts, macrophages and mast cells. The progeny of MEPs are megakaryocytes and 
erythrocytes. Dendritic cells can both have lymphoid and myeloid origin. All hematopoietic cells 
develop from the HSCs which lose their self-renewal potential during differentiation but still remain 
multipotent (MPPs). MPPs are a mixture of numerous different phenotypes, whose hierarchical 
organization is not entirely clear yet. Besides the classical differentiation pathway an alternative 
route involving the LMPP (lymphoid-primed multipotent progenitor) without MegE-lineage potential 
has been described. The hematopoietic hierarchy is still incomplete and subjected to constant 
changes. Image adapted from Rieger and Schroeder, 2007.  
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progenitor (LMPP) that did not have significant erythroid and megakaryocytic potential 
anymore (Adolfsson et al., 2005). Conflicting data about Flt3+ cells still retaining erythroid 
and megakaryocytic potential was published subsequently (Forsberg et al., 2006). In 
conclusion, there seems to be more than one pathway in adult hematopoiesis that allows the 
development of mature cell types. The question of this thesis deals with the lineage decision 
of a multipotent myeloid progenitor between the well-described and accepted 
granulocyte/macrophage progenitor (GMP) and megakaryocyte/erythrocyte progenitor 
(MEP). GMPs can further differentiate into dendritic cells, mast cells, basophilic/ 
eosinophilic/neutrophilic granulocytes and monocytes. MEPs only have lineage potential for 
erythrocytes and megakaryocytes that will further give rise to platelets. 
 
3.2 Factors Influencing Hematopoiesis 
3.2.1 Extrinsic Factors 
 
Adult HSCs do not exist as shielded entities, but usually reside in a very specialized bone 
marrow environment called the niche. The concept of the niche was already postulated a long 
time ago by Ray Schofield (Schofield, 1978). Only many years later, the existence of a niche 
as specialized cells for germline stem cells in Drosophila melanogaster could be proven 
(reviewed in Jones and Wagers, 2008; Morrison and Spradling, 2008). Since then, many stem 
cell niches in various tissues in mammals, especially in the mouse, have been identified: 
Those for example include niches for muscle cells under the basal lamina of myofibers, for 
intestinal epithelium in the base of crypts, for interfollicular epidermis in the basal layer and 
for central nervous system stem cells in the subventricular zone. As opposed to those rather 
rigid tissues, HSCs reside in a liquid organ. HSCs do not constantly remain in the niche, but 
circulate through the peripheral blood (Wright et al., 2001). Within the bone marrow HSCs 
have been found to be located in close proximity to both endosteum and sinusoidal blood 
vessels in trabecular bone (Nilsson et al., 2001; Kiel et al., 2005; Adams and Scadden, 2006). 
At the cellular level osteoblasts and osteoclasts play an important role in the endosteal niche. 
Signals from osteoblasts positively influencing HSC expansion, maintenance and quiescence 
are mediated through Notch activation, BMP signaling, N-Cadherin and Tie2/angiopoietin-1 
signaling (Calvi et al., 2003; Zhang et al., 2003; Arai et al., 2004). Ca2+-detection of HSCs 
mediated through a calcium-sensing receptor (CaR) keeps them in close proximity to the 
endosteum and the chemokine CXCL12 (SDF-1) allows homing of HSCs via CXCR4 
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signaling (Wright et al., 2002; Adams et al., 2006; Sugiyama et al., 2006). Osteoclasts were 
shown to degrade important niche components accompanied by hematopoietic progenitor 
mobilization upon stress induction (Kollet et al., 2006). Subendothelial progenitor cells were 
found to be capable of re-establishing HSC niches at developing sinusoids after 
transplantation and releasing Angiopoietin-1 (Sacchetti et al., 2007). Remarkably, HSCs also 
can reside in the spleen or liver upon stress induction, supporting the theory of perivascular 
niches. Recently, it also has been shown that progeny of stem cells also participates in 
regulating tissue homeostasis directly in the niche (reviewed in Hsu and Fuchs, 2012). In 
conclusion, the adult HSC microenvironment is highly dynamic and complex and various 
models  about  ‘the’  niche  exist which still need to be better refined.  
Besides direct cell-to-cell contact and paracrine signaling in the niche, hematopoiesis is 
largely influenced by cytokines. In general, cytokines are important for steady-state 
hematopoiesis, stress response and immunomodulation. They are peptides or glycopeptides 
that act as signaling molecules both within short distances but also as systemic agents in the 
bloodstream. Cytokines control individual cellular processes like survival, proliferation, 
lineage commitment, activation and migration. Some cytokines are lineage restricted and act 
on more mature cells, others are able to influence multiple lineages in more immature cells. 
Stem cell factor (SCF) is a cytokine that is important both for hematopoietic stem and 
progenitor cells (Ashman, 1999). Its receptor c-Kit is an important marker for the 
discrimination and purification of those cells. Thrombopoietin (TPO) acts at various levels of 
hematopoiesis: Together with SCF, TPO was shown to make HSCs self-renew in vitro, but 
TPO is also a strong stimulus for megakaryocyte colony formation (Ema et al., 2000). A very 
lineage restricted cytokine is erythropoietin (EPO) which was initially purified from urine of 
anemic patients (reviewed in Krantz, 1991). It is responsible for the survival and maturation 
of committed erythroid progenitors (Wu et al., 1995). Other examples of rather lineage-
restricted cytokines are the colony-stimulating factors (CSFs) G-CSF, M-CSF and GM-CSF 
that inherited their name from their ability to give rise to granulocyte and/or macrophage 
colonies in vitro, respectively (Metcalf, 2008). Interleukin-3 (IL-3) was originally also 
attributed to the group of CSFs, before it became clear that it allows the colony formation of 
not only granulocytes and macrophages, but also eosinophils, megakaryocytes and 
erythrocytes (reviewed in Zon, 2001). Interleukin-6 (IL-6) also has a broad spectrum of 
cellular targets and regulates both myelopoiesis and the innate as well as the adaptive immune 
response (Jones, 2005). Cytokines can be produces by a variety of tissue including myeloid 
cells, liver and kidney. Since the discovery of cytokines, the basic question if cytokines can 
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actively induce lineage choice (instructive) or only allow the survival of already progenitors 
(permissive) was unanswered (Enver et al., 1998). Recently, definite proof about an 
instructive role of the cytokines M-CSF and G-CSF could be provided (Rieger et al., 2009). 
 
3.2.2 Intrinsic Factors 
 
Like in many other cellular processes, epigenetics play an important role in hematopoiesis 
(reviewed in Butler and Dent, 2013). Epigenetics is defined as the stable and inheritable 
change of gene expression that is independent of alterations in the DNA sequence. A major 
molecular mechanism of epigenetics is the modulation of the chromatin structure. It involves 
posttranslational modifications of histones and chemical modifications of DNA bases. 
Dysregulation of epigenetic is often found in hematologic malignancies. In general, one 
distinguishes between two different   states   of   chromatin:   Euchromatin   denotes   an   ‘open’  
chromatin structure which makes DNA accessible for proteins like transcription factors and 
allows access of polymerase. It is accompanied by characteristic methylation and acetylation 
at specific lysine residues of histones and demethylated DNA. By contrast, heterochromatin 
denotes   a   ‘closed’   chromatin   structure   which   is   the   result   of   a   more   dense   packing   of  
chromatin leading to restricted access of DNA-accessory molecules. Hallmarks are 
hypoacetylation, methylation at (other) amino acid residues and methylation of cytosin in 
CpG islands. Other modifications of DNA have recently been discovered, but their biological 
relevance still need to be elucidated. A myriad of chromatin-modifying enzymes is involved 
in establishing, maintaining and erasing chromatin changes. Conditional knock-out 
experiments have established an essential role of certain enzymes for HSC self-renewal 
and/or for specific hematopoietic lineages. By sorting HSCs, MPPs, CLPs, CMPs, GMPs and 
MEPs and subsequent epigenetic characterization it was shown that multipotent cells 
exhibited   ‘open’  chromatin  structures  at  different   lineage-affiliated gene loci (Attema et al., 
2007).  During  differentiation  the  ‘open’  chromatin  was  either  maintained  at loci important for 
certain  lineages  or  chromatin  changed  into  a  ‘closed’  conformation  in  non-affiliated gene loci. 
In conclusion, different developmental stages are marked by different epigenetic 
modifications at various gene loci. Epigenetic is important for keeping cells in a multipotent 
and self-renewing status and for specification to certain lineages, as demonstrated by 
epigenetic dysregulation in cancers. 
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During recent years, non-coding RNAs have emerged as a new class of regulators in 
development (Mattick, 2007). Among those are microRNAs (miRNAs) which can regulate 
gene expression post-transcriptionally (reviewed in Filipowicz et al., 2008). MiRNAs are 
usually 21 nucleotides long and mediate translational repression or degradation of mRNAs 
through specific base-pair   binding   at   their   3’-untranslated   regions   (3’-UTR). Predictions 
estimate that 30% of mammalian genes are regulated by miRNAs. Within the hematopoietic 
system, more than 100 different miRNAs are expressed (reviewed in O'Connell and 
Baltimore, 2012). In general, a single miRNA has many predicted target molecules. 
Additionally, some mRNAs have predicted binding sites for several miRNAs. In 
hematopoiesis miRNAs function at different stages, including HSCs and both during 
lymphoid and myeloid development. Global disruption of the miRNA machinery in the T- or 
B-cell lineage severely affects their differentiation and function. Within the myeloid system 
important miRNAs for both the GM and MegE lineages also have been identified. Knock-outs 
and overexpression of individual miRNAs showed a potential role in lineage-commitment by 
binding to lineage-specific transcription factors. Due to their redundancy, the specific 
influence of miRNAs on individual target mRNAs is difficult to elucidate and remains to be 
investigated. 
Transcription factors are the ultimate determinants of hematopoiesis, because they have the 
capacity to directly regulate target gene expression. Transcription factors can either have a 
function in different HSPCs or they are very cell-type specific. They all are commonly 
believed to be part of a large transcription factor network (Laiosa et al., 2006). Most data 
about the importance of transcription factors for certain lineages was derived from knock-out 
experiments. Within the lymphoid part of the blood system, classic examples of lineage-
specific essential transcription factors are Pax5 for B-cells and Gata3 for T-cells (Ting et al., 
1996; Nutt et al., 1999; Mikkola et al., 2002). Another factor, E2A, has been shown to be 
important both for B- and T-cell lineages (Bain et al., 1994; Barndt et al., 2000). An example 
for a transcription factor being important both for HSPCs and certain myeloid lineages is 
Gata2 (Tsai and Orkin, 1997).  C/EBPα  was  originally  described  to  be  essential  for  neutrophil  
development, but its disruption also leads to enhanced HSC self-renewal (Zhang et al., 1997; 
Zhang et al., 2004). Due to its central role in hematopoiesis, the transcription factor PU.1 is 
one of the best studied ones in hematopoiesis (reviewed in Gupta et al., 2009). It is important 
for the development of granulocytes, macrophages and B-cells, but also a critical role in 
HSCs has been revealed. Another very well studied factor is Gata1 which has been associated 
with the megakaryocytic-erythroid lineage (reviewed in Ferreira et al., 2005). Gata1 also 
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plays a role in the development of the eosinophilic lineage and mast cells. The existence of a 
transcription factor network and the diverse role of individual factors are nicely displayed by 
the network dynamics: Usually, certain lineages are associated by the (enforced) upregulation 
of one transcription factor, but different lineages can also develop depending on the sequence 
of transcription factor expression (Walsh et al., 2002; Chou et al., 2009). For lineage-
determination between the GM and MegE lineage, PU.1 and Gata1 are commonly believed to 
be central transcription factors of a large network (Laiosa et al., 2006; Laslo et al., 2008; 
Krumsiek et al., 2011).  
 
3.3 The Transcription Factors PU.1 and Gata1 
3.3.1 Structure of PU.1 and Gata1 
 
The transcription factor PU.1 (Purine-rich box 1) was discovered as a putative oncogene by 
insertional mutagenesis in murine erythroleukemia induced by the spleen focus forming virus 
(SFFV) (Moreau-Gachelin et al., 1988). Therefore, PU.1 is also known as Spi-1 or Sfpi-1 
(SFFV proviral integration). The PU.1 gene is located on mouse chromosome 2 and consists 
of 5 exons. So far, there has only been one transcript described. The protein belongs to the 
ETS (E-twenty six) family of transcription factors, consists out of 272 amino-acids and has a 
predicted molecular weight of 31 kDa. PU.1 contains 3 functional domains which include a 
transactivation domain, a PEST domain (rich in proline, glumatic acid, serine and threonine) 
and the helix-turn-helix DNA-binding ETS domain. Post-translational modifications, like the 
phosphorylation at serin 148 of PU.1 have been described (Pongubala et al., 1993), but its 
importance in PU.1 functionality in not clear.  
The transcription factor Gata1 was first described as an erythroid-specific transcription factor 
binding to cis-elements of both human and chicken globin genes (Evans et al., 1988; Wall et 
al., 1988).  The  name  “Gata”  is  derived  from  its binding specificity to the consensus sequence 
(A/T)GATA(A/G) by two conserved zinc finger domains. Gata1 is member of the Gata-
family of transcription factors which contains five more structurally similar proteins (Gata2 – 
Gata6) out of which Gata1-Gata3 are highly specific to the hematopoietic system. However, 
Gata1 is also expressed in Sertoli cells (Ito et al., 1993). The murine Gata1 gene is located on 
the X chromosome and consists out of 6 exons with the start codon being on exon 2. There is 
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some debate  about  additional  5’-UTR exons which leaves some doubts about the total length 
of Gata1 transcripts (Lowry and Mackay, 2006). Murine Gata1 (43 kDa) is a 413 amino acids 
long protein and consist of a N-terminal transactivation domain and 2 consecutive zinc-
fingers, named N-finger and C-finger. Gata1 is subject to various post-translational 
modifications, including phosphorylation at 7 different serine residues (Crossley and Orkin, 
1994), acetylation (Boyes et al., 1998) and SUMOylation (Collavin et al., 2004). The 
functional importance of these modifications is largely unknown. Possible roles in DNA 
binding specificity and transcriptional activation are being discussed.  
 
3.3.2 PU.1 and Gata1 Knock-Outs 
 
The functional importance for certain lineages can be demonstrated best by in vivo knock-out 
models. Mouse embryos that carry a homozygous knock-out of the PU.1 DNA-binding 
domain by insertional mutagenesis die during late gestation (Scott et al., 1994). The reason 
for death was a multilineage defect in monocytes, granulocytes, B-cells and T-cells, 
demonstrating the necessity of PU.1 in the proper development of those lineages. 
Megakaryocytic and erythroid progenitor cells were unaffected by the PU.1 knock-out, but 
erythroblasts maturation was impaired. Heterozygous PU.1 knock-out embryos did not show 
a phenotype. Another study using a similar approach reported similar effects (McKercher et 
al., 1996): Mice with a homozygous PU.1 knock-out died shortly after birth due to severe 
septicemia. Again, mature neutrophils, macrophages, B-cells and T-cells were missing. When 
animals were treated with antibiotics, survival was prolonged and cells with neutrophil 
features could be detected, showing that PU.1 might not be absolutely essential for myeloid 
lineage choice. Besides the importance for mature lineages, PU.1 was also shown to be 
important for the maintenance of the HSC pool in adult mice (Iwasaki et al., 2005). In that 
conditional knock-out model, CMPs and GMPs could still be identified and sorted, but cells 
failed to give rise to mature colonies in vitro and only consisted of myeloblasts. 
The central importance of Gata1 for the erythroid lineage was first shown by targeted 
disruption of Gata1 in embryonic stem (ES) cells and their subsequent failure to give rise to 
mature red blood cells in chimeric animals (Pevny et al., 1991). In vitro differentiation 
experiments also showed that Gata1- ES cells were impaired in their erythroid development 
(Weiss et al., 1994; Pevny et al., 1995). Full embryonic Gata1 knock-outs died between 
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embryonic day 10.5 (E10.5) and E11.5 of gestation (Fujiwara et al., 1996). Those embryos 
completely lacked mature erythroid cells and instead showed an arrest at the proerythroblast 
stage, suggesting that Gata1 is not essential for erythroid lineage choice. Due to that severe 
phenotype the importance of Gata1 for other blood lineages had been elusive until the genetic 
manipulation of Gata1 regulatory sequences led to a megakaryocyte-specific phenotype 
(Shivdasani et al., 1997). Affected mice showed massively reduced platelet numbers and 
megakaryocyte maturation defects. A conditional Gata1 knock-out model in adult mice 
confirmed the results and again led to a maturation arrest at the proerythroblast stage and 
thrombocytopenia (Gutierrez et al., 2008). Furthermore, mice failed to have an erythropoietic 
stress response upon treatment with a hemolytic agent. 
In conclusion, both PU.1 and Gata1 are essential for embryonic and adult steady-state 
hematopoiesis. After knock-out of the transcription factors, mature cells of the respective 
lineages fail to develop. However, both transcription factors seem to be dispensable for the 
lineage choice in favor of the GM and MegE lineage, respectively.  
 
3.3.3 Reprogramming Potential of PU.1 and Gata1 
 
The power of individual transcription factors in reprogramming cells to certain lineages was 
first demonstrated by the generation of myoblasts from fibroblasts only by the overexpression 
of MyoD (Davis et al., 1987). Afterwards, the same potential was also shown for the 
transcription factor Gata1 whose enforced expression in a myeloid cell line induced 
megakaryocytic differentiation (Visvader et al., 1992). This observation was later confirmed 
and expanded by the overexpression of Gata1 in Myb-Ets-transformed chicken myeloblasts, a 
model for committed myelomonocytic cells (Kulessa et al., 1995). It could be shown that the 
enforced erythroid, megakaryocytic or eosinophilic lineage outcome was dependent on the 
dosage of Gata1. Additionally, Gata1 not only reprogrammed cells to other lineages, but 
actively repressed myelomonocytic markers. 
Reprogramming potential could also be conferred to the transcription factor PU.1 in the same 
model system: Enforced expression of PU.1 led to an instructive differentiation along the GM 
lineage in still multipotent cells (Nerlov and Graf, 1998). PU.1 both upregulated GM lineage-
specific genes and downregulated progenitor/thrombocyte-specific markers as well as Gata1. 
In the same publication, inducible forms of PU.1 were also used. PU.1 was fused to the 
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hormone-binding-domain of the human estrogen-receptor (ER), making its activation 
reversibly controllable by the application of estrogen or its derivates. Long-term activation of 
PU.1 led to GM cell fates again, whereas short-term activation led to the development of 
immature eosinophilic stages only. Gata1-ER fusions have also been described and proved 
their usefulness even in primary cells. Again, enforced expression of Gata1 led to the outcome 
of erythroid, eosinophilic and basophilic-like cell fates (Heyworth et al., 2002). Interestingly, 
reprogramming experiments with 2 transcription factors showed that the lineage outcome is 
dependent   of   the   sequence   of   the   expression   of  Gata2   and   C/EBPα   (Iwasaki et al., 2006). 
Therefore, inducible forms of transcription factors represent a powerful tool that makes their 
function easy to study in a timed, tunable and reversible way in the cell type of interest. 
 
3.3.4 Interactions of PU.1 and Gata1 
 
Along with the observation that PU.1 and Gata1 downregulate opposing lineage-specific 
genes, it could also be shown that both transcription factors directly bind to each other (Zhang 
et al., 1999; Nerlov et al., 2000). More in detail, in vitro protein interactions, electrophoresis 
mobility shift assays (EMSA), co-immunoprecipitations and luciferase reporter assays 
provided a detailed view about the biochemical interaction of PU.1 and Gata1. It could be 
demonstrated that the conserved C-finger of both Gata1 and Gata2 binds to the ETS domain 
of PU.1 which inhibits the transcriptional activity of PU.1. The inhibitory influence of PU.1 
on Gata1 is mediated by the N-terminus of PU.1 (Zhang et al., 2000). By binding of PU.1 to 
the C-finger of Gata1, Gata1 binding to DNA is disabled and transcriptional activity is 
directly blocked. Additionally, PU.1 interacts with pRB and cooperatively represses Gata1 
transcriptional activity and hence erythroid differentiation (Rekhtman et al., 2003). Direct 
negative influence of both transcription factors on the expression levels of the other factor 
could not be detected. To current knowledge the cross-antagonism is post-transcriptional only 
and it inhibits differentiation of the opposing lineage by inhibiting the central lineage-
determining factors PU.1 and Gata1 in a dose-dependent manner. Moreover, PU.1 is also able 
to create a repressive chromatin structure by binding to Gata1 directly at its target genes 
(Stopka et al., 2005). The direct biochemical interaction was also studied detailed at the 
molecular level by extensive mutagenesis and NMR spectroscopy (Liew et al., 2006). The 
binding between PU.1 and Gata1 is of stable affinity which cannot be interrupted by 
individual amino acid changes. Interestingly, a part of the Gata1 C-finger shares sequence 
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homology with the PU.1 co-factor c-Jun, suggesting a competitive binding mechanism that 
allows Gata1 to inhibit PU.1 activity.  
 
3.3.5 Autoregulation of PU.1 and Gata1 
 
After the discovery of the importance of Gata1 for the erythroid lineage, attempts of 
delineating its transcriptional regulation were made. Based on the observation that Gata1 
mRNA levels steadily increase during erythroid differentiation, promoter analysis of the 
Gata1 gene pointed to a double GATA motif (Tsai et al., 1991). DNA footprinting 
experiments in an erythroleukemic cell line could indeed show Gata1 binding to its own 
promoter. Therefore, a positive feedback loop was suggested leading to the maintenance of 
differentiation by keeping the promoter state ‘on’.  Transgenic  in vivo experiments in zebrafish 
embryos confirmed Gata1 binding to its own promoter and also showed that both the N- and 
C-finger are necessary for correct transcriptional function (Kobayashi et al., 2001). 
Furthermore, targeted deletion of the Gata1 binding site in vivo led to a selective loss of the 
eosinophilic lineage (Yu et al., 2002). Biochemically, a dimerization of Gata1 proteins seems 
to be important for full transcriptional activity at its own promoter (Crossley et al., 1995; 
Nishikawa et al., 2003).   
Similarly to Gata1 and its autoregulatory potential, binding sites for PU.1 are found in its own 
murine and human promoters (Chen et al., 1995). Mutation of the -39 bp PU.1 binding site 
significantly abolished promoter activity. Correct myeloid gene expression is also importantly 
mediated by a -14kb upstream regulatory element (URE) (Li et al., 2001). Interestingly, that 
URE is sufficient for correct reporter gene expression in vivo. Further detailed analysis with 
DNA binding experiments showed that PU.1 binds to a conserved region within the URE 
(Okuno et al., 2005). Mutation of that site led to a significant decrease of PU.1 binding and 
reporter gene expression in cell lines. Like in the case of Gata1, another PU.1 mediated 
positive autoregulatory loop was suggested for correct expression of PU.1 in the respective 
cell types.  
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3.3.6 Mutations of PU.1 and Gata1 
 
Targeted deletion of the aforementioned URE in vivo led to reduced PU.1 levels (20%) and 
predisposed mice to acute myeloid leukemia (Rosenbauer et al., 2004). Further analysis of the 
role of the URE showed its importance in regulating lymphoid development both in B- and T-
cells. Depending on the lineage the URE had different functions either as an enhancer or a 
repressor (Rosenbauer et al., 2006). By this study it could be shown that a missing control 
element leading to dose-changes of one transcription factor can induce cancer in several 
murine blood lineages. Adult mice with induced deletion of PU.1 exon 5 all developed 
myeloid leukemia and started to die after 13 weeks (Metcalf et al., 2006). Several PU.1 
mutations have been associated with AML in humans (Mueller et al., 2002) and PU.1 has 
been described as a tumor suppressor gene that is often mutated in radiation induced myeloid 
leukemia (Cook et al., 2004). Enforced expression of PU.1 in promyelocytic leukemia cells 
could rescue the phenotype. The potential of PU.1 as a therapeutic target in leukemic cells 
was supported by observations about terminal differentiation induced by lentiviral 
overexpression of PU.1 in human AML samples (Durual et al., 2007). More work of the 
group that discovered PU.1 as a putative oncogene could show that 50% of transgenic PU.1 
overexpressing mice developed erythroleukemia, caused by a differentiation block at the 
proerythroblast stage (Moreau-Gachelin et al., 1996). Interestingly, excessive PU.1 expression 
leading to tumor formation could be overcome by enforced expression of Gata1 (Choe et al., 
2003). Again, as a consequence the cells lost their tumorigenic potential and differentiated 
terminally. Gata1 mutations are also known to be involved in leukemia development 
(reviewed in Burda et al., 2010). Promoter manipulations leading to a Gata105/X genotype 
generated female blood cells with either normal Gata1 levels or 5% Gata1 levels. Blood cells 
that only expressed 5% Gata1 levels developed a myelodysplastic syndrome, suggesting that 
low Gata1 levels are not sufficient for proper differentiation (Takahashi et al., 1997; Shimizu 
et al., 2004). Highly abundant Gata1 mutations are prevalent in children with Down syndrome 
and are associated with acute megakaryoblastic leukemia (Wechsler et al., 2002). A very 
common mutation is the production of a N-terminally truncated Gata1 protein lacking the 
transactivation domain. The phenotype of hyperproliferative megakaryoblasts could also be 
transferred to a transgenic mouse model harboring N-terminally truncated Gata1 (Li et al., 
2005; Shimizu et al., 2009). 
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3.4 The	  ‘PU.1/Gata1	  Paradigm’:	  A	  Stochastic Switch? 
3.4.1 Lineage Priming 
 
Northern blot expression analysis of several multipotent hematopoietic progenitor cell lines 
could show that PU.1, Gata1 and other lineage-affiliated genes like the erythropoietin receptor 
are already expressed before definite GM and erythroid lineage commitment of multipotent 
progenitor populations, respectively (Crotta et al., 1990; Heberlein et al., 1992; Cross et al., 
1994). It was further observed that upon differentiation, lineage-affiliated genes exhibited a 
gradual  upregulation  in  ‘their’  lineages  and a gradual downregulation in lineages where they 
supposedly do not play a role. The co-expression of lineage-specific genes in presumptive 
uncommitted   progenitor   cells   was   called   ‘lineage   priming’.   In   part,   with   highly   sensitive  
reverse transcription polymerase chain reaction (RT-PCR) this lineage promiscuity could also 
be observed at the single-cell level in FDCPmix cells with the notion of heterogeneity 
between individual cells (Hu et al., 1997). Most abundant markers were the genes 
myeloperoxidase (MPO)   and   β-globin, specific for granulocytes and erythrocytes, 
respectively. One third of all cells investigated expressed both genes. However, the 
megakaryocyte-erythrocyte driving factor Gata1 was only expressed in 12% of all cells and 
PU.1 was not part of this study. Multilineage priming at the single cell level could also be 
shown for multipotent primary cells from the AGM region (Delassus et al., 1999). Again, the 
markers  MPO  and  β-globin were used and 50% of all cells exhibited coexpression. Many of 
the multipotent cells also expressed the transcription factors PU.1 and Gata2. After the 
description of the CLP (Kondo et al., 1997) and the CMP (Akashi et al., 2000) the concept of 
lineage priming was also investigated in adult primary hematopoietic cells (Miyamoto et al., 
2002). HSCs, CMPs, GMPs and MEPs were tested for gene expression by single-cell RT-
PCR   in   two   different   “myeloid   sets”,   each   containing   two   GM   (including   PU.1)   and   two  
MegE affiliated genes. Individual GMPs and MEPs were mostly classified into strong GM 
and MegE-profiles, respectively. On the other hand, half of all CMPs tested showed a 
promiscuous profile, whereas the rest mostly exhibited a GM- or MegE-profile only. HSCs 
exhibited mostly a primitive profile (none of the 4 markers was expressed), but a significant 
amount of cells also showed a promiscuous profile. That led the authors of the study to the 
conclusion that a promiscuous gene profile starts already to emerge at HSC level. This RNA 
data from primary cells was confirmed on a larger scale with microarray analysis of HSCs, 
MPPs, CLPs and CMPs (Akashi et al., 2003). It was demonstrated that HSCs express genes of 
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all hematopoietic lineages and, surprisingly, genes that are not affiliated with the 
hematopoietic tissue. MPPs, as opposed to CMPs, still expressed myeloid and lymphoid 
genes. This increasingly restricted gene pattern during differentiation was proposed to support 
the hypothesis of a more open chromatin structure in more immature cells. Besides looking at 
the   ‘classical’   differentiation   pathway   via   CLPs   and   CMPs,   lineage   priming   was   also  
investigated in LMPPs (Mansson et al., 2007). Both large-scale and single-cell analysis 
confirmed multilineage priming in HSCs and showed downregulation of MegE genes in 
LMPPs, supporting the hypothesis of their existence. This phenomenon was also shown not to 
be adult-specific, because a similar LMPP could be identified in embryonic hematopoiesis, 
too.  
 
3.4.2 The PU.1/Gata1 Network 
 
In general, lineage commitment is considered as a stochastic cell-intrinsic process (Robb, 
2007; Graf and Enver, 2009). After the discovery of primed multipotent progenitor cells the 
experimental observations were transformed into a model that assumed lineage priming in all 
multipotent cells characterized by low-level and/or sporadic transcription of lineage-affiliated 
genes associated with an open chromatin structure (Cross and Enver, 1997). Importantly, this 
model was marked by dynamics and fluctuations of different lineage-affiliated genes within 
thresholds   before   the   actual   commitment.   Lineage   priming   was   suggested   to   be   “a   ground  
state from which regulatory networks can develop through positive and negative feedback 
 
Figure 3-2: The ‘PU.1/Gata1 Paradigm’                   
Green balls represent PU.1, red balls represent Gata1. Summary of activatory and inhibitory 
functions of PU.1 and Gata1 (left panel). Lineage commitment to one lineage is determined by 
transcription factor fluctuations and decided by one factor exceeding to other one (right panel). 
Image adapted from Graf and Enver, 2009. 
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loops”.  Along  with  the  description  of  the  mutual  inhibitory  influence  of  PU.1  and  Gata1  the  
above mentioned model was specifically extended to the transcription factors themselves 
(Orkin, 2000; Cantor and Orkin, 2001): Due to the cross-antagonistic interplay of the 
transcription factors at low levels in uncommitted cells and, hence, the insignificant 
expression of lineage-specific target genes, cells were proposed to being kept multipotent. 
Lineage commitment then must be the consequence of stochastic upregulation of one factor 
above threshold levels or the induced upregulation because of external stimuli. As a result, 
one transcription factor stoichiometrically exceeds the other one and activates lineages-
specific target genes (Figure 3-2). Since the existence of the concept of stochastic gene 
expression, the PU.1/Gata1 stochastic switch has become an important aspect of adult 
hematopoiesis suggested also in other reviews, where the ratio between PU.1 and Gata1 is 
depicted as a balance that governs lineage choice (Graf, 2002) and lineage promiscuity at sub-
threshold levels precedes commitment (Miyamoto and Akashi, 2005). Whenever myeloid 
lineage choice from the HSCs  is  being  discussed,  the  ‘PU.1/Gata1  paradigm’  is  mentioned  as  
the central element (Laiosa et al., 2006; Iwasaki and Akashi, 2007; Orkin and Zon, 2008). 
 
3.4.3 Modeling Approaches 
 
After the conceptual hypothesis of myeloid lineage determination involving fluctuating 
transcription factor networks, modeling approaches tried to support this from a mathematical 
perspective: Under the assumptions of both PU.1 and Gata1 being transcriptional activators 
for themselves and (probably indirectly) for each other, mutual inhibition mediated by two 
different complexes and several simplifications (e.g. no post-transcriptional regulation and 
time-delays), it was concluded that the suggested model of interacting transcription factors is 
able to explain a switching behavior during lineage commitment (Roeder and Glauche, 2006). 
Depending on the parameter choice of the model equations, lineage priming could be 
explained either as a one step process (from lineage priming to commitment) or a two-step-
process in which lineage priming is preceded by an initialization. Mechanistically, in one 
instance increasing transcription rates were enough to induce differentiation, whereas in 
another instance previous perturbation of the system was needed for differentiation. In 
another even more simple mathematical model, taking into account mutual cross-inhibition 
and positive autoregulation only, the three cell states MPP, GM-committed cell and MegE-
committed cell were pictured in a three-dimensional attractor landscape as stable valleys 
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(Huang et al., 2007). Differentiation was suggested to take place either by changes in the 
ordinary differential equations (which e.g. would correspond to a strong upstream or 
extracellular signal) or by an intermediate unstable state that is the result of a transformation 
of a stable valley (MPP) to a hill-top from which cells could tip into both again stable valleys 
(differentiation), potentially caused by stochastic fluctuations of transcription factors 
networks. In order to find out which model reflected more the process of myeloid 
differentiated, transcriptome analysis of the myeloid progenitor cell line FDCPmix was 
performed. The multipotent cells were differentiated into GM- or MegE-cells by different 
cytokine treatment and their transcriptome changes were compared during the differentiation 
process between 0 h and 168 h. Interestingly, during the first 48 h the transcriptomes changed 
very  similarly,  only   later   they  developed  differently.  Thus,   the  authors’   conclusion was that 
differentiation follows a two stage process including a destabilization event and the actual 
lineage commitment by either stochastic fluctuations or exposure to upstream signaling 
events. In another model, Chickarmane and colleagues suggested the existence of an 
additional factor X, because additional experimental data about PU.1-Gata1 interaction did 
not support the above mentioned theories of bistable switches (Chickarmane et al., 2009). 
Suppression of that factor X still could explain the primed PU.1/Gata1 state. They 
additionally  suggested  that  another  downstream  antagonistic  transcription  factor  pair  (C/EBPα  
and FOG-1) inherits the information from PU.1 and Gata1 and thus reinforces lineage 
commitment.  
Functional important transcription factor cross-antagonism has also been suggested at other 
branching points of hematopoiesis. In this context, the transcription factors Fli-1 and EKLF 
were reported to be involved in regulating lineage choice between the erythroid and 
megakaryocytic lineage (Starck et al., 2003).   Likewise,   the   ratio   of   PU.1   and  C/EBPα  was  
reported to regulate monocytic versus granulocytic fate choice depending on the cytokine G-
CSF (Dahl et al., 2003). Nonetheless, the molecular mechanism behind the suggested 
regulation remained   covert,   also   because   both   PU.1   and   C/EBPα   are   highly   expressed   in  
monocytic and granulocytic lineages. A deeper analysis of that cell fate decision led to the 
additional downstream transcription factors Egr-1,2/Nab-2 and Gfi-1 that again were 
suggested to form a gene regulatory network with bistable behavior (Laslo et al., 2006). More 
cross-antagonistic transcription factor pairs from many more different branching points of 
development are summarized in Graf and Enver, 2009. 
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In a general, metaphorical view, cell differentiation has long been regarded as a ball rolling 
down a three dimensional landscape with different, irreversible branching points 
corresponding to individual lineage choices during development (Waddington, 1957). 
Amazingly, this model is still valid today (Enver et al., 2009). Taking into account the 
knowledge about stem cells, progenitor cell types and mature cells, mathematical modeling 
can now shed some light about how the ball rolls down the hill and how its journey can be 
influenced to take different routes. However, mathematical modeling is always a simplified 
illustration of the truth and a can only integrate what is known to date. Still, it can be a 
powerful tool to setup hypothesis that later can be tested in practice in order to proof, 
contradict or refine the theoretical framework.  
 
3.5 (Dis)proving the ‘PU.1/Gata1 Paradigm’ 
3.5.1 Requirement for Continuous Single-Cell Analysis 
 
The existence of a PU.1/Gata1 stochastic switch is an intuitive and attractive model about the 
control of lineage choice between the GM- and MegE-lineage, respectively. It is based on the 
experimental   observations   about   ‘lineage   priming’,   the   essentiality   of   both   transcription  
factors   for   ‘their’   mature lineages, their reprogramming potential, their positive 
autoregulatory  feedback  loops  and  their  potential  of  mutually  inhibiting  each  other’s  function  
by molecular interaction. Mathematical modeling of all that plausible experimental data 
furthermore supported the hypothesis that transcription factor networks are involved in 
governing lineage choice. However, direct evidence about PU.1 and Gata1 indeed regulating 
lineage choice has never been provided. 
The   phenomenon   of   ‘lineage   priming’   has   only   been   shown at RNA-level, but never at 
protein  level,  first  in  a  multipotent  cell  line,  later  in  primary  cells.  So  far,  ‘lineage  priming’  in  
terms of double expression of PU.1 and Gata1 at protein levels in multipotent primary cells 
has never been demonstrated. The convincing experimental data about PU.1/Gata1 molecular 
interaction was derived from in vitro pull-down assays, ectopic overexpressions in cell lines 
and leukemic cell lines which abnormally express both transcription factors at the same time. 
To date, no interaction of PU.1 and Gata1 has been shown in unmanipulated primary cells.   
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HSC differentiation has mostly been investigated at population level of defined 
subpopulations in order to get enough material for classical biochemical and molecular 
analysis like Western blotting or microarrays. A big issue about this approach is that 
presumptive homogeneous phenotypically identical populations can exhibit a large degree of 
heterogeneity (Huang, 2009). An easy example is shown in Figure 3-3: A classical population 
analysis (e.g. Western blot) time-course experiment can only display the population average 
of any marker of interest X which results in increasing strength of bands. Trying to explain 
that observation, it might be possible that a population changes homogeneously in the 
expression of the marker X which in a single-cell FACS analysis results in a gradual 
movement of the histogram along the axis. Or it could be the case that individual cells within 
the population start their expression of marker X earlier than others which in FACS analysis 
results in the appearance of two histograms. Thus, the biological conclusions from single-cell 
analysis can be completely different.  
 
The potential of FACS analysis as a very powerful technique can also be demonstrated by the 
following example: With the multipotent hematopoietic cell line EML it could be shown that 
cells exhibit large heterogeneity of the stem cell marker Sca-1 (Chang et al., 2008). By sorting 
and comparing Sca-1low and Sca-1high expressing cells of a clonal population, it was shown 
that both low and high Sca-1 expressing populations could reconstitute the original 
distribution within one week of culture. Interestingly, the two different populations had 
distinct transcriptomes and a different preference for the erythroid (Sca-1low) and the GM 
(Sca-1high) lineage accompanied by high Gata1 and high PU.1 expression, respectively.  
 
Figure 3-3: Single cell analysis can reveal heterogeneity of cell populations               
As opposed to population analysis (e.g. Western blot) which only reports a population average of a 
cell population, single cell analysis (e.g. FACS analysis) can report heterogeneity among the cells 
leading ultimately to different biological conclusions. Image adapted from Schroeder, 2011. 
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Despite its potential in single-cell analysis, flow cytometry only allows the investigation of 
one or several markers at one single timepoint. Any potential fluctuations cannot be 
determined by that method, because the necessary continuous single-cell identity is being lost 
between timepoints. In two extreme scenarios, heterogeneity of a population can either be 
stable with very little or no fluctuation over time of a marker of interest or it can be very noisy 
with very high fluctuations within a short period of time. The only available method to 
observe any potential fluctuations at the single-cell level is continuous live-cell imaging.  
In   conclusion,   in   order   to   (dis)prove   the   ‘PU.1/Gata1   paradigm’ or investigate the role of 
transcription factor networks in general, one has to look continuously at protein levels in 
individual living unmanipulated primary cells before, during and after lineage commitment. 
Otherwise the foundation of the hypothesis, i.e. the behavior of PU.1 and Gata1 expression 
levels will be missed (Figure 3-4). During recent years, long-term time-lapse imaging has 
become a very powerful technique to observe HSPCs in vitro at the single-cell level (Eilken et 
al., 2009; Rieger et al., 2009; Schroeder, 2011). A novel approach including suitable hard- 
and software tools allows the observation of individual cells at high temporal resolution to 
keep  their  identity.  With  the  help  of  the  supervised  tracking  program  ‘Timm’s  Tracking  Tool’  
(TTT), pedigree trees over many consecutive generations can be generated. Thus, this 
technique allows, amongst many other scientific questions, the observation of the 
 
Figure 3-4: Only continuous single-cell analysis can reveal transcription factor behavior              
Continuous single cell analysis at protein levels is the only possibility to reveal the behavior of the 
transcription factors and investigate their potential role in lineage decision. Image adapted from 
Schroeder, 2011. 
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differentiation process form individual sorted primary HSCs. In order to quantify PU.1 and 
Gata1 expression in a non-invasive way, protein levels can be quantified by fluorescence from 
transgenic reporter mice.  
 
3.5.2 Existing PU.1 and Gata1 Fluorescent Reporter Mice 
 
Fluorescent proteins have been proven to be a very powerful tool which culminated in the 
award of the Nobel Prize in chemistry to three scientists for the discovery and development of 
the green fluorescent protein (GFP) in 2008. GFP was first isolated from the jellyfish 
Aequorea victoria (Shimomura et al., 1962). After the cloning of GFP cDNA thirty years 
later, the application of GFP as a fluorescent reporter has become a standard method in cell 
biology (Prasher et al., 1992). It can be used as a transgenic marker for ectopic expression, 
live readouts of promoter activity and fusions to any protein of interest. Application of 
fluorescent proteins as biosensors by reporting cellular signaling have been developed 
recently (reviewed in Endele and Schroeder, 2012). Fluorescence can then be followed both in 
space and time by exposing cells to the correct excitation wavelengths and detecting a proper 
spectrum of emitting light. Variants of GFP with blue, cyan and yellow fluorescence (named 
accordingly BFP, CFP and YFP) have been cloned and allowed the simultaneous detection of 
more than one protein at the same time (summarized in Kremers et al., 2011). Additionally, 
improved versions of fluorescent proteins have been engineered (enhanced GFP, enhanced 
YFP) and the spectrum of fluorescent proteins was massively expanded with mutated variants 
discovered in other species. 
In order to follow the expression of PU.1 and Gata1, several transgenic fluorescent reporter 
mice have been created: One PU.1 reporter line was made by a knock-in of eGFP into exon 1 
of the PU.1 gene which replaced the expression of PU.1 itself (Back et al., 2004). Mice were 
kept heterozygously, because homozygous PU.1eGFP/eGFP embryos resembled the severe 
phenotype from PU.1 knock-out mice (Scott et al., 1994; McKercher et al., 1996). 
Investigation of erythroid progenitors of PU.1eGFP/eGFP embryos suggested low level 
expression of PU.1 and an important functional role in those cells. Similar effects were 
observed in adult PU.1wt/eGFP heterozygous animals, too. In another report with the same 
mouse line PU.1GFP was shown to be expressed in most GMPs, in 50% of CMPs, not in 
MEPs, in 50% of MPPs and in 25% of HSCs (Back et al., 2005). However, this knock-in 
approach is not suitable to follow PU.1 levels by fluorescence because of a potential different 
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half-life of eGFP and PU.1. Another PU.1 reporter mouse strain was created by knocking an 
IRES (internal ribosomal entry site)-GFP construct into the endogenous PU.1 locus (Nutt et 
al., 2005). As a result two different proteins were produced from one mRNA. The expression 
of the upstream wildtype PU.1 was supposedly unaffected by the downstream insertion which 
was supported by the notion that homozygous PU.1GFP/GFP mice   didn’t   have   a   phenotype.  
PU.1GFP was expressed in all HSCs, CLPs, GMPs, but not in MEPs. Most CMPs also 
expressed PU.1 and Flt3- CMPs exhibited a bimodal distribution with the GFPlow population 
being highly enriched for committed MegE progenitors. Notably, PU.1 and GFP exhibited a 
different half-life which made that mouse line not useful to quantify real endogenous PU.1 
protein levels. Instead, the supposedly best solution available for following PU.1 was a direct 
fusion of PU.1 to eYFP by a knock-in of the eYFP reading frame into the endogenous PU.1 
locus, right after the last codon (Kirstetter et al., 2006). No data about correct functionality of 
PU.1eYFP has been published yet. The question if that mouse line does not have a phenotype 
and proves to be a reliable reporter of PU.1 expression is part of this thesis.   
GFP Reporter mice for Gata1 have also been created (Iwasaki et al., 2005). In those animals 
the endogenous Gata1 locus remained untouched and the reporter construct was a randomly 
integrated transgene containing a promoter construct with all three known DNase 
hypersensitivity regions, all 6 Gata1 exons and GFP replacing Gata1 Exon 2. The mouse 
strain was used to identify Gata1GFP eosinophil-committed progenitor cells downstream of 
GMPs. Additionally, Gata1GFP was reported to be expressed in freshly isolated MEPs, but not 
in GMPs. In order to quantify endogenous Gata1 levels, this mouse strain was not useful.  
In a combined study using both the above mentioned PU.1wt/eGFP (eGFP knock-in into PU.1 
Exon 1) mice (Back et al., 2004) and the transgenic Gata1 GFP reporter mice (Iwasaki et al., 
2005) it was suggested that the activation of either PU.1 and Gata1 marks the specification of 
multipotent progenitor cells into cell with granulocytic/monocytic/lymphoid and 
granulocytic/monocytic/megakaryocytic/erythroid potential, respectively (Arinobu et al., 
2007). This could explain both the classical differentiation pathway through CLPs and CMPs 
and the existence of LMPPs. Due to the fact that both mouse lines expressed GFP as a 
reporter it was not possible to look at the simultaneous expression of PU.1 and Gata1 in 
individual cells. In order to do so, two different colors of fluorescent proteins have to be used.  
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4 Goals of the Thesis 
 
Fluctuating transcription factor networks are commonly believed to regulate myeloid lineage 
choice. In this thesis,   the   widely   accepted   ‘PU.1/Gata1   paradigm’   should   be   investigated  
experimentally. Additionally to an existing PU.1eYFP knock-in mouse line, another knock-in 
line that simultaneously allows the readout of Gata1 in living HSPCs should be created. The 
influence of the transcription factor fusions on hematopoiesis in the newly created 
PU.1eYFP/Gata1mCHERRY knock-in line should then be investigated in order to evaluate 
the relevance of the fluorescent reporters. The relative expression levels of PU.1eYFP and 
Gata1mCHERRY in well-defined HSPCs should be determined and newly discovered 
myeloid subpopulations should be characterized. Establishing HSC culture conditions should 
further allow the development of all myeloid lineages within a reasonable amount of time and 
the choice of proper markers should permit the lineage readout in vitro. At last, transcription 
factor kinetics and dynamics in primary differentiating HSPCs should be determined by time-
lapse imaging, single-cell tracking and continuous quantification of absolute molecule 
numbers in individual cell genealogies. 
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5 Results 
5.1  Generation of Gata1mCHERRY Knock-In 
5.1.1 Choice of Fluorescent Protein 
 
There was already a mouse line existing that contained a knock-in of eYFP fused to the 
reading frame of the endogenous PU.1 reading frame (Kirstetter et al., 2006). With the goal of 
generating another fluorescent protein knock-in into the Gata1 locus that did not overlap in its 
spectral properties with eYFP, the red fluorescent proteins mCHERRY and tdTOMATO 
(Shaner et al., 2004) were chosen. Gata1 overexpression has been shown to reprogram 
primary hematopoietic cells with neutrophil and monocyte potential into cells with an 
erythroid, eosinophil or basophil phenotype (Heyworth et al., 2002). In order to choose a 
suitable fusion protein for the Gata1 knock-in similar in vitro reprogramming experiments 
were performed. Both fluorescent protein candidates were each cloned as N- and C-terminal 
fusion and tested for their reprogramming efficiency of primary LMPPs that have a strong 
bias for the GM lineage under permissive myeloid culture conditions (Adolfsson et al., 2005). 
Wildtype Gata1 overexpression in LMPPs from C57BL/6 mice led to an increase of 
multipotent and MegE colonies in subsequent colony-forming assays from 15.3% to 91.9% 
 
Figure 5-1: Gata1 in a fusion with mCHERRY reprograms LMPPs as efficiently as wildtype Gata1            
LMPPs were sorted and infected with lentivirus containing the designated fusion proteins. After 24 h 
cells were subjected to a colony-forming assay that permits development of all myeloid lineages. 
Fluorescent colonies were scored after 1 week. Blast = blast colony; GEMMeg = granulocytic, 
erythroid, monocytic, megakaryocytic; MegE = megakaryocytic-erythroid; Meg = megakaryocytic; E = 
erythroid; GM = granulocytic-monocytic; M = monocytic; G = granulocytic. Data are mean ± standard 
deviation (n=3).  
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(Figure 5-1). Both the N- and C-terminal fusion of Gata1 with mCHERRY showed very 
similar reprogramming capacity leading to an increase of GEMMeg/MegE colonies to 88.1% 
and 84.7%, respectively. In constrast, both N- and C-terminal fusions of Gata1 with 
tdTOMATO were not as efficient in reprogramming and just lead to an increase of 63.0% and 
58.4%, respectively. Although mCHERRY was directly fused to Gata1, it did not change the 
reprogramming capacity in primary wildtype LMPPs, whereas the fusion to the double-sized 
tandem protein tdTOMATO led to a lower reprogramming capacity. Since PU.1 and Gata1 
directly interact with each other at the molecular level (Liew et al., 2006) and fusion proteins 
of both interactions partners could lead to a malfunction of the PU.1eYFP/Gata1-fluorescent 
protein complex, the Gata1 overexpression experiments were repeated in LMPPs from the 
PU.1eYFP mouse. Again, overexpression of Gata1 wildtype and Gata1 as a N- and C-
terminal fusion protein with mCHERRY increased GEMMeg/MegE output from 3.7% to 
80.8%, 81.7% and 89.1%, respectively, whereas Gata1 as a fusion with tdTOMATO just 
increased the output to 35.8% and 37.0% (Figure 5-2). Due to a lower reprogramming 
efficiency of tdTOMATO fusion proteins and in order not to change the expression levels of 
endogenous Gata1 expression levels by a different sequence at the start codon, it was decided 
to generate a C-terminal fusion knock-in with mCHERRY. 
 
 
 
Figure 5-2: Gata1 in a fusion with mCHERRY reprograms PU.1eYFP+ LMPPs as efficiently as wildtype 
Gata1                       
LMPPs of a PU.1eYFP mouse were sorted and infected with lentivirus containing the designated 
fusion proteins. After 24 h cell were subjected to a colony-forming assay that permits development 
of all myeloid lineages. Fluorescent colonies were scored after 1 week. GEMMeg = granulocytic, 
erythroid, monocytic, megakaryocytic; MegE = megakaryocytic-erythroid; Meg = megakaryocytic; E = 
erythroid; GM = granulocytic-monocytic; M = monocytic; G = granulocytic. Data are mean ± standard 
deviation (n = 2; except tdTOMATOGata1, n = 1). 
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5.1.2 Gata1mCHERRY Knock-In Strategy 
 
The knock-in strategy was completely designed in silico (Figure 5-3): First suitable restriction 
enzyme sites were chosen that upon successful knock-in of mCHERRY would lead to a 
significant restriction fragment length polymorphism (RFLP). Next, potential unique genomic 
sequences were identified in order to detect RFLPs by Southern blotting and a specific 
radioactively labeled probe. After checking the specificity of putative Southern probes on 
 
 
Figure 5-3: Gata1mCHERRY knock-in strategy                  
(a) Overview of Gata1mCHERRY knock-in strategy. BamHI and XbaI were chosen as suitable 
restriction enzymes in order to generate RFLPs for screening successful knock-ins. Genomic 
sequences for Southern probes were identified at designated locations. The final knock-in construct 
contained  a  5.0  kilo  base  pairs   (kbp)   long  5’  homology  arm   lasting  until the last codon of Gata1, a 
short linker sequence (AGAGCATCAGGTACCAGTGGAGCT), the open reading frame (ORF) of 
mCHERRY, a FRT-flanked Neomycin-resistance cassette (including a eukaryotic and a prokaryoctic 
promoter and a polyadenylation signal) and a 4.6 kbp  long  3’  homology  arm. (b) Complete sequence 
of endogenous Gata1 locus after successful knock-in. Underlined bases were removed after Flp-e 
mediated recombination of FRT-sites. 
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digested genomic C57BL/6 DNA (data not shown), the knock-in construct was cloned using 
classical restriction enzyme mediated cloning and recombineering (Yu et al., 2000). After 
sequencing and confirming the accordance with the in silico prediction, 25 µg of the final 
plasmid were linearized, purified and frozen for subsequent electroporation of ES cells. 
 
5.1.3 Screening of ES Cell Clones 
 
Electroporation and selection of JM8.N4 ES cells (Pettitt et al., 2009) were performed by Dr. 
Antje Bürger (EUCOMM, Institute of Developmental Genetics, Helmholtz Center Munich). 
Briefly, ES cells were electroporated, selected in Neomycin containing medium and 
individual clones were picked and kept separated. ES cell clones were then multiplied and 
either frozen in liquid nitrogen or subjected to Southern screening by myself. First, ES cell 
clones   were   screened   for   correct   integration   at   their   3’-end. Gata1 is located on the X 
chromosome. Hence, positively targeted male ES cell clones resulted in a single band shift 
from 11.1 kbp to 5.7 kbp (Figure 5-4a). The targeting efficiency was 30%. Positive clones 
were  further  checked  for  correct  integration  in  5’-direction by another Southern blot. 21% of 
investigated clones showed the expected band shift from 9.9 kbp to 11.1 kbp (Figure 5-4b). 
Two double-positive ES cell clones were then selected for thawing and expansion (Dr. Antje 
Bürger) in order to aggregate them with E2.5 CD1 morulas and transfer into pseudopregnant 
             
 
Figure 5-4: Positively targeted ES cell clones were identified by Southern blot                                          
Genomic DNA from ES cell clones was purified, subjected to restriction digest, agarose 
gelelectrophoresis and Southern blotting. RFLPs were identified by radioactively labeled probes. One 
representative example is shown   for   3’- (a) and   5’-Southern blots (b), respectively. The targeting 
efficiency  in  the  3’-Southern blot was 30% (29 out of 96 clones). Of those 24 were further checked 
for  correct  integration  at  the  5’-end. 21% (5) were positively targeted. 
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CD1 mice. ES cell aggregation was performed by Heide Oller (Institute of Diabetes and 
Regeneration Research, Helmholtz Center Munich). 
            
 
5.1.4 Genotyping of Gata1mCHERRY Mice 
 
The chimerism of the generated animals was estimated by coat color: Genetically pure CD1 
mice have a white coat, whereas progeny of the targeted ES cell line (on C57BL/6 
background) would have given rise to a dark coat. The chimerism of pups was up to 90% in 
favor of the targeted ES cell line, making it very likely that the JM8.N4 ES cells also gave rise 
to the germ line. In fact, progeny of one male animal mated with CD1 female mouse 
exclusively gave rise to dark colored pups, showing that Gata1mCHERRY+ animals are viable 
and fertile. The male chimera was then used for matings with a Flp-e deleter strain that 
constitutively expressed Flp-e recombinase (Turan and Bode, 2011) in order to excise the 
Neomycin cassette whose strong promoter activity could influence the expression levels of 
Gata1mCHERRY. Progeny was then genotyped by PCR for successful excision of the 
Neomycin resistance cassette, the presence/absence of the Flp-e transgene and the Gata1 
allele(s) (Figure 5-5). 
 
 
Figure 5-5: Genotyping of Gata1mCHERRY(-FRT-NEO-FRT) mice              
Progeny of Gata1mCHERRY-NEO-FRT-NEO mouse mated with a Flp-e deleter strain was genotyped by 
PCR. (a) Presence of the Flp-e transgene led to a 176 bp band. (b) The successful excision of the 
Neomycin resistance cassette led to a 223 bp band instead of a 387 bp band in the case of its 
presence. (c) Gata1 wildtype allele led to a 297 bp band, whereas Gata1mCHERRY allele led to 223 
bp band. Note that the Gata1 locus is on the X-Chromosome.  ‘+’  in  normal  writing  resembles  positive  
control. H2O negative controls did not contain template DNA. 
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5.1.5 Comparison of Fetal Livers from Wildtype and Gata1mCHERRY Mice 
 
Gata1 plays an important role during embryonic hematopoiesis (Pevny et al., 1991; Fujiwara 
et al., 1996). Since pups are born and survive into adulthood, Gata1 function in a fusion with 
mCHERRY is obviously not completely abolished. Still, Gata1 function could be impaired 
and alter normal (embryonic) hematopoiesis. In order to assess as early as possible if 
Gata1mCHERRY showed normal functionality and, hence, could be used as a reliable 
reporter, the composition of E14.5 fetal livers of Gata1mCHERRY+ pups was compared to 
C57BL/6 wildtype embryos of the same age. No major changes in the embryonic HSPC pool 
could be detected, demonstrating normal Gata1 function (Figure 5-6). HSC/MPP, CMP, 
GMP, MEP and most importantly erythroid progenitor numbers were not obviously altered.  
Therefore, Gata1mCHERRY knock-in mice were expected to also exhibit normal 
hematopoiesis in adult mice. The Gata1mCHERRY strain was then mated to the PU.1eYFP 
knock-in strain (Kirstetter et al., 2006). 
 
  
 
Figure 5-6: Gata1mCHERRY knock-in does not alter embryonic hematopoiesis              
Fetal livers (FL) of E14.5 embryos were collected, subjected to Ficoll-density centrifugation, pooled 
(C57BL/6 7 FLs, Gata1mCHERRY 6 FLs) and analyzed by flow cytometry with typical markers to 
discriminate HSCs/MPPs (Lin-,Sca-1+,c-Kit+), CMPs/GMPs/MEPs (Lin-,Sca-1-,c-Kit+)  and erythroid 
progenitors (CD71+ or -/Ter119+ or -). Shown are percentages of the parental gate. Upper panels: 
C57BL/6, lower panels: Gata1mCHERRY. 
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5.2 Functional Analysis of PU.1eYFP/Gata1mCHERRY Double Knock-In 
Mice 
5.2.1 Progeny of PU.1eYFP/wtGata1mCHERRY/wt Mice 
 
After successful removal of the Neomycin resistance cassette, Flp-e-Gata1mCHERRY+ mice 
were mated with PU.1eYFP+ mice for the generation of a double knock-in mouse. In order to 
generate homo-/hemizygous offspring for PU.1eYFP and Gata1mCHERRY, PU.1eYFP 
heterozygous and Gata1mCHERRY heterozygous female mice were mated with PU.1eYFP 
heterozygous and Gata1mCHERRY hemizygous male mice. Genomic DNA from pups was 
genotyped and Mendelian ratios of the offspring were determined (Table 5-1). The analysis 
showed that homo-/hemizygous animals were born with the same frequency as their 
heterozygous or wildtype counterparts, pointing out that the functionality of the fusion 
proteins does not confer any advantage or disadvantage to embryos. Double homo-
/hemizygous knock-in mice did not show any increased mortality in adulthood (spontaneous 
death rate < 2% out of 250 adult observed animals) and reached old ages without any obvious 
indications of hematopoietic diseases. All subsequent analyses were performed with adult 
PU.1eYFP homozygous, Gata1mCHERRY hemi-/homozygous animals at 12-18 weeks of age 
unless otherwise stated. 
 
 
 
 
 
Table 5-1: Homo-/Hemizygous PU.1eYFP/Gata1mCHERRY mice are born at Mendelian ratios   
Genotypes of in total 52 pups from the mating ♀ GATA-1mCHERRY/WT PU.1eYFP/WT x ♂ Gata1mCHERRYY 
PU.1eYFP/WT. Off. = offspring; Freq. = actual frequency; Exp. = expected frequency. 
Gata1 and PU.1 Off. Freq. Exp.  Gata1  Off. Freq. Exp. 
Gata1WTY PU.1WT/WT 3 5,8% 6,3%  Gata1WTY 9 17,3% 25,0% 
Gata1WTY PU.1WT/eYFP 5 9,6% 12,5%  Gata1mCHERRYY 15 28,8% 25,0% 
Gata1WTY  PU.1eYFP/eYFP 1 1,9% 6,3%  Gata1mCHERRY/WT 18 34,6% 25,0% 
Gata1mCHERRYY PU.1WT/WT 3 5,8% 6,3%  Gata1mCHERRY/mCHERRY 10 19,2% 25,0% 
Gata1mCHERRYY PU.1WT/eYFP 9 17,3% 12,5%      
Gata1mCHERRYY PU.1eYFP/eYFP 3 5,8% 6,3%  PU.1 Off. Freq. Exp. 
Gata1mCHERRY/WT PU.1WT/WT 2 3,8% 6,3%  PU.1WT/WT  10 19,2% 25,0% 
Gata1mCHERRY/WT PU.1eYFP/WT 11 21,2% 12,5%  PU.1eYFP/WT  30 57,7% 50,0% 
Gata1mCHERRY/WT PU.1eYFP/eYFP 5 9,6% 6,3%  PU.1eYFP/eYFP 12 23,1% 25,0% 
Gata1mCHERRY/mCHERRY PU.1WT/WT 2 3,8% 6,3%      
Gata1mCHERRY/mCHERRY PU.1eYFP/WT 5 9,6% 12,5%      
Gata1mCHERRY/mCHERRY PU.1eYFP/eYFP 3 5,8% 6,3%      
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5.2.2 Blood Counts of PU.1eYFP/Gata1mCHERRY Mice 
 
 
PU.1 and Gata1 are central blood-specific transcription factors. Fusions with fluorescent 
proteins do not lead to increased death rates of animals but in their role as important 
regulators normal hematopoiesis could be altered. Therefore, peripheral blood counts of 
PU.1eYFP/Gata1mCHERRY were analyzed and compared to wildtype C57BL/6 mice. 2 
individual mice from the PU.1eYPF/Gata1mCHERRY strain had increased white blood cell 
levels potentially due to an infection at the time of analysis (data not shown). Among the 
white blood cells the composition of lymphocytes, monocytes and granulocyctes was not 
altered. The amount of red blood cells was the same between two groups. The amount of 
hemoglobin in blood or red blood cells and the hematocrit were also comparable. Platelet 
counts were generally subjected to a high variance. Differences in the size of red blood cells 
and platelets could not be detected. In total, there was no significant difference between 
control and knock-in mice, leading to the conclusion that PU.1 and Gata1 as fusion proteins 
do not change steady-state hematopoiesis at the level of mature blood cells (Table 5-2). 
Neither did the results of the blood counts point to any anemia, specifically proofing the 
correct function of the erythroid master regulator Gata1. 
 
 
 
 
Table 5-2: Homo-/Hemizygous PU.1eYFP/Gata1mCHERRY mice have normal bloodcounts            
Peripheral blood counts from male C57BL/6 (n=6) and PU.1eYFP/Gata1mCHERRY (n=9) knock-in 
mice. A one-way multivariate analysis of variance (MANOVA) did not detect any significant difference 
between C57Bl/6 and PU.1eYFP/Gata1mCHERRY mice (p-value > 0.09). 
Value Unit C57BL/6 PU.1eYFP/Gata1mCHERRY 
White blood cells (wbc) /mm3 2.87 · 103 ± 1.72 · 103 6.17 · 103 ± 3.85 · 103 
   % Lymphocytes of  wbc % 78.78 ± 4.27 80.79 ± 6.95 
   % Monocytes of  wbc % 4.57 ± 0.67 4.6 ± 1.39 
   % Granulocytes of  wbc % 16.65 ± 3.70 14.61 ± 6.08 
      % Eosinophils of granulocytes % 5.8 ± 2.07 3.31 ± 2.05  
Red blood cells /mm3 10.11 · 106 ± 0.70 · 106 9.13 · 106 ± 1.71 · 106  
Platelets /mm3 9.77 · 103 ± 6.81 · 103  5.91 · 103 ± 3.74 · 103 
Hemoglobin g/dl 14.94 ± 1.05 13.01 ± 2.18 
Hematocrit % 52.65 ± 3.82  46.98 ± 9.10 
Mean corpuscular volume µm3 52.17 ± 0.98  51.33 ± 1.00 
Mean corpuscular hemoglobin pg 14.78 ± 0.20 14.31 ± 0.37 
Mean corpuscular hemoglobin concentration g/dl 28.38 ± 0.73 27.84 ± 0.96 
Red cell distribution width % 12.95 ± 0.23 13.49 ± 0.24 
Mean platelet volume µm3 6.31 ±  1.03 6.84 ± 0.37 
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5.2.3 Bone Marrow Analysis of PU.1eYFP/Gata1mCHERRY Mice 
 
In order to exclude that PU.1 and Gata1 as fusion proteins change hematopoiesis at the stem 
and progenitor cell level, bone marrow of PU.1eYFP/Gata1mCHERRY double knock-in mice 
was analyzed and compared to C57BL/6 wildtype bone marrow. First, the percentage of the 
 
Figure 5-7: Composition of wildtype and PU.1eYFP/Gata1mCHERRY bone marrow is comparable       
(a) FACS gating strategy for the identification of HSPC subpopulations. (b) Comparison of C57BL/6 
and PU.1eYFP/Gata1mCHERRY bone marrow according to the protocol of Akashi et al. (2000).  (c) 
Comparison of C57BL/6 and PU.1eYFP/Gata1mCHERRY bone marrow according to the protocol of 
Pronk et. al (2007). A one-way multivariate analysis of variance (MANOVA) did not detect any 
significant difference between C57BL/6 and Pu.1eYFP/Gata1mCHERRY mice for (b) and a slight 
significant difference (p < 0.03) for (c) due to megakaryocyte progenitors. Shown are mean ± 
standard deviation (n = 4). Lin- = lineage-negative cells; Prog = myeloid progenitors; MkP = 
megakaryocyte progenitors; CFU-E = colony-forming unit erythrocyte; Pro Ery = proerythroblasts. 
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‘LSK‘  gate (Lin-Sca-1+c-Kit+) (Osawa et al., 1996; Adolfsson et al., 2005; Kiel et al., 2005; 
Wilson et al., 2008) that contains the HSCs and MPPs, and the percentages of the myeloid 
progenitor   subpopulations   ‘common   myeloid   progenitors’   (CMPs), GMPs and MEPs were 
determined (Akashi et al., 2000). Additionally, the myeloid compartment was further 
analyzed following a more precise protocol to distinguish GM and MegE subpopulations 
(Pronk et al., 2007). Representative gating strategies for the identification of the respective 
subpopulations are shown in Figure 5-7a. The PU.1eYFP and Gata1mCHERRY double 
knock-in did not lead to an altered lineage output between the classical GM- and MegE-
compartment (Figure 5-7b). Due to their reprogramming potential an increased activity of 
PU.1 or Gata1 by a fusion to a fluorescent protein would have been expected to lead to a more 
prominent lineage output of the respective lineage. A more refined investigation of the 
myeloid compartment could detect a slight significant difference (p < 0.03) between wildtype 
and PU.1eYFP/Gata1mCHERRY mice (Figure 5-7c), which was not obvious by just 
comparing individual populations from both mouse strains. By using another staining to 
analyze the erythroid compartment with the markers CD71 and Ter119 during different 
erythroblasts stages (Zhang et al., 2003) no significant difference could be detected  (Figure 
5-8a) again. The levels of T-cells, B-cells and mature GM cells in bone marrow were not 
altered either (Figure 5-8b). In total, the comparison of wildtype and PU.1eYFP/Gata1- 
   
Figure 5-8: PU.1eYFP/Gata1mCHERRY mice have normal levels of erythroblasts, T-cells, B-Cells and 
mature GM-cells in bone marrow                    
(a) Comparison of bone marrow levels of different erythroblasts stages between wildtype and 
PU.1eYFP/Gata1mCHERRY mice. (b) Comparison of bone marrow levels of T-cells (CD3+), B-cells 
(CD19+/B220+) and mature GM cells (Mac-1+) between wildtype and PU.1eYFP/Gata1mCHERRY mice. 
Data are mean ± standard deviation (n = 4). A MANOVA for each panel did not detect any significant 
difference between wildtype and PU.1eYFP/Gata1mCHERRY mice. 
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mCHERRY bone marrow led to the conclusion that steady-state hematopoiesis at the 
progenitor cell level is not affected by fusions of the respective transcription factors to 
fluorescent proteins. 
 
5.2.4 Biochemical Stability of PU.1 and Gata1 and Their Respective Fusions 
 
Next, the biochemical stability of PU.1/PU.1eYFP and Gata1/Gata1mCHERRY, respectively, 
were compared in order to check if the fluorescent proteins change the half-life of the 
transcription factors. Freshly sorted PU.1eYFP+ progenitor cells were distributed into equal 
aliquots and cultured with cycloheximide, a chemical inhibitor of eukaryotic 
proteinbiosynthesis. After 1, 2 and 3 hours whole cell lysates were prepared and subjected to 
polyacrylamidgelelectrophoresis (PAGE) and Western blotting. PU.1 and PU.1eYFP were 
detected using an anti-PU.1 antibody and a secondary antibody catalyzing a 
chemiluminescent reaction. PU.1eYFP levels of whole cell lysates were always higher than 
PU.1 levels (Figure 5-9a). If that was the case due to different expression levels or an artefact 
like different blotting efficiency for PU.1 and PU.1eYFP was indiscernible. Surprisingly, both 
         
Figure 5-9: Transcription factors and their respective fusions have similar biochemical stabilities   
(a) PU.1+ progenitor cells were sorted, resuspended in medium containing 50 µg/ml cycloheximide, 
distributed to equal aliquots and whole cell lysates were obtained after 0, 1, 2 and 3 h  and stored at 
-20 °C until PAGE and Western blotting. (b) Equal numbers of cells from Gata1mCHERRY+ and 
wildtype E14.5 fetal livers were mixed, cultured in medium containing 50 µg/ml cycloheximide, 
distributed to equal aliquots and whole cell lysates were obtained after 0, 1, 3 and 5 h  and stored at 
-20 °C until PAGE and Western blotting. Protein levels were determined using chemiluminescence 
and quantification of intensity levels on a x-ray film. Shown are mean ± standard deviations (n = 3). A 
statistical test for differences between paired time-resolved observations did not detect any 
significant difference between WT and PU.1eYFP/GATA1mCHERRY mice (p>0.16) (Brand et al., 2013). 
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PU.1 and PU.1eYFP levels increased after 1 h. The general trend of both PU.1 and PU.1eYFP 
levels was comparable over 3 h of culture.  
The very same approach for comparing the stability of Gata1 and Gata1mCHERRY was not 
possible to do: Since the Gata1 locus is on the X chromosome, male mice are hemizygous for 
Gata1(mCHERRY) and cells from female mice exhibit random X chromosome inactivation at 
uncertain ratios. Compared to PU.1+ progenitors, Gata1+ progenitors are rarer and more 
fragile during the sorting procedure (data not shown). Therefore, it was decided to skip 
sorting and mix equal cell numbers of Gata1mCHERRY+ and wildtype E14.5 fetal liver cells 
which contain a high percentage of Gata1+ cells. Due to potential miscounts the expression 
levels were normalized each to initial Gata1 and Gata1mCHERRY levels at t = 0 h (Figure 
5-9b). Again, the general trend of Gata1(mCHERRY) expression levels over 5 hours of 
culture was comparable and exhibited a constant decline in both cases. 
 
5.2.5 Colony-Forming Potential of PU.1eYFP/Gata1mCHERRY Bone Marrow Cells 
 
As a last functional analysis, the colony-forming potential of freshly isolated PU.1eYFP/   
Gata1mCHERRY bone marrow cells was determined and compared to the potential of 
C57BL/6 wildtype cells. Possible malfunctions of the transcription factor fusions could still 
be masked in vivo through compensatory mechanisms of the organism. In fact, bulk bone 
marrow from the knock-in mice showed the same myeloid differentiation potential as bone 
marrow from wildtype mice (Figure 5-10). The assay used did not allow any lymphoid 
development. In conclusion, the comparison of double homo-/hemizygous 
PU.1eYFP/Gata1mCHERRY and C57Bl/6 mice in terms of their in vivo features like viable 
progeny, blood counts, bone marrow comparison at the progenitor cell level as well as in vitro 
features like biochemical stability and colony forming potential did not reveal any major 
differences. Therefore, the novel created PU.1eYFP/Gata1mCHERRY mouse strain was 
believed to be a truthful reporter for a live read-out of real endogenous transcription factor 
levels by fluorescence at any given timepoint. 
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5.3 Detection of Endogenous Transcription Factor Levels by Fluorescence 
5.3.1 Relative Expression Levels of PU.1eYFP and Gata1mCHERRY in HSPCs 
 
After generation of PU.1eYFP/Gata1mCHERRY double knock-ins and the analysis regarding 
the normal function of the fusion proteins in vivo and in vitro, relative protein levels of both 
transcription factors in HSPCs could be quantified by flow cytometry: Negative gates for the 
separation  of  signal  from  background  noise  were  set  in  such  a  way  that  ‘positive  signal’  from  
individual myeloid progenitor cell populations of wildtype C57BL/6 mice cells did not exceed 
1.0% in one experiment (Figure 5-11). 84.7% of multipotent HSCs (Lin-Sca-1+c-Kit+CD150+ 
CD48-CD34-) express PU.1eYFP, but no distinct Gata1mCHERRY expression could be 
detected compared to wildtype cells. Of the remaining 15.3% most cells are very close to the 
positive gate, making it likely that they are in fact PU.1eYFP positive, too, but fluorescence 
levels were below the sensitivity threshold: PU.1eYFP in HSCs could always be detected 
when freshly sorted cell were imaged right away (see Figure 5-24 below). Of  the  ‘LSK’  gate  
which besides 10% HSCs contains all different MPPs nearly all cells expressed PU.1eYFP 
(96.1%), whereas Gata1mCHERRY could only be detected in a very small fraction of cells 
                                               
Figure 5-10: In vitro colony-forming potential of PU.1eYFP/Gata1mCHERRY cells is not altered         
2 ·104 freshly isolated bone marrow cells from PU.1eYFP/Gata1mCHERRY and C57BL/6 mice were 
subjected to a colony-forming assay using Methocult M3434, containing serum and the cytokines 
SCF, IL-3, IL-6 and EPO. After 7 days of culture, colonies were scored according to their lineage 
potential. GEMMeg = granulocytic, erythroid, monocytic, megakaryocytic; MegE = megakaryocytic-
erythroid; Meg = megakaryocytic; E = erythroid; GM = granulocytic-monocytic; M = monocytic; G = 
granulocytic. Data are mean ± standard deviation (n = 3). A Wilcoxon rank sum test did not detect 
any significant difference between C57Bl/6 and PU.1eYFP/Gata1mCHERRY mice for every population 
independently (p-value > 0.2). 
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 (6.7% compared to 1.2% in wildtype cells). After gating for Lin-Sca-1-c-Kit+ myeloid 
progenitor cells (Figure 5-7), 4 populations emerged: PU.1eYFP+Gata1mCHERRY-, 
PU.1eYFPmidGata1mCHERRYmid, PU.1eYFPlow/-Gata1mCHERRYmid and PU.1eYFP-
Gata1mCHERRYhigh cells. When the antigens CD16/32 and CD34 where used to further 
subdivide the myeloid progenitors, it turned out that the previously reported CMP is not a 
homogeneous population, but a mixture of PU.1eYFP+Gata1mCHERRY- and PU.1eYFPlow/-
Gata1mCHERRYmid cells. GMPs are not homogeneous either, but they consist of mostly 
PU.1eYFP+Gata1mCHERRY- cells (87.2%) and PU.1eYFPmidGata1mCHERRYmid cells 
                
 
Figure 5-11: Simultaneous detection of PU.1eYFP and Gata1mCHERRY in primary cells reveals new 
hematopoietic subpopulations            
Bone marrow from wildtype C57BL/6 mice and PU.1eYFP/Gata1mCHERRY double knock-in mice was 
isolated and stained with different antibodies for the identification of HSPC subpopulations. One 
representative FACS density plots shows PU.1eYFP and Gata1mCHERRY fluorescent intensity for each 
designated cell type. Numbers in plots show mean abundance (%) in the respective quadrants (n = 4). 
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(11.7%). MEPs express nearly no PU.1eYFP (93.6%) but mostly only Gata1mCHERRY 
(92.5%). In conclusion, the simultaneous detection of PU.1eYFP and Gata1mCHERRY 
allowed the discovery of various hematopoietic subpopulations and the correction of current 
HSPC purification protocols. 
 
5.3.2 Relative Expression Levels of PU.1eYFP and Gata1mCHERRY in the Myeloid 
Compartment 
 
Additionally   to   the   expression   levels   of   PU.1eYFP   and   Gata1mCHERRY   in   the   ‘classic’  
myeloid subpopulations CMPs, GMPs and MEPs (Akashi et al., 2000), it was also interesting 
to further allocate the transcription factor levels in more refined myeloid subpopulations 
(Pronk et al., 2007) (for gating see Figure 5-7): Instead of using the marker CD34 for 
discriminating between the GM- and MegE-lineage, the markers CD150, CD105 and CD41 
were   used:   Like   in   the   case   of   ‘classic’  GMPs,   it   could   be   confirmed   that   the   ‘new’  GMP  
population consists of PU.1eYFPhighGata1mCHERRY- cells and PU.1eYFPhighGata1mid cells 
              
Figure 5-12: PU.1eYFP and Gata1mCHERRY expression levels can be allocated to certain myeloid 
subpopulations                     
PreGMs, GMPs, Pre MegEs, MkP (megakaryocytic progenitors), Pre CFU-Es (colony-forming unit 
erythrocyte), CFU-Es and Pro Erys (proerythroblasts) were identified as described (Pronk et al., 2007). 
Shown is one representative example of PU.1eYFP and Gata1mCHERRY expression among those 
subpopulations. 
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(Figure 5-12). In fact, CD16/32+CD34+ GMPs and CD16/32+CD150- GMPs strongly overlap 
functionally (Pronk et al., 2007) and phenotypically (data now shown). 
Both Pre MegEs and megakaryocytic progenitors (MkPs) clearly contribute to the newly 
discovered PU.1eYFPlow/-Gata1mCHERRYmid population. The already erythroid committed 
progenitor populations Pre CFU-Es, CFU-Es and Pro Erys instead account for the PU.1eYFP-
Gata1mCHERRYhigh population. Previously described Pre GMs are a mixture of mostly 
PU.1eYFPhigh, PU.1eYFPmidGata1mCHERRYmid and PU.1eYFPlow/-Gata1mCHERRYmid 
cells. That nicely overlaps with the published data about Pre GMs having mostly GMP 
potential   “although   rare   megakaryocytic   and/or   erythroid   elements   were   also   consistently  
observed  from  this  cell  population”  (Pronk et al., 2007). In summary, the majority of myeloid 
subpopulations had a characteristic profile of the endogenous transcription factors PU.1eYFP 
and Gata1mCHERRY expression, which will be of use to further discriminate specific cell 
types more accurately on top of the usage of cell surface antigens. 
 
5.3.3 Colony-Forming Potential of CMP Subpopulations 
 
 
In order to determine if the newly discovered PU.1eYFPhigh and Gata1mCHERRYmid 
subpopulations of CMPs were functionally different, they were subjected to a colony-forming 
assay under permissive conditions. For that, PU.1eYFPhigh or Gata1mCHERRYmid CMPs 
were sorted from fresh bone marrow and seeded at low density in medium under conditions 
that allow the differentiation of all myeloid lineages in methylcellulose. After one week the 
lineage outcome of clonogenic colonies was scored by cell and colony morphology. 
Additionally, benzidine staining was applied to stain for erythroid cell specific hemoglobin. 
PU.1eYFPhigh CMPs turned out to have granulocytic and/or monocytic lineage potential only 
(98.9%) and Gata1mCHERRY+ CMPs were highly restricted (96.0%) to the megakaryocytic 
and/or erythroid lineage (Figure 5-13). This finding has profound influence on the current 
model of hematopoietic hierarchy. Much published data relied on the existence of true CMPs 
(Akashi et al., 2000) which are now shown to rather be a mix of GMPs and MEPs.  
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5.3.4 Colony-Forming Potential of Myeloid Progenitors Discriminated by Only 
PU.1eYFP and Gata1mCHERRY   
 
 
Next, it was investigated which lineage potential the newly discovered Lin-Sca-1-c-Kit+ 
PU.1eYFPmid and Gata1mCHERRYmid cell population has. FACS analysis showed that this 
population has a Pre GM or GMP phenotype. It could be possible that due to the so far 
missing simultaneous PU.1/Gata1 readout and the relative rareness among the myeloid 
progenitors this population might be  a  ‘real’  CMP  with  multilineage  potential.  Additionally,  
the in vitro colony potential of PU.1eYFPhighGata1mCHERRY-, PU.1eYFPlow/-
Gata1mCHERRYmid and PU.1eYFP-Gata1mCHERRYhigh cells independently of any other 
markers   than   ‘LSK’   was   determined:   As   expected PU.1eYFPhighGata1mCHERRY- cells 
exclusively gave rise to granulocytic and/or monocytic colonies (Figure 5-14). PU.1eYFP-
Gata1mCHERRYhigh cells that have phenotypes of committed erythroid cells did not show 
any colony potential. PU.1eYFPlow/-Gata1mCHERRYmid cells which strongly overlap with 
                                              
 
Figure 5-13: CMP subpopulations are restricted to one lineage already              
PU.1eYFPhigh and Gata1mCHERRY+ CMPs were sorted and seeded in colony-forming assay medium 
Methocult M3434 under permissive conditions (serum, SCF, IL-3, IL-6, EPO). Colony potential was 
scored after one week by cell morphologies, colony morphologies and benzidine staining. Data is 
normalized to the amount of counted colonies. The mean clonogenicity was 55.5% and 40.8% for 
PU.1eYPFhigh and Gata1mCHERRY+ CMPs, respectively. Blast = myeloid blasts; GEMMeg = 
granulocytic, erythroid, monocytic, megakaryocytic; MegE = megakaryocytic-erythroid; Meg = 
megakaryocytic; E = erythroid; GM = granulocytic-monocytic; M = monocytic; G = granulocytic. 
Shown are mean ± standard deviation (n = 3).  
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Pre MegE and MkP cells mostly had megakaryocytic and/or erythroid lineage potential 
(82.8%). The remaining lineage potential was granulocytic/monocytic (8.4%) and GEMMeg 
(8.5%). Multilineage and megakaryocytic and/or erythroid potential could also be detected in 
PU.1eYFPmidGata1mCHERRYmid cells (each 11.3%). Though, the majority of the cells gave 
rise to granulocytic and/or monocytic colonies only (76.4%) which is expected from cells that 
mostly express CD16/32, the marker for GMPs. 
 
 
 
5.3.5 Fold-Changes of PU.1eYFP Levels Between Different HSPC Populations  
 
Unlike Gata1, PU.1 is already expressed in HSCs. During the lineage decision process 
between the GM- and the MegE-lineage, PU.1 levels either increase or go down to levels 
below the detection threshold, respectively. In the case of differentiation into MegE-lineages 
it is not known when and how long before definitive lineage choice Gata1 is being expressed. 
At   least   along   the   ‘classical’   differentiation   pathway   via   different   multipotent   progenitor  
levels   and   the   ‘CMP’   it   cannot   be   answered   from   snapshot   analysis, if there is a cell 
population where PU.1 and Gata1 are equally expressed and stochastic fluctuation takes 
                                    
 
Figure 5-14: PU.1eYFPmidGata1mCHERRYmid cells have mostly GM-lineage potential             
Myeloid progenitor cells were sorted according to Lin-Sca-1-c-Kit+ marker expression and designated 
fluorescent levels of PU.1eYFP and Gata1mCHERRY and subjected to a colony-forming assay in 
Methocult M3434 (serum, SCF, IL-3, IL-6, EPO). Colonies were scored after one week. Data are 
normalized to the amount of counted colonies. PU.1eYFP-Gata1mCHERRYhigh did not have colony 
potential anymore. Mean cloning efficiency of the other populations was between 32% and 40%. 
Blast = myeloid blasts; GEMMeg = granulocytic, erythroid, monocytic, megakaryocytic; MegE = 
megakaryocytic-erythroid; Meg = megakaryocytic; E = erythroid; GM = granulocytic-monocytic; M = 
monocytic; G = granulocytic. Shown are mean data ± standard deviations out of 3 independent 
experiments. 
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place. It is also important to mention explicitly that analysis shown so far reflect endogenous 
transcription factor levels. Those levels do not differ by magnitudes, but only several-fold, 
which makes it difficult to separate different populations just by their expression levels. In the 
case of PU.1eYFP levels of yet uncommitted ‘LSK’  cells  compared  to  committed GMP and 
MEP populations, the three different populations show overlapping histograms (Figure 5-15). 
In other words, single snapshot analysis of PU.1eYFP cannot lead to a definitive attribution to 
a cell population. One also has to bear in mind, that PU.1eYFP levels might change by 2-fold 
during one single cell-cycle simply due to the doubling of absolute PU.1eYFP numbers for 
expression maintenance during division. If there is any fluctuating transcriptional behavior it 
will be impossible to observe that in snapshot analysis. The only way to resolve those issues 
is to look continuously at the single cell level over time.  
 
 
 
5.4 Quantification of Transcription Factor Molecule Levels by Imaging 
5.4.1 Imaging of Freshly Sorted Progenitor Cells 
 
Different HSPC levels differ in their endogenous PU.1eYFP and Gata1mCHERRY levels by 
less than a 10-fold difference. In FACS-analysis different populations show partially 
overlapping fluorescence levels which leads to the question if those low differences can be 
resolved by epifluorescence microscopy in order to combine imaging quantification with  
                                            
 
Figure 5-15: PU.1eYFP levels overlap between different cell populations in snapshot analysis            
Designated cell populations were gated in FACS and PU.1eYFP distributions are being displayed as 
histograms. Data shows mean relative fluorescence differences ± standard deviations (n = 4).  
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well established long-term time-lapse microscopy (Eilken et al., 2009; Rieger et al., 2009). 
Therefore, PU.1eYFPhighGata1mCHERRY-, PU.1eYFPlow/-Gata1mCHERRYmid and 
PU.1eYFP-Gata1mCHERRYhigh cells were sorted and subsequently imaged (Figure 5-16). 
The differences between PU.1eYFPhigh and PU.1eYFPlow/- cells as well as the difference 
between Gata1mCHERRYmid and Gata1mCHERRYhigh cells from flow cytometry could be 
seen by subjective imaging analysis. When fluorescence levels were tried to be quantified by 
pixel intensities, it turned out that this cannot happen without a suitable background 
subtraction: Fluorescence intensity quantifications were massively dependent on microscope 
setup, lifetime of the light source and exposure time. Additionally, the illumination within one 
field of view was highly uneven (data not shown). The center part of one picture was 
generally much better illuminated than the corners and edges. That means that quantification 
of the very same object either in the bright center or in a dim area would have led to 
completely different results. Taken into account that transcription factor and, hence, 
fluorescence levels just differ by on average 2-3 fold between different cycle stages or cell 
populations, a proper imaging quantification would not have been possible. That is why a 
background estimation algorithm was developed in cooperation with the group of Prof. 
Fabian Theis (Institute of Computational Biology, Helmholtz Center Munich) 
(Schwarzfischer et al., 2011). In brief, the algorithm works in such a way that the background 
is estimated in every single picture that was subjected to imaging analysis. This allows correct 
quantification of fluorescent levels independently of the position within the picture and 
independently of the acquisition time and technical variability. All further analysis described 
below was performed using that algorithm. 
 
 
Figure 5-16: Quantification of transcription factor levels in imaging subjectively resembles intensity 
difference from flow cytometry                   
(a) Designated progenitor were sorted and subsequently imaged by epifluorescence microscopy (b). 
Scale bar is 50 µm. 
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5.4.2 Fluorescent Fold-Changes in Flow Cytometry and Imaging 
 
In order to determine if quantification of pixel intensities in imaging is an equally well and 
reliable method of fluorescence measurement as flow cytometry, the fold-changes of different 
hematopoietic progenitor cell populations were compared (Figure 5-17). The fold-changes in 
the PU.1eYFP fluorescent channel were well comparable between flow cytometry and 
imaging: The difference between PU.1eYFPhigh and PU.1eYFPmid expressing cells was 8.3-
fold ± 2.4-fold and 8.8-fold ± 1.3-fold, respectively. The difference between PU.1eYFPmid and 
PU.1eYFP- cells was 2.6-fold ± 0.7-fold and 3.8-fold ± 1.3-fold in flow cytometry and 
imaging, respectively. Equally good comparison was the result in the Gata1mCHERRY 
fluorescent channel, too. The difference between Gata1mCHERRYhigh and 
Gata1mCHERRYmid cells in flow cytometry and imaging was 2.2-fold ± 0.3-fold and 2.3-fold 
± 0.3-fold, respectively, and the difference between Gata1mCHERRYmid and 
 
Figure 5-17: Fold-changes of fluorescent intensities are comparable between FACS and imaging       
Three different Lin-Sca-1-cKit+ progenitor cell populations (PU.1eYFPhighGata1mCHERRY-, PU.1eYFPmid 
Gata1-mCHERRYmid, PU.1eYFP-Gata1mCHERRYhigh) were freshly sorted and subsequently imaged. 
Fold-changes of fluorescent intensities of PU.1eYFP and Gata1mCHERRY both in flow cytometry and 
imaging were quantified and compared. Shaded histograms represent corresponding WT C57BL/6 
cell populations (FACS) or typical cell areas on empty background (imaging). The dotted lines 
represent the 99%-quantile of negative cells (FACS) or background signal (imaging). Shown are means 
± standard deviation from three independent experiments. Figure was provided and adapted from 
Michael Schwarzfischer (Institute of Computational Biology, Helmholtz Center Munich).  
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Gata1mCHERRY- cells was 21.7-fold ± 5.6-fold and 17.5-fold ± 6.0-fold, respectively. A 
difference between flow cytometry and imaging could be found in regard of fluorescent 
detection of supposedly PU.1eYFP- and Gata1mCHERRY- cells.  Both  ‘negative’  populations  
could be better discriminated from real negative signals (C57BL/6 cells or background pixels) 
in imaging than in flow cytometry. A more detailed analysis can be found in the next chapter.  
 
5.4.3 Sensitivity and Dynamic Range in Flow Cytometry and Imaging 
 
Here, sensitivity is defined as the percentage of cells of a certain population that is above the 
detection   threshold   (99%  quantile)   of   ‘negative’   signal   in   a   fluorescent   channel.   ‘Negative’  
signal in flow cytometry means signal from wildtype C57BL/6 cells without fluorescent 
proteins and in imaging it means signal from background pixels from typical cell sizes. The 
dynamic range is defined as the fold-change (in decibel) between the 99% quantile of a 
fluorescent signal of a certain population and the detection threshold (99% quantile) of 
‘negative’  signal.  As  expected,  all  PU.1eYFPhigh cells, as determined by flow cytometry, were 
above the detection threshold in imaging (Figure 5-18). PU.1eYFPmid cells whose distribution 
in flow cytometry is only partially above the detection threshold (67.8% ± 15.0%) are nearly 
entirely (99.5% ± 0.4%) above the detection threshold in imaging. Hence, imaging is even 
more sensitive than flow cytometry for PU.1eYFP signals. In the Gata1mCHERRY channel, 
all Gata1mCHERRYmid and Gata1mCHERRYhigh cells are positive both in flow cytometry 
and imaging. Among Gata1mCHERRY- cells in flow cytometry which are mostly below the 
detection threshold (0.9% ± 0.5%) a significant amount of signal could be detected in imaging 
(38.0% ± 31.6%). Although this seems to be a lot, the impact of this signal detection does not 
alter the fold-changes between different populations in imaging which are the same in flow 
cytometry (Figure 5-17). The dynamic range for negative/low, middle and high PU.1eYFP 
and Gata1mCHERRY signals is significantly higher in imaging compared to flow cytometry. 
In conclusion, fluorescence quantification by measuring pixel intensities in imaging proves to 
be an even more sensitive and better resolving method than fluorescence quantification by 
flow cytometry. 
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5.4.4 Estimation of Transcription Factor Molecule Numbers in Primary Cells 
 
Modeling approaches can build an interesting framework to elucidate potential mechanisms 
that regulate transcription factor networks. They are partially built on experimental 
observations which are transformed into differential equations. A central aspect that has been 
elusive so far is how many transcription factor molecules exist in a single cell. In order to 
provide that central information (important transcription factor fluctuations would be more 
likely to happen at low molecule numbers), Western blot analysis with protein lysates from 
primary cells and a defined amount of recombinant protein were performed (Figure 5-19). 
Based on the known molecular weight of both the transcription factor fusions and the 
recombinant protein, molecule numbers per cell population (and per cell) could be calculated. 
For estimation of PU.1eYFP molecule numbers, PU.1eYFPhigh expressing progenitor cells and 
commercially available GFP were chosen. Since eYFP and GFP are very closely related 
  
 
Figure 5-18: Imaging is more sensitive and has a larger dynamic range than flow cytometry                
The upper panels show the PU.1eYFP (upper left) and Gata1mCHERRY (upper right) sensitivity (% of 
signals above detection threshold) for different hematopoietic progenitor populations both in flow 
cytometry and imaging. The lower panels show the dynamic ranges (fold-change between signal and 
‘negative’  signal)  for  PU.1eYFP  (lower  left)  and  Gata1mCHERRY  (lower  right)  for  flow  cytometry  and  
imaging, respectively. Data are mean ± standard deviation from three independent experiments. 
Figure was provided and adapted from Michael Schwarzfischer (Insitute of Computational Biology, 
Helmholtz Center Munich).  
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fluorescent proteins, the respective antibody can detect its epitopes equally well on both 
molecules. The estimation of Gata1mCHERRY molecule numbers was supposed to happen 
likewise with recombinant mCHERRY protein, sorted primary cells and an anti-mCHERRY 
antibody. Gata1mCHERRY+ progenitor cells were sorted in the first place but they are more 
fragile than PU.1eYFP+ progenitor cells (data not shown).   Additionally,   the   α-mCHERRY 
antibody  turned  out  to  be  a  magnitude  worse  than  the  α-GFP antibody. Therefore, fetal liver 
cells instead of bone marrow cells were chosen as source cells. Erythroid and, hence, 
Gata1mCHERRY+ cells are highly abundant in E14.5 fetal livers. By using whole litters of a 
pregnant mouse, enough cells could be provided and sorting times could be significantly 
decreased. 
 
 
 
 
 
 
Figure 5-19: Western blot analysis allows estimation of molecule numbers per cell                                 
(a) Whole cell lysates from 1.33 · 105 PU.1eYFP+ progenitor cells (Lin- Sca-1- c-Kit+) were loaded onto a 
polyacrylamidgel together with defined amounts of recombinant GFP. PU.1eYFP and GFP-bands were 
detected using an anti-GFP antibody. (b) 1.16 · 106 Gata1mCHERRY+ FL cells were loaded onto a 
polyacrylamidgel together with defined amounts of recombinant mCHERRY. Signals were quantified 
using a secondary antibody labeled with horseradish peroxidase and exposure to x-ray films 
detecting chemiluminescence. Shown is one representative example each from three independent 
experiments.  * Signal omitted due to uncomplete loading of sample. 
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5.4.5 Exact Calculation of Molecule Numbers in Flow Cytometry and Imaging  
 
With the knowledge of mean transcription factor molecule numbers in freshly sorted primary 
cells and the relative fold-changes between different populations in flow cytometry, molecule 
numbers in any other cell population could be calculated (Table 5-3). Gata1mCHERRY+ 
sorted fetal liver cells for Western blot analysis expressed 23.0 ± 9.3 · 103 Gata1mCHERRY 
molecules per cell. PU.1eYFP+ progenitor cells expressed on average 43.1 ± 10.6 · 103 
PU.1eYFP molecules. GMPs which highly overlap with that sorted population expressed 42.7 
± 11.7 · 103 molecules. The calculated molecule numbers for PU.1eYFPhigh and PU.1eYFPmid 
sorted cells (Figure 5-15) were 47.3 ± 12.9 · 103 and 5.9 ± 1.8 · 103, respectively. 
Gata1mCHERRYmid and Gata1mCHERRYhigh cells expressed 25.5 ± 12.3 · 103 and 54.6 ± 
23.8 · 103 Gata1 molecules, respectively. HSCs expressed only 8.1 · 103 ± 2.1 · 103 molecules 
Table 5-3: Average transcription factor protein numbers per cell               
The first two cell populations were used to determine average PU.1eYFP and Gata1mCHERRY 
molecule numbers per cell, respectively (Figure 5-19). Based on that information and from relative 
relationships in flow cytometry and imaging, transcription factor molecule numbers were calculated 
in all other cell populations. Detection thresholds for PU.1eYFP and Gata1mCHERRY are also shown 
for flow cytometry and imaging. * Imaging data are from freshly sorted PU.1eYFPhigh or 
Gata1mCHERRYhigh expressing cells and were mapped to PU.1eYFPmid and Gata1mCHERRYmid signals, 
respectively; GMP molecule numbers in imaging were mapped to HSC numbers. Data shows mean ± 
total error (variability in Western   blot   and   flow   cytometry   or   imaging)   from   ≥   3   independent  
experiments. n.d. = not determined; -- = cell population below detection threshold. Final protein 
numbers were provided and calculated by Michael Schwarzfischer (Institute of Computational 
Biology, Helmholtz Center Munich). 
Cell Population PU.1eYFP Gata1mCHERRY 
Flow Cytometry   
    PU.1eYFP+ LK progenitor 43.1 ± 10.6 · 103 n.d. 
    E14.5 Gata1mCHERRY+ fetal liver n.d. 23.0 ± 9.8 · 103 
    PU.1eYFPhighGata1mCHERRY- 47.3 ± 12.9 · 103 -- 
    PU.1eYFPmidGata1mCHERRYmid 5.9 ± 1.8 · 103 25.5 ± 12.3 · 103 
    PU.1eYFP-Gata1mCHERRYhigh -- 54.6 ± 23.8 · 103 
    HSC 8.1 ± 2.1 · 103 --  
    LSK 16.4 ± 4.3 · 103 --  
    GMP 42.7 ± 11.7 · 103 -- 
    MEP --  49.4 ± 21.4 · 103 
    Detection threshold (C57BL/6 GMPs) 4.4 ± 1.2 · 103 6.5 ± 3.8 · 103 
    Detection threshold (C57BL/6 MEPs) 4.7 ± 1.5 · 103 8.4 ± 4.6 · 103 
Imaging   
    PU.1eYFPhighGata1mCHERRY- 47.3 ± 12.9 · 103*  -- 
    PU.1eYFPmidGata1mCHERRYmid 5.5 ± 4.4 · 103 25.6 ± 16.3 · 103 
    PU.1eYFP-Gata1mCHERRYhigh -- 54.6 ± 23.8 · 103* 
    HSC 8.1 ± 2.1 · 103* -- 
    GMP 40.1 ± 4.7 · 103 -- 
    Detection threshold 1.1 ± 2.0 · 103 1.9 ± 4.4 · 103 
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per cell in flow cytometry and the whole LSK (Lin-Sca-1+c-Kit+) population expressed 16.4 ± 
4.3 · 103 on average. The concrete detection thresholds for PU.1eYFP in flow cytometry were 
4.4 ± 1.2 · 103 and 4.7 ± 1.5 · 103 for C57BL/6 GMPs and MEPs, respectively. Different cell 
populations seem to have different autofluorescence levels in flow cytometry, especially in 
the Gata1mCHERRY channel: Detection thresholds were 6.5 ± 3.8 · 103 in GMPs and 8.4 ± 
4.6 · 103 in MEPs, respectively. The previously described better sensitivity in imaging 
lowered the detection threshold down to 1.1 ± 2.0 · 103 for PU.1eYFP and 1.9 ± 4.4 · 103 for 
Gata1mCHERRY. Based on HSC molecule numbers at the time of sorting and the general 
proof about fluorescent fold-changes being reliable in imaging (Figure 5-17), estimation of 
molecule numbers could also be applied to below described long-term time-lapse imaging.  
 
5.5 Time-lapse Imaging 
5.5.1 Culture Conditions 
 
The culture conditions to follow HSC differentiation   in   culture   should   allow   ‘permissive’  
development of all myeloid lineages. Cells were cultivated in defined serum-free expansion 
medium (SFEM) developed specifically for hematopoietic cells. Without addition of 
cytokines cells did not proliferate and had very low colony-forming potential (data not 
shown). Therefore, the cytokines SCF, IL-3, IL-6, EPO and TPO were chosen to be added to 
the medium. SCF is important for HSC survival, proliferation and differentiation. Moreover, 
it is expressed at least until GMP and MEP stages (Ashman, 1999). IL-3 and IL-6 are general 
differentiation and proliferation cytokines. EPO is essential for the development of mature 
erythroid lineages. TPO is similarly important for proper development of the megakaryocytic 
lineage. Additionally it is involved in HSCs maintenance (Metcalf, 2008). In order to test 
differentiation potential of freshly sorted HSCs in vitro, cells were cultured for 4 – 6 days and 
analyzed for expression of CD16/32 and Gata1mCHERRY (Figure 5-20a). CD16/32 is a 
well-established marker for defining fresh GMPs from bone marrow (Akashi et al., 2000). 
Since Gata1mCHERRY could only be detected in MegE cells (except the 
PU.1highGata1mCHERRYmid post-GMP population), it was hypothesized that 
Gata1mCHERRY expression itself comes along with lineage commitment. During a 7 day 
culture of HSCs, its expression does not overlap with the expression of Gata1mCHERRY 
(data not shown). CD16/32+ cells (3.6%) and Gata1mCHERRY+ (7.0%) cells could be 
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detected on day 4 of culture. The percentage of CD16/32+ cells increased considerably on day 
5 and 6 (28.9%; 42.4%), whereas the percentage of Gata1mCHERRY+ cells remained 
relatively low (2.4%; 2.9%). The colony-forming potential of individual HSCs was analyzed 
after 5 – 7 days of liquid culture (Figure 5-20b). Most colonies still contained many cells 
without any obvious lineage commitment (CD16/32 expression or megakaryocyte 
morphology) at the time of analysis (data not shown). 75.1% of colonies contained GM-
committed cells, but no megakaryocytes. On the contrary, 9.7% of all colonies contained 
megakaryocytes but no CD16/32+ cells. 8.0% of all colonies could be attributed to both GM 
cells and megakaryocytes and 7.1% did not exhibit any lineage commitment yet. In 
conclusion, the chosen culture conditions allowed the development of both GM and 
megakaryocyte lineages. Variation of the culture conditions did not change lineage outcome 
significantly in colony assays (data now shown). Without further marker usage the potential 
detection of erythroid cells was not possible. 
 
 
Figure 5-20: Culture condition allows development of both GM- and MegE-lineages            
Analysis of HSCs cultured in SFEM and SCF, IL-3, IL-6,   EPO,   TPO   and   α-CD16/32-AlexaFluor 647 
antibody. (a) Flow cytometric population analysis of HSCs cultured for 4 - 6 days (d4, d5, d6). 
CD16/32 and Gata1mCHERRY expression were interpreted as markers for GM- and MegE-lineages, 
respectively. Notably, more than 50% of all cultured cells did not express any of both markers on day 
6 yet (day 4: mean from n = 3; day 5/6 n = 1). (b) Individual HSCs were cultured spatially separated 
and colony potential was examined after 5 – 7 days of culture. CD16/32 was used as a marker for 
GM-lineage and megakaryocyte morphology was used as marker for megkaryocytic colony potential. 
On day 5 - 7, the majority of all colonies still contained cells that could not attributed to any lineage 
yet. Figure denotes colonies that contain GM cells (GM), megakaryocytes (Mega), GM cells and 
megakaryocytes (GMMeg) or none of both lineages (Ø). Data are mean from 3 independent 
experiments  with  ≥  79  colonies  per  experiment. 
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5.5.2 Markers for Lineage Commitment 
  
In order to investigate if CD16/32 and Gata1mCHERRY expression could be used as truthful 
markers for the GM and the MegE lineage, respectively, positive cells were sorted on day 4 of 
culture and subjected to further analysis (Figure 5-21): As a gating control, cultures of 
C57BL/6 cells were kept in parallel (data not shown). The PU.1eYFP and Gata1mCHERRY 
negative gate was drawn in such a way that it contained all cells from the culture of wildtype 
cells without fluorescent proteins (Figure 5-21a). CD16/32 expression was positively 
correlated with levels of PU.1eYFP and mutually exclusive with Gata1mCHERRY 
expression. PU.1eYFP-Gata1mCHERRY-, PU.1eYFP-Gata1mCHERRY+ and PU.1eYFP+ 
CD16/32+ cells were subjected to a colony-forming assay that generally allows differentiation 
into all myeloid lineages (Figure 5-21b). PU.1eYFP-Gata1mCHERRY- cells (compared to 
C57BL/6 culture) mostly (86.7%) gave rise to granulocytic and/or monocytic colonies. 8.4% 
of sorted cells gave rise to megakaryocytic colonies and 4.9% of cells gave rise to erythroid, 
 
Figure 5-21: CD16/32 and Gata1mCHERRY expression can be used as markers for lineage 
commitment                  
(a) HSC cultures of PU.1eYFP/Gata1mCHERRY mice with CD16/32-AlexaFluor 647 live antibody 
staining were subjected to sorting on day 4 of culture. Gates were drawn according to C57BL/6 
culture kept in parallel (data not shown). One representative example out of three independent 
experiments is shown. (b) PU.1eYFP-Gata1mCHERRY- (clonogenicity 47.1%), PU.1eYFP-
Gata1mCHERRY+ (clono-genicity 17.2%) and PU.1eYFP+CD16/32+ cells (clonogenicity 47.0%) were 
subjected to a colony-forming assay under permissive conditions. GEMMeg = granulocytic, erythroid, 
monocytic, megakaryocytic; MegE = megakaryocytic-erythroid; Meg = megakaryocytic; E = erythroid; 
GM = granulocytic-monocytic; M = monocytic; G = granulocytic Data are mean ± standard deviation 
out of 3 independent experiments. (c) PU.1eYFP-Gata1mCHERRY+ (left panel) and 
PU.1eYFP+CD16/32+cells (right panel) were subjected to a cytospin analysis. Scalebar = 10 µm. 
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megakaryocytic/erythroid or granulocytic/erythroid/monocytic/megakaryocytic (GEMMeg) 
colonies. CD16/32 proved to be a very reliably marker for the GM-lineage, since all colonies 
(100%) derived from CD16/32+ cells could be attributed to that lineage. 86.9% of PU.1eYFP-
Gata1mCHERRY+ cells gave rise to megakaryocytic colonies, the remaining ones were GM-
colonies. Colonies with erythroid cells could not be found among those cells, although the 
medium allowed the development of erythroid colonies (compare to PU.1eYFP-
Gata1mCHERRY- cells). Additionally, the clonogenicity of PU.1eYFP-Gata1mCHERRY+ 
cells (17.2%) was clearly lower than from PU.1eYFP-Gata1mCHERRY- and 
PU.1eYFP+CD16/32+ cells (47.1% and 47.0%) which led to the assumption that 
Gata1mCHERRY+ cells from HSC in vitro cultures lack erythroid colony-forming potential. 
Therefore, the sorted cells were subjected to a cytospin which allows classification of primary 
cells according to histological staining (Figure 5-21c). CD16/32+ cells exhibited a myeloblast 
phenotype whereas Gata1mCHERRY+ cells were significantly smaller (data not shown) and 
resembled an erythroblast phenotype. In conclusion, as soon as cells turn on CD16/32 in vitro 
they were committed to the GM-lineage. On the other hand, the vast majority of 
Gata1mCHERRY+ cells was committed to the MegE-lineage. Hence, both events could be 
used as markers for live lineage readout in time-lapse imaging. 
 
5.5.3 Generation of Cell Genealogy Trees 
 
Time-lapse imaging and single-cell tracking of freshly sorted HSCs was performed for up to 
one week. Due to exponential proliferation and culture overgrowth, tracking was not possible 
longer because the time interval of brightfield pictures every 1.5 min was not sufficient to 
keep single-cell identity. The longer the movie ran, the higher the probability of losing 
individual cells was. Fluorescent pictures of PU.1eYFP and Gata1mCHERRY were acquired 
every 30 min and CD16/32 expression was checked every 4 h. Gata1mCHERRY expression, 
megakaryocyte morphology and CD16/32 expression were manually annotated (Figure 5-22). 
No obvious transient Gata1mCHERRY or CD16/32 positive stages could be observed. When 
either marker was started to be expressed, it remained detectable until the end of imaging. 
Like in flow cytometric analysis of HSC cultures Gata1mCHERRY and CD16/32 expression 
were mutually exclusive (compare to Figure 5-21a). Cell death was a very rare event. Only 
3.7% of all tracked cells that were not lost in tracking during their life-time died. That 
included many cells at the end of movies when medium was used up. In general, sister cells  
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and even more distantly related cells exhibited a high degree of synchronism in their cell 
cycle lengths, but cells with asymmetric fate (like different cell-cycle length or different 
lineage outcome) could also be observed occasionally. In conclusion, this approach allowed 
the required quantification of PU.1 and Gata1 protein expression in living HSPCs throughout 
their differentiation into GM or MegE lineages. 
 
5.5.4 Individual Time Courses of Transcription Factor Dynamics in Primary Cells 
 
Based on the cell genealogies, PU.1eYFP and Gata1mCHERRY expression was quantified in 
differentiating multipotent HSCs before, during and after lineage choice. Endogenous protein 
levels with absolute molecule numbers were calculated and displayed (Figure 5-23). After cell 
divisions, PU.1eYFP and Gata1mCHERRY levels were symmetrically distributed between 
both daughter cells and signal intensity dropped by half. Asymmetric distribution of 
transcription factors could not be observed. In accordance with flow cytometric analysis, all 
HSCs and several daughter cell generations expressed PU.1eYFP. Cells were considered 
Gata1mCHERRY-positive when 5 consecutive timepoints were twice above the detection 
threshold of 1900 molecules. In the case of cells differentiating into the GM-lineage, 
Gata1mCHERRY was never expressed before cells were definitely committed (CD16/32 
expression) (Figure 5-23, upper panel). In other words, multipotent HSCs and their progeny 
did not pass through a PU.1eYFP/Gata1mCHERRY double positive state during GM-lineage 
choice, which would be the prerequisite for PU.1/Gata1 interdependent fluctuations. As soon  
 
Figure 5-22: Time-lapse Imaging Allows Generation of Cell Genealogy Trees        
HSCs were cultured for up to seven days, tracked at the single-cell level and cell genealogy trees 
were created. Up to 11 consecutive cell divisions could be followed. Manual annotations show 
Gata1mCHERRY expression (red), megakaryocyte morphology (purple) and CD16/32 expression 
(green).  No  transient  Gata1mCHERRY  or  CD16/32  positive  stages  could  be  observed.  ‘X’  =  cell  death;  
‘?’  =  single cell identity was lost. 
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as Gata1mCHERRY could be detected, cells and their progeny remained Gata1mCHERRY 
positive until the end of the movie and PU.1eYFP dropped below threshold levels or 
remained at low levels (Figure 5 23, middle and lower panel). Gata1mCHERRY expression 
onsets could be as early as 50 h after moviestart or anytime later until the end of the movie. A 
formal double-positive state with even stoichiometrically balanced 
PU.1eYFP/Gata1mCHERRY levels could be observed occasionally, but neither 
interdependent fluctuations nor another outcome than further Gata1mCHERRY upregulation 
and PU.1eYFP downregulation could be detected. This double-positive state was also 
observed in flow cytometric analysis of freshly isolated bone marrow: PU.1eYFPlow/-
Gata1mCHERRYmid cells were already committed to the megakaryocytic-erythroid lineage 
(Figure 5-14). Hence, the double-positive state of differentiating HSCs and their progeny did 
not have any functional relevance. Furthermore, PU.1eYFP was already downregulated (see 
 
Figure 5-23: PU.1/Gata1 interdependent fluctuations do not precede GM/MegE lineage choice           
Panels show continuous PU.1eYFP (blue) and Gata1mCHERRY (red) protein number quantifications in 
consecutive daughter cells in a time interval of 30 min. Upper panel shows cell traces that 
differentiate into GM-cells (CD16/32+, green). Middle panel show cells traces of a cell that will 
commit to the MegE-lineage (yellow) without further morphological features (Gata1mCHERRY wins). 
Lower panel shows a cell genealogy that differentiates into a megakaryocyte (Gata1mCHERRY wins, 
yellow, and megakaryocyte morphology, purple). All individual timepoints were manually inspected. 
If quantification was not possible at a certain timepoint, it was excluded from analysis. Horizontal 
black lines in graphs denote Gata1mCHERRY detection threshold of 2100 molecules. Vertical dashed 
lines denote cell divisions. For clarity, only one daughter cell is shown per generation, respectively.  
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also Figure 5-24 below) many generations before the actual Gata1mCHERRY onset which 
shows that Gata1mCHERRY was not the initial cause of PU.1eYFP downregulation (Figure 
5-23, middle and lower panel). 
 
5.5.5 Summary of Time Courses of Transcription Factor Dynamics in Primary 
Cells 
 
The above mentioned examples only depict PU.1 and Gata1 expression in individual differen-
tiating cells. To illustrate their expression behavior in a large number of differentiating cells, 
all single-cell time courses are summarized in Figure 5-24.  GM-committed cells (normalized 
to onset CD16/32+ to t = 0 h) emerge as a population by constant upregulation of PU.1eYFP 
without an intermediate PU.1eYFP/Gata1mCHERRY double-positive state. The population of 
committed MegE-cells (Gata1mCHERRY+) emerges out of the starting population first by 
 
Figure 5-24: Lineage commitment in primary HSPCs takes place without passing through a 
PU.1eYFP/Gata1mCHERRY double positive state                 
Summary of all tracked and manually inspected single-cell time courses from continuous time-lapse 
imaging. Timepoints denote time relative to lineage commitment t = 0 h (Gata1mCHERRY or CD16/32 
onset). The light blue oval indicates the starting population of PU.1eYFPlow HSCs/early MPPs. n-
numbers show datapoints that contributed to the respective panel. Summary of 102 individual HSC 
colonies, with 167 cells in the first generation (after division of starting cell) with in total 349 
Gata1mCHERRY onsets and 348 CD16/32 onsets from 3 independent experiments. Figure provided 
from Michael Schwarzfischer (Institute of Computational Biology, Helmholtz Center Munich). 
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downregulation of PU.1eYFP followed by upregulation of Gata1mCHERRY. The summary 
of all time-courses fit to the representative examples described above (Figure 5-23).  
 
5.5.6 Stoichiometry between PU.1eYFP and Gata1mCHERRY 
 
PU.1eYFP levels were always quantifiable until they reached the detection limit. In that case 
cells had already upregulated Gata1mCHERRY and were committed to the MegE-lineage, so 
detection issues for PU.1eYFP are not relevant for the question of myeloid choice. With the 
current experimental setup and sensitivity, no PU.1eYFP/Gata1mCHERRY double-positive 
stage could be observed in cells that differentiated into the GM-lineage. Therefore, the 
minimal molecule numbers of PU.1eYFP have to be taken into account and have to be 
compared to the detection limit of Gata1mCHERRY. 44.1% of all GM-traces increased their 
PU.1eYFP levels during differentiation compared to initial values in freshly sorted 
multipotent HSCs (Figure 5-25a). 16.5% of all cells GM-traces never dropped below 104 
PU.1eYFP molecules. Surprisingly, 53.1% of all GM-traces  ‘dropped’  their  PU.1eYFP  levels  
below initial values, before PU.1eYFP then was upregulated and CD16/32 onset could be 
detected later. Although lower than HSC starting values, 19.7% of all GM-traces never 
dropped below 104 molecules. The biological meaning of this phenomenon is not clear. 
Independently  of  ‘dropping’  behavior,  only  1.8% of all GM-traces fell below 2000 molecules. 
All remaining GM-traces remain above 2000 molecules and, hence, the vast majority of GM-
traces stoichiometrically outbalanced any potential Gata1mCHERRY molecules below the 
detection threshold of 1900 molecules all the time.  
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Figure 5-25: PU.1eYFP stoichiometrically exceeds potential present Gata1mCHERRY below 
detection levels in the vast majority of GM-traces                        
Panels include 218 traces of CD16/32-onsets from three independent experiments. The mean 
PU.1eYFP molecule numbers of the first three timepoints of every generation are plotted, in order to 
be independent from cell cycle stages. PU.1eYFP levels either never fell below the initial PU.1eYFP 
levels (a) or passed through an intermediate state with PU.1eYFP levels below the initial value (b). 
Initial values were calculated by setting the mean of the distribution of the initial PU.1eYFP value 
(mean of the first three timepoints of the start of the movie) to 8.1 · 104. Percentages denote traces 
of all GM-traces that are always above 104 or are below 104, 8 · 103, 6 · 103, 4 · 103 or 2 · 103, 
respectively, at least once. Individual CD16/32+ can originate from the same starting cell. Cells with 
their lowest PU.1eYFP value in the last generation were excluded from the analysis (2.8%). 
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5.5.7 Transcription Factor Dynamics in Definite Multipotent Cells 
 
In vitro differentiation experiments have been carried out with HSCs. Despite their 
multipotency, sister cells (even in early generations) and their progeny often but not always 
differentiated into the same lineage (see Figure 5-22). Manual tracking did not always lead to 
completely analyzed trees. Instead of generating complete trees, which is highly laborious, 
tracking was preferentially performed in many different colonies in order to investigate the 
transcription factor dynamics in many different clones. Due to time issues those trees were 
mostly fragmented. Still, some definite multipotent cells could be detected by time-lapse 
imaging whose progeny gave rise both to cells of the GM- and the MegE-lineage (Figure 
5-26). The general observations mentioned above about no transient Gata1mCHERRY stages 
and upregulation of PU.1eYFP in the case of GM-lineage choice and downregulation of 
PU.1eYFP already before Gata1mCHERRY onset in the case of MegE-lineage choice were 
equally well observable here. Therefore, all data above (Figure 5-23 to Figure 5-25) can be 
used trustfully to interpret transcription factor dynamics in myeloid lineage choice, although 
the majority of genealogy trees were not analyzed completely (and therefore not definitely 
multipotent). Data from multilineage trees revealed that multipotent cells before lineage 
choice did not express any Gata1mCHERRY making fluctuating transcription factor networks 
again very unlikely to be the cause of myeloid lineage choice. Additionally, PU.1eYFP 
protein number dynamics behaved very similarly in sister cells whose progeny will either 
commit to the GM- or the MegE-lineage, respectively. Hence, PU.1eYFP upregulation does 
not seem to be the initial cause of GM-lineage commitment. Although the progeny of one 
sister cell will differentiate into the MegE-lineage, Gata1mCHERRY could not be detected 
during the life-time of that very same cell, but only up to 4 generations later only. This also 
strongly argues against Gata1 being the MegE lineage deciding. In summary, neither does a 
PU.1eYFP/Gata1mCHERRY double-positive multipotent cell state exist nor do PU.1eYFP 
and Gata1mCHERRY dynamics in committing cells point to any specific behavior although 
the progeny of sister cells will differentiate into opposing lineages. Therefore, it could be 
shown that, in contrast to the current opinion in the field, the PU.1-Gata1 stochastic switch is 
not responsible for GM versus MegE lineage choice. 
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                        (to be continued) 
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Figure 5-26: PU.1eYFP and Gata1mCHERRY do not exhibit different behavior in cells that will 
differentiate into GM- and MegE cells, respectively                 
Examples of multilineage trees that contain cells that will commit both to the GM- and the MegE-
lineage. (a)-(g) Each panel contains (from bottom to top) the tracked and inspected cell genealogy 
tree, Gata1mCHERRY protein numbers and PU.1eYFP protein numbers. Grey cells and traces denote 
still multipotent cells. Green cells and traces denote cells that will commit to the GM-lineage. Yellow 
cells and traces denote cells that will commit to the MegE-lineage. Grey boxes denote cells that most 
likely will make the lineage decision. The generation before the grey boxes was definitely still 
multipotent. ‘?’  =  Cell  lost  during  tracking;  ‘X’  =  Cell  died  during  tracking. 
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6 Discussion 
6.1 Experimental	  Investigation	  of	  the	  ‘PU.1/Gata1	  Paradigm’ 
 
The   ‘PU.1/Gata1   paradigm’, suggesting PU.1 and Gata1 being a stochastic switch, has 
emerged as an interesting and intuitive model about myeloid lineage choice between the GM- 
and MegE-lineage, respectively. It is based on several experimental observations: (i) Both 
transcription factors have been shown to be the master-regulators  of  ‘their’  lineages.  Knock-
out experiments of PU.1 and Gata1 in both embryonic (complete knock-out) and adult 
(conditional knock-out) backgrounds have demonstrated their absolute necessity for proper 
development  of  ‘their’  mature  lineages  (Pevny et al., 1991; Scott et al., 1994; Fujiwara et al., 
1996; McKercher et al., 1996; Iwasaki et al., 2005; Gutierrez et al., 2008). PU.1 and Gata1 are 
very powerful transcription factors, because upon ectopic overexpression they are able to 
reprogram   other   celltypes   to   ‘their’   lineages   (Visvader et al., 1992; Kulessa et al., 1995; 
Nerlov and Graf, 1998; Heyworth et al., 2002).  (ii)  The  phenomenon  of  ‘lineage  priming’  has  
led to conclusion that opposing lineage-specific genes (like PU.1 and Gata1) are already 
expressed at low levels in presumptive multipotent cells (like HSCs, MPPs and CMPs). This 
assumption is mostly based on RNA-data from Northern blot analysis of cell populations and 
later from microarrays and from sensitive single-cell RT-PCR (Crotta et al., 1990; Heberlein 
et al., 1992; Cross et al., 1994; Hu et al., 1997; Delassus et al., 1999; Akashi et al., 2003). (iii) 
PU.1 and Gata1 can both positively autoregulate themselves via binding sites in their own 
promoters and UREs (Tsai et al., 1991; Chen et al., 1995; Crossley et al., 1995; Li et al., 
2001; Nishikawa et al., 2003; Okuno et al., 2005) and   also   mutually   inhibit   each   other’s  
transcriptional activity by binding to each other (Zhang et al., 1999; Nerlov et al., 2000; 
Zhang et al., 2000; Rekhtman et al., 2003; Liew et al., 2006). Therefore, PU.1 and Gata1 have 
been suggested to be the central elements of a fluctuating transcription factor network that 
directly competes for myeloid lineage choice ultimately elicited by a stochastic event that 
leads to a strong imbalance and one factor dominating the other (Cross and Enver, 1997; 
Orkin, 2000; Cantor and Orkin, 2001; Graf, 2002; Laiosa et al., 2006; Iwasaki and Akashi, 
2007; Orkin and Zon, 2008). As a result one factor is being highly upregulated and initiates 
lineage specific target gene expression along with strong repression of the other factor and 
opposing lineage specific target genes. Although very attractive, the PU.1/Gata1 stochastic 
switch model has never been proven experimentally and both conflicting and insufficient data 
leave the hypothesis at least questionable: (i) Knock-out experiments of PU.1 and Gata1 
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showed   the   essentiality   of   both   factors   for   mature   cells   of   ‘their’   lineages,   but   closer  
investigation allowed in both cases the discovery of lineage-committed progenitors cells 
implying that both factors might not be absolutely essential for myeloid lineage choice 
(Fujiwara et al., 1996; McKercher et al., 1996; Iwasaki et al., 2005; Iwasaki et al., 2005; 
Gutierrez et al., 2008).   (ii)   ‘Lineage   priming’   in   terms of simultaneous PU.1 and Gata1 
expression has never been shown at the protein level. Some studies used GFP as a reporter for 
either PU.1 or Gata1 and could already show that not all HSCs, MPPs or CMPs expressed 
GFP reflecting PU.1 or Gata1 expression (Back et al., 2005; Nutt et al., 2005; Arinobu et al., 
2007). (iii) All biochemical studies about direct interaction of PU.1 and Gata1 have been 
carried out in cell lines involving strong overexpression of both proteins or in leukemic cell 
lines which are (amongst other aspects) leukemic because of constant expression of one factor 
leading to a differentiation block and proliferation of committed blast cells (like PU.1 
expression in erythroleukemia). (iv) To date, no experimental proof about fluctuating 
behavior of PU.1 and Gata1 has been adduced because cells (single or populations) have only 
been analyzed at single time points. Cell populations exhibit are large degree of heterogeneity 
and must not be expected to behave synchronously (Huang, 2009). In addition, any potential 
fluctuations have to be investigated at the single-cell level, otherwise the data will get lost in 
population noise.   
In order to properly investigate the transcription factor dynamics, novel knock-in mouse lines 
were generated and used to simultaneously readout endogenous protein levels in individual 
living primary cells by fluorescence. By using advanced long-term time-lapse imaging at the 
single cell level which allows generation of cell genealogies over many generations and novel 
quantification methods, PU.1eYFP and Gata1mCHERRY expression levels were 
continuously quantified before, during and after the process of lineage choice. In cell 
genealogies that differentiated into GM-cells Gata1mCHERRY expression could never be 
detected. In cells with onset of Gata1mCHERRY expression, it was always followed by 
lineage commitment to the MegE-lineage. In conclusion, no data was found that supported the 
hypothesis that PU.1 and Gata1 as parts of a transcription factor network are directly involved 
in lineage choice. Importantly, the prerequisite of both factors being co-expressed (in 
stoichiometric numbers) before lineage choice was missing in the vast majority of cells. 
Additionally, PU.1eYFP downregulation before Gata1mCHERRY detection was often 
observed, demonstrating that other factor(s) than Gata1 are controlling that downregulation. 
Hence, the experimental analysis of PU.1 and Gata1 expression levels over time suggested 
that myeloid lineage choice is not essentially controlled by the PU.1/Gata1 stochastic switch. 
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The   existence   and   relevance   of   the   ‘PU.1/Gata1   paradigm’   remains   highly   questionable. 
Several aspects of the experimental approach and the biological conclusions will be discussed 
below.  
 
6.2 Choice of Knock-In Approach and Effects on Functionality 
 
For the relevance of this project, it was crucial to investigate real endogenous protein levels. 
Therefore, most of the published reporter lines were not suitable: Both existing PU.1 GFP-
reporter lines were not made as knock-in fusion proteins, but either as GFP knock-in into 
exon 1 of PU.1, thereby abolishing and replacing PU.1 expression from one locus, or as a 
knock-in of an IRES-GFP construct into the endogenous PU.1 locus (Back et al., 2005; Nutt 
et al., 2005). In the first case, mice were only heterozygously expressing PU.1, which might 
influence its proper function, and GFP has a different half-life and does not reflect 
endogenous PU.1 levels by altered decay rates. The latter approach allowed the generation of 
bicistronic mRNA and, hence, the possibility that both PU.1 and GFP are being transcribed 
from the same mRNA molecule. However, different decay rates of PU.1 and GFP again might 
not allow proper readout of PU.1 expression levels through GFP. Additionally, expression of 
the second gene (in this case GFP) was expected to be significantly lower compared the first 
gene (in this case PU.1) in the bicistronic mRNA (Mizuguchi et al., 2000), potentially leading 
to detection problems due to low GFP expression and to wrong conclusions.  
Gata1 GFP reporter mice were generated using another approach (Iwasaki et al., 2005): The 
mice carried a randomly integrated transgenic construct harboring the Gata1 locus with a GFP 
knocked into exon 2 and all three known DNase hypersensitivity sites in the promoter region. 
Besides again potentially different half-lives of Gata1 and GFP another problem was that yet 
undiscovered regulatory elements might have been missed and not included into the 
transgenic construct. Additionally, the random integration into the genome might change 
expression of closely located genes. However, irrelevant GFP levels and again wrong 
conclusions about endogenous Gata1 expression would be the consequence. 
Therefore, in order to read out endogenous transcription factor levels, the technical best 
solution is a fusion protein between the transcription factor and fluorescent protein 
homozygously expressed from the endogenous locus. In the case of PU.1, such a mouse line 
(PU.1eYFP) had been published (Kirstetter et al., 2006). Unfortunately, no data about the 
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functionality of the mouse line was available, but at least no phenotypes were known so far 
(personal communication with Prof. Dr. Claus Nerlov). In a complementary approach within 
this project a Gata1mCHERRY knock-in line was made. Although technically the best 
solution, the fusion of fluorescent proteins to the transcription factors must not change its 
functionality, otherwise it is worthless for proper biological conclusions. Interestingly, Gata1 
in a fusion with the fluorescent protein tdTOMATO was not as efficient in reprogramming 
LMPPs to the megakaryocytic-erythroid lineage as wildtype Gata1 or Gata1 in a fusion with 
mCHERRY. Whether this effect was due to steric issues of altered protein stability cannot be 
answered here. This demonstrates that fluorescent proteins have to be chosen with care.  
In general, eYFP and mCHERRY do not seem to be toxic to the cells, because heterozygous 
(and more importantly homo-/hemizygous) mice with fusion proteins are born. Fusion to 
fluorescent proteins does obviously not abolish the transcription factors function, otherwise 
no homo/hemizygous offspring would be born (Gata1) or survive long enough after birth 
(PU.1). Those phenotypes would be expected because of the embryonic knock-outs without 
any transcription factor being expressed at all. Blood counts of adult double homo-
/hemizygous PU.1eYFP/Gata1mCHERRY mice were analyzed and no significant difference 
compared to wildtype C57BL/6 mice could be found. Since blood is a very complex organ 
with a lot of compensatory mechanisms, steady-state hematopoiesis at the stem and 
progenitor level was also investigated: Again, the abundance of many different well defined 
progenitor cell types was nicely comparable between knock-in and wildtype mice. 
Additionally, in vitro colony-forming potential of bulk bone marrow was not altered in knock-
in mice. Dysregulated, hypormorphic mouse models of both PU.1 and Gata1 have been 
demonstrated to develop highly prevalent leukemia (Takahashi et al., 1997; Rosenbauer et al., 
2004; Shimizu et al., 2004). On the other hand, deregulated ectopic expression of one 
transcription factor often leads to a differentiation block in the opposing lineage and to 
proliferation of blast cells, like PU.1 overexpression in erythroleukemia (Moreau-Gachelin et 
al., 1988; Moreau-Gachelin et al., 1996). Therefore, if the knock-in of open reading frames of 
fluorescent   proteins   into   the   endogenous   loci   had   changed   regulatory   sequences   in   the   3’-
UTRs or altered the overall stability of the fusion proteins compared to wildtype transcription 
factors, leukemias would have been expected to be observed. But neither blood counts nor 
bone marrow analysis pointed to any leukemia development. Additionally, double knock-in 
mice survived into old age and spontaneous death (e.g. due to leukemia) did not occur. 
Ultimately, the biochemical stability of wildtype transcription factors and their respective 
fusions was compared after cycloheximide treatment and no differences could be found. 
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Gata1 and Gata1mCHERRY exhibited a constant decay. Unexpectedly, PU.1 and PU.1eYFP 
showed even an increase in expression after the start of cycloheximide treatment. Importantly, 
the wildtype and fusion protein behaved the same way, showing that biochemical stability is 
not altered. 
In conclusion, PU.1eYFP and Gata1mCHERRY fusion proteins proved themselves as fully 
functional transcription factors and reporter proteins at the same time. Since double knock-in 
mice expressed PU.1eYFP and Gata1mCHERRY homozygously (hemizygously for 
Gata1mCHERRY in male mice), no wildtype protein was produced anymore from the 
endogenous locus and all fluorescence intensity can directly be correlated with expression 
levels of the transcription factors. In imaging it could be observed that all fluorescence is 
exclusively located, as expected for active PU.1 and Gata1, in the nuclei of cells. 
After verification of its normal functionality, the PU.1eYFP/Gata1mCHERRY double homo-
/hemizygous knock-in mouse line was then used to elucidate the expression levels in defined 
HSPCs by flow cytometry. Unlike other PU.1-GFP reporter strains, PU.1eYFP could be 
detected in nearly all HSCs and MPPs. The other studies only observed subpopulations that 
expressed GFP, showing that the knock-in approach here is more suitable to readout complete 
PU.1 expression (Back et al., 2004; Nutt et al., 2005). Even GMPs which were exclusively 
PU.1eYFP+ were not reported to be entirely GFP+, leaving the value of previous reporter lines 
questionable at best. In terms of Gata1 expression the published data using a transgenic GFP 
reporter accorded with the Gata1mCHERRY expression in HSCs, MPPs and MEPs (Arinobu 
et al., 2007). In previous analyses at least 35% of CMPs were GFP+, reading out either PU.1 
or Gata1 expression. By now using two different fluorescent proteins, it was possible for the 
first time to readout PU.1 and Gata1 expression simultaneously. Interestingly, the CMP 
population was clearly divided into cells that exclusively expressed PU.1eYFP only or 
Gata1mCHERRY (and still low levels of PU.1eYFP). This clear separation became even 
more meaningful when those two distinct populations were sorted and used in a permissive 
colony-forming assay: The presumptive CMP was already pre-committed into the MegE- or 
the GM-lineage. This has far-reaching consequences for the interpretation of a lot of 
published data which assumed the CMP to be the true mother cell of GMPs and MEPs.  
Evidently, the phenomenon of lineage priming could not be reproduced at the protein level by 
flow cytometric analysis. Simultaneous PU.1eYFP and Gata1mCHERRY expression could 
not be observed in any defined cell population between multipotent HSCs and lineage-
restricted GMPs and MEPs. The only true PU.1eYFP/Gata1mCHERRY double-positive 
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population has a clear GMP phenotype and never significantly gave rise to MegE-cells in 
colony-forming assays. The low percentage of MegE-colonies was probably due its close 
proximity to the PU.1eYFPlowGata1mCHERRYmid cells in flow cytometry that overlap with 
the pre-MegE population. One observation of the knock-in approach was that endogenous 
transcription factor levels differ by only 2 – 3-fold between different defined HSPCs. As a 
consequence, the populations are not clearly discriminable by PU.1eYFP and 
Gata1mCHERRY levels without further markers. The PU.1eYFP/Gata1mCHERRY double 
positive GMP subpopulation will rather be important for the development of the post-GM 
lineages eosinophils, basophils and mast cells (Martin et al., 1990; Zon et al., 1993; Iwasaki et 
al., 2005). From the missing double expression of PU.1eYFP and Gata1mCHERRY in still 
multipotent cells it could be inferred that a simultaneous balanced expression of PU.1 and 
Gata1 cannot be the reason for cells remaining multipotent for all myeloid lineages. 
Alternatively, PU.1/Gata1 fluctuation could be a transient  state   that  has  to  be  ‘turned  on’   in  
the first place. Therefore, the whole differentiation process from multipotent cells to 
committed GM- and MegE-lineages was followed continuously at the single-cell level in 
vitro. 
 
6.3 Continuous Time-Lapse Imaging 
 
After the discovery that CMPs are not true multipotent for all myeloid lineages but already 
pre-committed, they obviously were not a suitable population to follow in vitro differentiation 
and transcription factor dynamics. MPPs which constantly upregulate PU.1eYFP depending 
on their maturation stage have a strong bias for the GM-lineage. This phenomenon is also 
reflected by the existence of the LMPP (Adolfsson et al., 2005). Therefore, it was decided to 
use true multipotent long-term reconstituting HSCs for in vitro differentiation experiments. 
The protocol for the prospective isolation of HSCs combined two different approaches and 
purity of the stem cell population was expected to be at least 50%. This remarkably high 
percentage was deduced from single-cell transplantation experiments which demonstrate that 
one single HSC can reconstitute the whole blood system of lethally irradiated recipient mice 
(Osawa et al., 1996; Kiel et al., 2005). By this gold-standard proof of stemness it could be 
assumed that the majority of all HSCs used for time-lapse imaging experiments were truly 
multipotent. 
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One important issue of choosing HSCs as starting cells was the fact that HSCs would need 
more time to differentiate than for example MPPs because they are more immature. As a 
consequence, tracking of individual tree genealogies was much more laborious: If a single 
HSC and all its progeny divided symmetrically 10-times and no individual cells were lost 
during the tracking process, it would have led to 1024 (210) final cells and a tree consisting of 
in total 2047 cells. Just one more generation of cells would have led to 2048 (211) final cells 
and a tree with in total 4095 cells. In other words, every single generation more increases the 
tracking time by more than 2-fold. First, the bulk cell numbers increases by the factor 2 and 
second tracking of later generations is more difficult and time-consuming because of the 
exponential increase in cell density of the culture dish. Therefore, the culture conditions for 
time-lapse imaging experiments had to be chosen under certain aspects: (i) They had to allow 
the differentiation process in a reasonable amount time that allows keeping single-cell identity 
until the time point of lineage commitment. (ii) They had to allow development of all myeloid 
lineages. (iii) Ideally, culture condition should consist of defined components to later allow 
targeted manipulations of culture conditions in order investigate the individual effects of 
culture components. As a result, serum which is commonly used in in vitro differentiations 
was omitted. In serum-free cultures, cytokines are an essential component with allows 
differentiation of various lineages. Cytokines are highly pleiotropic and influence both many 
different hematopoietic cell types and many different cell processes like survival, 
proliferation, migration and maturation. To which extent cytokines control also differentiation 
in terms of lineage choice has been elusive for many years. Recently, the cytokines M-CSF 
and G-CSF have been demonstrated to be instructive, i.e. directly influencing lineage choice 
of GMPs (Rieger et al., 2009). Cytokine conditions were therefore chosen in a way that all 
lineages to be analyzed can be generated from HSCs. SCF was an obvious choice because it is 
essential for the culture of HSCs. Furthermore, its receptor c-Kit is expressed at least until 
GMP and MEP stages. It has general pro-survival and pro-proliferative effects. EPO was 
added to allow survival and proliferation of committed erythroid cells. Instructive influence 
on cells has never been demonstrated (Wu et al., 1995). The main reason for addition of TPO 
was its positive effect on development of the megakaryocytic lineage. TPO has also been 
shown to influence HSCs (Ema et al., 2000). In combination with SCF it was published as a 
condition that maintains HSCs. IL-3 and IL-6 were added as general pro-differentiation 
cytokines. They are mostly important for the development of GM-lineages. In combination 
with SCF and EPO, IL-3 and IL-6 (and serum) are used in commercially available standard 
assays to determine the myeloid potential of myeloid cells. In relation to the in vitro 
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differentiation of HSCs within one week of culture, the conditions led to a definite GM- or 
MegE-lineage choice in 50% of cells. Practically, under current physical culture conditions 
longer tracking is hardly possible. Therefore, the amount of true multilineage trees within 7 
days of culture cannot be determined easily because individual colonies often did not contain 
cells with definite GM- or MegE-fate yet. Compared to Gatat1mCHERRY+ (marker for 
MegE-lineage) cells, CD16/32+ (marker for GM-lineages) cells were always more abundant. 
Here, it has to be taken into account that GM-committed cells never stopped proliferating 
after marker onset. In contrast, erythroid-committed cells did not survive long enough in the 
cultures and megakaryocytes at some point stopped proliferating  but  only  ‘divided’  internally  
doing endomitosis. Therefore, the imbalance of Gata1mCHERRY+ and CD16/32+ cells on 
day 5 – 7 does not necessarily reflect an imbalance in lineage choice. Nonetheless, under the 
chosen culture conditions and many other similar conditions, there is a bias towards GM-cells 
at the expense of MegE-cells. The best readout for multipotent colonies under similar culture 
conditions is only after day 10 – 12 (personal communication with Dirk Löffler). Tracking 
that long and deep into individual tress is not feasible at the moment. Nevertheless, shorter 
tracking as performed here is good enough because the in vitro differentiation process from 
multipotent HSCs to committed myeloid cells could be followed. 
Having investigated PU.1eYFP and Gata1mCHERRY transcription factor dynamics in 
individual  HSCs  under   ‘permissive’  conditions,   the   influence  of  several  culture  components  
can now be tested experimentally and compared to the basic description of PU.1eYFP and 
Gata1mCHERRY behavior. Individual cytokines can either be omitted completely or added 
additionally or concentrations of cytokines can be altered and their influence on the 
transcription factor dynamics can be tested. Besides the manipulation of external signals, it is 
also possible to influence the transcription factor network directly: This includes both the 
direct manipulation of PU.1 and Gata1 by either (temporal) knock-down or (temporal) 
overexpression. Overexpression can nicely be achieved by lentiviral delivered tamoxifen 
sensitive ER fusion proteins: In theory, they consists out of the transcription factor, optionally 
a fluorescent protein (in eYFP/mCHERRY or any different color) and a tamoxifen-sensitive 
variant (ERT) of the estrogen receptor. Ideally, those proteins are expressed and stay in the 
cytoplasm. Upon tamoxifen-induction they move to the nucleus and can exert their function 
as transcription factors. The advantage of this system is its theoretical rapidness, titratability 
and reversibility. Alternatively, other transcription factors can be added or knocked-down and 
the influence on the core transcription factors PU.1 and Gata1 can be tested.  
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6.4 Endogenous Protein Numbers and Their Implications for Biology 
 
In order to better understand the stoichiometric differences between PU.1eYFP and 
Gata1mCHERRY levels, Western blot analysis with a defined amount of PU.1eYFP+ 
progenitor cells and Gata1mCHERRY+ FL cells and defined amount of recombinant GFP or 
mCHERRY, respectively, were performed. The reason for choosing those populations was 
that they are quite abundant and sorting effort and time is reasonable for the amount of cells 
to receive. Additionally, both cell populations express high amounts of transcription factors. 
Still, the amount of protein was at the lower end of standard curves which were fairly at the 
detection limit of Western blotting. Despite of antibody optimization, signal intensities could 
not be increased. Protein lysate from even more cells could have been purified, but due to 
longer sorting times, cell survival would have decreased and cells would have been longer out 
of the bone marrow leaving the relevance of protein quantifications doubtful.   
From the relative differences in flow cytometry molecule numbers from all other HSPCs of 
interest could be inferred. By using background calculation algorithms, quantification of 
endogenous transcription factor levels was also possible in imaging (Schwarzfischer et al., 
2011). Although flow cytometry is very sensitive technology, image quantification even 
proved to have a higher dynamic range (fold-change   to   ‘negative’   signals)   and   more  
importantly sensitivity in quantifying low signals was even increased. However, every 
quantification technology has a certain detection limit. PU.1eYFP detection limit in imaging 
was 1.1 ± 2.0 · 103. PU.1eYFP is expressed in HSCs and clearly above background levels. In 
image quantification, a PU.1eYFP- HSC has never been found. On the contrary, only 80% 
HSCs in flow cytometry were definitely PU.1eYFP+. During differentiation into GM-cells 
PU.1eYFP intensity never dropped below the detection threshold. In cells differentiating into 
the MegE-lineage, PU.1eYFP was only not detectable anymore when cells already had 
committed and expressed Gata1mCHERRY. Therefore, the biological conclusion for 
PU.1eYFP levels dropping below detection levels is irrelevant for the questions addressed 
here because this happened only after lineage commitment to the MegE-lineage. 
The detection threshold for Gata1mCHERRY in imaging was 1.9 ± 4.4 · 103 molecules. In 
cells that differentiated into MegE cells, PU.1eYFP had already been downregulated before 
Gata1mCHERRY could be detected. Gata1 can prevent PU.1 from binding to its co-factor c-
Jun which further could interfere which the positive autoregulatory loop of PU.1. Due to the 
stoichiometric imbalance in favor of PU.1eYFP, Gata1mCHERRY seems very unlikely to be 
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the initial cause of PU.1eYFP downregulation. During differentiation of cells into the GM-
lineage Gata1mCHERRY was never detected and fluctuations of PU.1eYFP and 
Gata1mCHERRY as a mechanism seem to be very unlikely. Nonetheless, in order to critically 
interpret that result, one has to assume that – although unlikely – ‘real’   Gata1mCHERRY  
levels might always have been just below the detection threshold. Following this idea, half of 
all GM-traces never even dropped below the initial PU.1eYFP levels of 8.1 · 103 molecules. 
That means that more than half of all GM-traces always exhibited at least a 4-fold excess of 
PU.1eYFP over Gata1mCHERRY. Among the majority of all other GM-traces PU.1eYFP 
still exhibited a stoichiometric overbalance over Gata1mCHERRY. In conclusion, a 
theoretical stoichiometric balance of PU.1eYFP and Gata1mCHERRY in still multipotent 
cells was rarely the case (1.8%). Gata1mCHERRY was never transiently expressed but only 
always led to a sustained future expression and lineage choice into MegE cells, which was 
proven by sorting Gata1mCHERRY+ cells and subjecting them to a cytospin or a colony-
forming assay. 
All above mentioned interpretations rely on the presence/absence of transcription factors in 
general and more specifically on the dynamics of their molecule numbers over time. 
Fluorescent signals were always detected in the nuclei of cells only and, therefore, also 
assumed to be active. In order to verify true transcriptional activity one could try to deliver 
specialized reporter constructs into primary cells. Such constructs could be derived from 
published constructs that harbor multiple binding sites for PU.1 or Gata1, a minimal promoter 
and the ORF for luciferase (Zhang et al., 1999; Zhang et al., 2000). Those constructs were 
used to determine transcriptional activity in cell lysates at the population level by a 
photometric assay. Instead of killing the cells and providing the substrate for the enzymatic 
reaction, the readout could be transferred to the single-cell level by cloning fluorescent 
reporters after the promoters. Then, by choosing another color than eYFP or mCHERRY 
transcriptional activity could be readout together with transcription factor levels and potential 
correlations with the protein numbers of PU.1 and Gata1 could be investigated.   
 
6.5 Implications of Primary Data for Mathematical Modeling 
 
Several studies tried to transform the experimental observations of lineage priming, positive 
autoregulation and mutual cross-antagonism of PU.1 and Gata1 into mathematical models in 
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order to test the hypothesis of a switch-like  behavior  by  one  factor  being  ‘defeating’  the other  
leading directly to lineage choice (Roeder and Glauche, 2006; Huang et al., 2007; 
Chickarmane et al., 2009; Duff et al., 2012; Strasser et al., 2012). All models built their 
assumptions, equations and parameters just on relative expression levels. After having 
quantified real endogenous protein dynamics and numbers for the first time here, those can be 
taken into account and confer much more relevance to modeling approaches. Besides now 
being able to continuously quantify protein number dynamics, recent technological advances 
have allowed to quantify specific mRNA numbers at the single-cell level by digital RT-PCR 
(Warren et al., 2006): Whole RNA samples from single primary cells are reversely transcribed 
into cDNA and diluted into 1200 portions on a microfluidic chip, so that each individual 
portion contains either none (mostly the case) or one cDNA template of the gene of interest. 
Then, highly sensitive PCR with specific primers amplifies the cDNA of interest. The 
amounts of successful PCR reactions from all individual microfluidic chambers corresponds 
to the numbers of original cDNAs and, hence, mRNAs: The mean amount of PU.1 mRNA in 
21 individual tested HSCs was as low as 8.5 per cell. In that study GMPs were not 
investigated, but Flt3+ CMPs which overlap well with GM pre-committed CMPs were 
reported to express 21.7 PU.1 mRNAs per cell (mean). That further means that one single 
mRNA serves as the template for 1000 PU.1 molecules in every HSC (mean PU.1eYFP 
expression level 8100). With that knowledge, the bottle neck of PU.1 production seems to be 
the amount of mRNAs. In order to get more insights into production rates, PU.1eYFP and 
Gata1mCHERRY primary could be exhibited to the established method of fluorescence 
recovery after photobleaching (FRAP) (reviewed in Ishikawa-Ankerhold et al., 2012): The 
existing fluorescent proteins linked to PU.1 or Gata1 can be bleached in live-cell imaging and 
fluorescence will only be detected again when new molecules will be produced. From the 
dynamics of fluorescent intensities, production rates in any cell-type of choice can be inferred. 
Complementary to that, protein decay rates can also be quantified by fluorescent signal 
decline in time-lapse imaging at the single-cell level (data now shown, manuscript in 
preparation). Instead of using magnitudes more of cells for classical determination of decay 
rates in Western blot, around 100 cells are already enough to quantify protein decay in 
imaging. Besides the advantage of saving a lot of time and effort for population analysis, 
single-cell analysis has the additional advantage of being able to detect heterogeneities in 
protein decay rates from a presumptive homogeneous cell population. In conclusion, primary 
data from single-cell analysis will contribute to better be able to model biological 
observations in a systems biology approach. As a result modeling approaches are well able to 
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propose further experiments in order to answer specific experimental question which then will 
again help to improve the models. 
Although the PU.1/Gata1 switch does not seem the essential mechanism of myeloid lineage 
choice,  both  factors  have  central  importance  for  the  development  of  their  ‘lineages’.  Instead  
of necessarily being the decision makers, the PU.1/Gata1 interaction network seems more 
importantly to be a lock-down mechanism that allows terminal differentiation into GM- or 
MegE-cells in order to prevent blast stages from uncontrolled proliferation. Indeed, PU.1 and 
Gata1 expression levels are often deregulated in myeloid leukemias (Burda et al., 2010). In 
addition, the theoretical frame-work of a stochastic switch behavior can still be valid for other 
lineage choices and in other cellular systems. Furthermore, the dynamics of PU.1 and Gata1 
and the importance of a switch-like behavior in regard of differentiation into eosinophils, 
basophils and mast cells from GMPs still need to be elucidated using the same technical 
approach as applied to the investigation of GM- versus MegE-lineage choice. Additionally, 
other knock-in lines with interesting transcription factor candidates (like Gata2,   C/EBPα,  
Runx1, SCL) with different colors can still be made and added to the already existing 
PU.1eYFP/Gata1mCHERRY knock-in line. Since emission spectra of fluorescent molecules 
can share a significant of overlap, sophisticated imaging approaches like linear unmixing have 
to be used (Zimmermann, 2005). That approach allows the correct calculation of signal 
contribution of individual fluorophores to emission spectra. Moreover, new technologies like 
strong LED excitation sources of defined wavelengths will contribute to make excitation of 
fluorophores more specific and, hence, live-cell imaging less toxic.  
 
6.6 Relevance for Myeloid Lineage Choice in vivo 
 
The  investigation  of  the  ‘PU.1/Gata1  paradigm’  here  has  been  carried  out  by  isolating  primary  
HSCs and differentiating them in vitro under constant cytokine conditions that are very 
unlikely to overlap with the real in vivo conditions. In order to confer more realistic 
conditions for culturing primary cells the time-lapse imaging of suspension cells at the single-
cell level can also be done on bone marrow stromal cell lines (Song et al., 2010). In another 
recent study, blood cells have been shown to emerge from endothelial cells between stroma 
cells using time-lapse imaging (Eilken et al., 2009). The stromal cell line OP9 (Kodama et al., 
1994) used in that study is a widely accepted model for in vitro differentiation experiments 
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from ES cells into blood (Nakano et al., 1994; Nakano et al., 1996) or for adult bone marrow 
progenitors into lymphoid cells (Wang et al., 2005; Wang et al., 2006). Unlike other stromal 
cells lines, OP9 cells have not been shown to support maintenance of adult HSCs. In contrast, 
the stromal cell lines PA6 (Kodama et al., 1982) and AFT024 (Moore et al., 1997) have been 
shown to both maintain adult HSCs and allow proliferation and development of mature cell 
lineages (Kodama et al., 1984; Szilvassy et al., 1996; Shimizu et al., 2008). Of course, in vitro 
differentiation on stromal cell lines can additionally be influenced by the addition of 
cytokines or other compounds of interest. Additionally, large scale transcriptome analysis and 
genetic manipulation of the stromal cells allows testing the influence of individual factors 
expressed by the niche cells on in vitro hematopoiesis. 
Ultimately, the observation of transcription factor dynamics at the single-cell in vivo would be 
highly desirable. Due to missing labeling technology and many other obvious difficulties, in 
vivo imaging of transcription factor dynamics in humans is not possible. In contrast, in vivo 
imaging of HSCs in their long bone marrow niche has been performed using highly invasive 
fiber-optics insertion through the femoral head (Lewandowski et al., 2010) or by two-photon 
imaging of mechanically thinned tibiae of anesthetized mice (Kohler et al., 2009). In another 
less invasive study, labeled HSCs were imaged in the calvarium bone marrow of transplanted 
mice (Lo Celso et al., 2009). The temporal resolution at imaging timepoints in any of those 
studies was within the minute range, but the duration between the timepoints was at least 
several days witch would not allow to follow individual cells long enough. The biggest 
obstacle for continuous long-term imaging is the frequency and duration of individual 
anesthesias which need to be high and long, respectively, in order to keep single-cell identity. 
Additionally, since long-term continuous imaging has never been performed, cells might be 
highly mobile and get lost by changing their location to other areas than the imaging site or 
even to other bones through the circulation.  
Another model organism that has itself proven to be highly suitable for imaging is the 
zebrafish (Danio rerio). The fish are relatively small, transparent and allow a deep tissue 
penetration of light. Moreover, they develop and proliferate fast and are susceptible to general 
genetic manipulation as well as screening approaches. During the last decade, zebrafish has 
also become a valuable model for normal and malignant hematopoiesis (reviewed in Jing and 
Zon, 2011). Valuable assays like clonal analysis of hematopoietic progenitors that are 
commonly used in mouse hematopoiesis research have been established for the zebrafish 
model system, too (Stachura et al., 2011). Definitive hematopoiesis in zebrafish has further 
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been shown to be initiated through a committed erythromyeloid progenitor (EMP) (Bertrand 
et al., 2007) and other myeloid progenitors can be identified by forward/side scatter 
characteristics and transgenic reporter lines (Traver et al., 2003). PU.1 and Gata1 are highly 
conserved transcription factors and their interplay has also been suggested to determine 
myelo-erythroid progenitor cell fate in zebrafish (Rhodes et al., 2005). In order to elucidate 
the   ‘PU.1/Gata1  paradigm’   in vivo endogenous transcription factor levels would need to be 
quantified in the same approach like it has been done in this thesis. In zebrafish, endogenous 
PU.1 and Gata1 transcription factor levels have not been investigated due to missing 
protocols. Although targeted knock-in approaches by homologous recombination are 
commonly used in mouse hematopoietic research, this method is not well established in 
zebrafish. Other approaches like zinc-finger nuclease mediated mutation protocols have been 
provided recently and might allow more targeted genetic manipulations possible in future 
(Jing and Zon, 2011). In conclusion, to date it is not possible yet to investigate endogenous 
transcription factor levels continuously in vivo. Further technological developments including 
mostly reliable continuous long-term deep tissue imaging in mice or the generation of knock-
in lines in zebrafish are necessary to be  able   to  elucidate   the   ‘PU.1/Gata1  paradigm’   in   the  
model organism of choice.  
 
6.7 Upstream Regulators of PU.1 and Gata1 
 
In vitro differentiation experiments showed that no clear PU.1/Gata1 double positive state 
precedes myeloid lineage choice. Rather than being decision makers between the MegE- and 
the GM-lineage, their role in myelopoiesis seems to be restricted to executing lineage choice 
by upregulating lineage-specific genes (and downregulating opposing lineage specific genes). 
Investigation of transcription factor dynamics in multipotent HSCs and their progeny has 
revealed that lineage choice in favor of the GM-lineage is preceded by upregulation of PU.1 
without any transient Gata1 expression. Cells were committed to the MegE lineage as soon as 
Gata1 could be detected whose expression mostly happened after PU.1 had already been 
downregulated (independently of Gata1). Those observations immediately lead to the 
question which factors upstream of PU.1 and Gata1 regulate their expression and, ultimately, 
which factors are the decision-makers (reviewed in Wolff and Humeniuk, 2013). 
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Cytokines play an important role in hematopoiesis. This becomes even more apparent under 
stress-induced hematopoiesis, e.g. after massive blood loss or during infections. Steady-state 
hematopoiesis obviously must react to external cues. After decades of intensive debate, only 
recently it has been shown that the cytokines M-CSF and G-CSF can instruct cell fate in 
GMPs (Rieger et al., 2009). It was also suggested that subjection of M-CSF to HSCs both in 
vitro and in vivo directly leads to an increase in PU.1 levels and further to a lineage-bias in 
differentiation (Mossadegh-Keller et al., 2013). The influence of more cytokines on 
endogenous transcription factor levels and, hence, lineage choice has not been revealed, yet. 
Cytokine signaling cannot be regarded as a strict unidirectional process, but its significance 
can be strongly influence by internal factors: The transcription factor MafB was demonstrated 
to regulate the sensitivity of M-CSF signaling on multipotent progenitors (Sarrazin et al., 
2009). MafB-/- HSCs exhibited a competitive repopulation advantage of the myelomonocytic 
compartment that still was dependent of M-CSF and PU.1. Therefore, cytokine signaling and 
transcription factors are no independent entities, but exhibit large interdependency as part of 
huge networks. Candidates that might be involved in regulation myeloid lineage choice can be 
inferred from myeloid leukemias. Both PU.1 and Gata1 themselves are often dysregulated in 
leukemias (Wolff and Humeniuk, 2013), but also many other genes are dysregulated in 
hematologic malignancies which also can lead to imbalances in the MegE/GM lineage switch. 
An example of another type of internal factor that might be upstream of PU.1 and Gata1 and 
might regulate myeloid lineage choice is the tumor-suppressor gene p15Ink4b. It was 
originally described as a cyclin-dependent kinase inhibitor and is very often deregulated in 
patients with AML (Drexler, 1998). Knockout experiments of p15Ink4b in vivo and in vitro 
showed a lineage-bias in favor of the granulocyte-monocyte lineage at the expense of the 
erythroid compartment (Rosu-Myles et al., 2007). P15Ink4b is higher expressed in MEPs than 
in GMPs and ectopic expression in primary multipotent cells leads to an increase in mitogen-
activated protein kinase/extracellular signal-regulated kinase (MEK/ERK) signaling and to an 
increase in Gata1 expression as well as a decrease in PU.1 expression. Observations from 
zebrafish have suggested the factor transcription intermediate factor-1γ (tif1γ)   to  be  another  
modulator of the PU.1/Gata1 switch by positively regulating Gata1 and negatively regulating 
PU.1 (Monteiro et al., 2011). A signaling molecule having opposing function by negatively 
regulates Gata1 expression and positively regulating PU.1 is Desert Hedgehog (Dhh) (Lau et 
al., 2012). Dhh-deficient CMPs preferentially differentiated into MegE cells than into GM 
cells. Additionally, Dhh negatively regulated erythroblast differentiation and erythroid 
progenitor populations were increased in Dhh deficient mice.  
Discussion 
82 
 
In summary, unlike hypothesized for many years, PU.1 and Gata1 do not seem to be the 
central transcription factors deciding myeloid lineage choice. Their role rather seems to be 
restricted to carrying out lineage choice and locking it down. Along with the discovery of 
many factors that can influence myeloid choice, there does not seem to be a master regulator 
of GM- or MegE-lineage choice. Individual cytokines, signaling components, transcription 
factors, epigenetic regulators and other molecules all function as a small part in a huge 
network. Technically, the PU.1eYFP/Gata1mCHERRY double knock-in mouse is a perfect 
tool in order to directly image and quantify endogenous transcription factor levels upon 
exposure to any external cue of interest or coordinated genetic manipulation controlled both 
in time and space in freshly isolated primary cells. Further technological development will 
allow the quantification of endogenous transcription levels and their consequences in lineage 
outcome also in vivo. Therefore, the knowledge about the influence of individual molecules 
on PU.1 and Gata1 and myeloid lineage choice will increase drastically in near future. The 
integration of new experimental data into mathematical models and the interpretation of the 
data from the point of systems biology will help to (i) suggest more relevant experiments, (ii) 
further understand what exactly orchestrates myeloid lineage choice and (iii) elucidate how it 
might be manipulated in order to influence hematopoiesis and attenuate hematopoietic 
diseases.  
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7 Experimental Procedures 
7.1 Molecular Biology 
7.1.1 Cloning Strategy 
 
All cloning strategies were designed in silico using Clone Manager Professional 9 software 
(Scientific & Educational Software, Cary, USA) based on complete sequences of available 
plasmids and bacterial artificial chromosomes (BACs). 
 
7.1.2 Restriction Digests and Ligations 
 
Restriction digests and ligations were carried out using enzymes and suitable buffers from 
New England Biolabs (Ipswich, USA) or Thermo Fisher Scientific (Waltham, USA) 
according  to  manufacturer’s  instructions.   
 
7.1.3 Polymerase Chain Reaction (PCR) 
 
PCR primers were designed using Clone Manager Professional 9 software. Annealing 
temperature was chosen according to the software. PCR was carried out according to 
manufacturer’s   instruction   using   Taq   polymerase   from   Thermo   Fisher   Scientific   (Cat.   Nr. 
EP0072, Waltham, USA) for genotypings or Advantage Polymerase 2 from Clontech (Cat. 
Nr. 639206, Mountain View, USA) for cloning.  
 
7.1.4 Agarosegel 
 
DNA fragments from genomic digests, restriction digests and PCR products were separated 
on 0.7% to 1.5% agarose (Cat. Nr. 840004, Biozym, Oldendorf, Germany) gels prepared in 
TAE-buffer composed of 40 mM tris-(hydroxymetyhl)-aminomethane (TRIS) (Cat. Nr. 
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5429.3, Roth, Karlsruhe, Germany), 20 mM acetic acid (Cat. Nr. 1000632511, Merck, 
Darmstadt, Germany) and 1 mM ethylenediaminetetraacetate (EDTA) (Cat. Nr. 8043.2, Roth, 
Karlsruhe, Germany). Agarosegels were stained with 1% ethidium bromide solution (Cat. Nr. 
2218.2, Roth, Karlsruhe, Germany) at a concentration of 6 µl per 100 ml agarose solution. 
DNA fragments were separated with voltages between 30 V and 150 V in TAE-buffer 
depending on the size of gels.  
 
7.1.5 Purification of DNA Fragments 
 
DNA fragments were cut out from agarose gels using a scalpel and purified using the 
QIAquick Gel Extraction Kit (Cat. Nr. 28704, Qiagen, Hilden, Germany) and QIAEX II Gel 
Extraction Kit (Cat. Nr. 20021, Qiagen, Hilden, Germany). Purification of individual PCR 
fragments was performed using the QIAquick (Cat. Nr. 28104, Qiagen, Hilden, Germany). 
DNA fragments were resuspended in H2O bidest and DNA concentration was measured on a 
NanoDrop spectrophotometer nd-1000 (Thermo Scientific, Waltham, USA).  
 
7.1.6 Isolation of Plasmid DNA 
 
High  copy  plasmids  from  DH5α  Escherichia coli bacteria were purified from 5 ml overnight 
cultures using the QIAprep Spin Miniprep Kit (Cat. Nr. 27104, Qiagen, Hilden, Germany) or 
a modified protocol replacing columns with an isopropanol (Cat. Nr. 6752.2, Roth, Karlsruhe, 
Germany) precipitation step and self-made   buffers   replacing   manufacturer’s   buffers.  
Purification from 150 ml overnight cultures was performed using Qiagen Plasmid Maxi Kit 
(Cat. Nr. 12165, Qiagen, Hilden, Germany). 
 
7.1.7 Isolation of BAC DNA 
 
Bacteria containing BACs were inoculated in 5 ml of LB medium (Cat. Nr. 12780-029, 
Invitrogen, Karlsruhe, Germany) with 25 µg/ml chloramphenicol (Cat. Nr. 3886.2, Roth, 
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Karlsruhe, Germany). Overnight cultures were centrifuged at 4680 rcf for 15 min at 4 °C. 
Supernatant was removed and pellet was resuspended in 250 µl buffer P1 (QIAprep Spin 
Miniprep Kit). 250 µl buffer P2 were added and bacteria were lysed for 5 min at RT. 250 µl 
of buffer P3 were added and the solution was incubated for 5 min on ice. Solution was 
centrifuged for 5 min at maximum speed at 4 °C in a table-top centrifuge. Supernatant was 
transferred to a new tube and the centrifugation step was repeated. 750 µl isopropanol were 
added, mixed and incubated for 10 min on ice. The DNA precipitate was centrifuged for 10 
min in a table-top centrifuge at 4 °C. Supernatant was removed and the pellet was washed 
with 1 ml of 70% ethanol (Cat. Nr. 1.00983.2500, Merck, Darmstadt, Germany). After 
another centrifugation step, the pellet was air-dried and resuspended in 30 µl H2O bidest.  
 
7.1.8 Transformation of Bacteria 
 
Transformation  was  performed  by  thawing  chemical  competent  DH5α  bacteria  frozen  at  – 80 
°C for 15 minutes on ice. Up to 100 ng of plasmid or ligation cocktail were added to bacteria 
suspension and incubated 30 minutes on ice. After heatshock treatment of bacteria for 90 s at 
42 °C, the suspension was cooled 2 min on ice. Afterwards, 1 ml LB-medium was added to 
the cells and cells were incubated shaking 1 h at 37 °C. Then, different dilutions of bacteria 
suspension were plated on LB agar (Cat. Nr. 244520, Becton Dickinson, Heidelberg, 
Germany) with adequate antibiotic for selection of successfully transformed bacteria. LB agar 
plates were incubated overnight at 37 °C.  
 
7.1.9 Phenol-Chloroform Extraction  
 
The volume of the DNA solution was increased to 900 µl with H2O bidest. An equal volume 
of phenol-chloroform-isoamylalcohol (25/24/1) (Cat. Nr. A156.3, Carl Roth, Karlsruhe, 
Germany) was added to the DNA and vortexed for 10 s. The solution was centrifuged in a 
table-top centrifuge for 5 min at maximum speed. The aqueous layer was carefully transferred 
to a new tube. In order to remove residual phenol, an equal volume of chloroform was added, 
vortexed and centrifuged again. The aqueous layer was transferred to a new tube again and 
the steps were repeated 2 more times. 
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7.1.10 Ethanol Precipitation 
 
3 M sodium acetate (10% of sample volume) (Cat. Nr. 6773.1, Roth, Karlsruhe, Germany) 
was added to DNA solution. Then, 100% ethanol (2 sample volumes) was added to the 
sample. Solution was incubated at -20 °C overnight. DNA sample was centrifuged in a table-
top centrifuge at maximum speed for 15 minutes at 4 °C. Supernatant was removed and the 
pellet was washed with ice-cold 70% ethanol. DNA solution was centrifuged again and 
supernatant was removed. The pellet was air-dried and resolved in H2O bidest. 
 
7.1.11 Generation of Gata1mCHERRY Knock-In Construct 
 
The Gata1mCHERRY knock-in construct was generated using classical cloning and 
recombineering (Yu et al., 2000). Recombineering allows site directed exchange of large 
DNA fragments depending on homology sites at the end of linearized DNA. Recombineering 
was used for the retrieval of the Gata1 locus from a BAC using homology sequences defined 
by  the  primer  pairs  5’-GTTTGTCCACTGACCTCCAGA TAG-3’/5’-CCAAAGCTACTGGC 
TTCCTCTG-3’   and  5’-TCCCTCCCTCTTTCCCATTCTTC-3’/5’-TAAGTATGCTCCCGC 
AAGATGACCTG-3’.  The  sequence  of  the  Gata1 locus was changed using the primer pairs 
5’-GTAGCAGCAGTAGTGGGAATTGTG-3’/5’-TGCCACAAGGTCAAGGCTATTCTG-
3’   and 5’-AGGTACACAGAATAGCCTTGACCTTGTG-3’/5’-AAAGCCAGCCTAGGCTG 
CATAG-3’.  The  change  included  the  removal  of  the  endogenous  stop  codon  of  Gata1 and the 
addition of a short linker sequence (AGAGCATCAGGTACCAGTGGAGCT) and the open 
reading frame of mCHERRY (Shaner et al., 2004) and a FRT-site flanked neomycin 
resistance cassette with a eukaryotic promoter (PGK), a eukaryotic promoter (EM7) and a 
polyadenylation signal.  
 
7.1.12 BAC Electroporation 
 
BACs containing the Gata1 locus (Cat. Nr. RPCIB731C02198Q, Source BioScience, Berlin, 
Germany) were electroporated into EL350 bacteria. This strain was derived from E. coli 
DH10B and  contains  a  defective  λ  prophage  with  the  recombination  proteins  exo, bet and gam 
Experimental Procedures 
87 
 
which are controlled by a temperature-sensitive repressor (Lee et al., 2001). For preparation 
of electrocompetent bacteria an overnight culture in 5 ml LB medium was inoculated at 32 °C 
(to prevent expression of heat-shock inducible genes). The next day, the culture was diluted 
1:50 in 50 ml LB medium and grown until an optical density (OD600) of 0.6. The culture was 
incubated 5 min on ice and centrifuged at 4680 rcf for 10 min at 4 °C. All subsequent steps 
for removing residual salt were carried out on ice. The supernatant was exhausted and the 
pellet was resuspended in 1.8 ml ice-cold 10% glycerol and the solution was transferred to a 2 
ml Eppendorf tube. The sample was centrifuged at 4 °C in a table-top centrifuge at maximum 
speed for 20 s. Supernatant was exhausted and the pellet was resuspended in 1.8 ml 10% ice-
cold glycerol. The washing step was repeated 3 more times. After the last wash, the pellet was 
resuspended in a total volume of 100 µl 10% glycerol. 3 µg of BAC DNA were mixed with 
50 µl of competent bacteria and left 5 minutes on ice. The bacteria were transferred to a pre-
cooled 1 mm cuvette (Cat. Nr. 165-2089, Bio-Rad, Munich, Germany) and electroporated at 
1700  V,  25  µF  and  200  Ω.  For  successful  electroporation,  the  resulting  time  constant  should  
be close to 5 ms. 1 ml of LB medium was immediately added and the bacteria were shaken at 
32 °C for 1 h. Bacteria were then plated on LB agar plates containing 30 µg/ml 
chloramphenicol and incubated at 32 °C.  
 
7.1.13 Recombineering 
 
For site-directed recombineering, electrocompetent bacteria were prepared as described above 
with an additional heat-shock step (7.1.12): After an OD600 = 0.6 the 50 ml culture was 
divided in 2 aliquots. One was left at RT, the other one was placed in a 42 °C water bath and 
shaken for 15 min. Both cultures were then kept one ice and electrocompetent bacteria were 
prepared as described. One 25 ml culture was sufficient for 4 electroporations. 2 
electroporations (heat-shocked and not heat-shocked) with 15 ng of linearized plasmid were 
carried out. Cultures were plated at different dilutions on LB agar containing suitable 
antibiotics and incubated at 32 °C overnight.  
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7.1.14 Isolation of Genomic DNA from ES Cell Clones 
 
Individual ES cell clones were grown to confluence in gelatin-coated (Cat. Nr. G1890, Sigma-
Aldrich, Taufkirchen, Germany) 96-well plates (Cat. Nr. 167008, Thermo Scientific, 
Waltham, USA). Proteinase K (Cat. Nr., 3115801001, Roche, Penzberg, Germany) was 
freshly added to the lysis buffer to a final concentration of 1 mg/ml. The lysis buffer consisted 
of 10 mM TRIS (pH = 7.5), 10 mM EDTA, 10 mM sodium chloride (NaCl) (Cat. Nr. 3957.1, 
Roth, Karlsruhe, Germany) and 0.5% N-lauroylsarcosine sodium salt (Cat. Nr. L5777, Sigma-
Aldrich, Taufkirchen, Germany). The medium was exhausted and ES cells were washed twice 
with DPBS (Cat. Nr. 14040-091, Invitrogen, Karslruhe, Germany). 50 µl of lysis buffer were 
added to each well and incubated overnight at 55 °C in a humidified chamber. On the next 
day, 150 µl 5 M NaCl were added to 10 ml icecold 100% ethanol. 100 µl of NaCl/ethanol 
were added to each well and plates were incubated at room temperature for 2 h. DNA 
emerged as a filamentous network at the bottom of each well. The plates were carefully 
inverted and dried on a paper towel. DNA was washed 3 times with 150 µl 70% ethanol. 
After drying DNA was resuspended in 25 µl H2O bidest. 
 
7.1.15 Restriction Digest of Genomic DNA 
 
Restriction digest of genomic DNA from ES cell clones was performed using 10 U EcoRI (or 
XbaI), the appropriate buffer, 1 mM spermidine (Cat. Nr. 7161.3, Roth, Karlsruhe, Germany), 
100 µg/ml RNase A (Cat. Nr. 19101, Qiagen, Hilden, Germany) and H2O bidest in a total 
volume of 50 µl per well.  
 
7.1.16 Southern Blot 
 
Digested genomic DNA was separated on a 0.7% agarose gel at 30 V overnight. A picture 
with a fluorescent ruler was taken the next day. Gel was shaken 15 minutes in depurination 
solution (0.4 M hydrochloric acid) (Cat. Nr. 1.00319.2511, Merck, Darmstadt, Germany) and 
washed with H2O bidest. Then, gel was incubated 45 min in denaturation solution (0.2 M 
sodium hydroxide, 0.6 M NaCl) (sodium hydoxide, Cat. Nr. 9356.1, Roth, Karlsruhe, 
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Germany) and washed with H2O bidest. At last, gel was incubated 45 min in neutralization 
solution (1 M TRIS, 0.6 M NaCl) and washed again with H2O bidest. Gel was blotted onto a 
Hybond-N+ nylon membrane (Cat. Nr. RPN203B, GE Healthcare, Freiburg, Germany) with 
20x saline-sodium citrate (SSC) buffer (3 M NaCl, 342 mM trisodium citrate (Cat. Nr. 
3580.4, Roth, Karlsruhe, Germany), pH = 7) overnight. Membranes were air-dried and baked 
for 30 min at 80 °C to fix the DNA. 
 
7.1.17 Generation and Hybridization of Southern Probes 
 
Southern probes were generated by PCR using the Gata1 BAC as a template and the specific 
primer  pairs  5’-CAGCCACTGCCCAAATAGGTGGAG-3’/5’-ATTTCCCTAAAACTGTGC 
TGATGTG-3’   (upstream   Southern   probe)   and   5’-CTGAAGTGGTGCTCTGGACTTTAC-
3’/5’-TGAGGAAGAGGGAAGGATGTGAAG-3’   (downstream   Southern   probe).   PCR 
product   was   run   on   an   agarose   gel,   purified   and   labeled   with   radioactive   [α-32P] 
deoxycytidine triphosphate (3000 Ci/mmol, 10 mCi/ml) (Cat. Nr. NEG513H400UC, Perkin 
Elmer LAS, Rodgau-Jügesheim, Germany) using the Prime-It II Random Primer Labeling Kit 
(Cat.   Nr.   300385,   Agilent   Technologies,   Santa   Clara,   USA)   according   to   manufacturer’s  
instructions. 1 µl of the radioactive labeled probe was measured and cleared for usage, if 
liquid scintillation counts exceeded 300000 counts per minute on a Triathler Multilabel Tester 
(Cat.Nr. 425-004, Hidex, Turku, Finland). The probe was then prepared for hybridization: 500 
µl of 10 mg/ml herring sperm single-stranded DNA (Cat. Nr. ab46666, Abcam, Cambridge, 
United Kingdom) was incubated 10 min in a 100 °C water bath and mixed with the desired 
amount of probe. 50 µl of 10 M NaOH was slowly added during constant shaking followed by 
300 µl 2M TRIS, pH = 8. At last 475 µl of 1 M hydrochloric acid (HCl) (Cat. Nr. P074.3, 
Roth, Karlsruhe, Germany) were added very slowly. Denatured probe was added to 
membranes at least 3 h prehybridized with hybridization juice at 65 °C (1000000 counts of 
the probe per 1 ml hybridization juice). Hybridization juice consisted of 1 M NaCl, 5% 1 M 
TRIS (pH = 7.5), 0.1 g/ml dextran sulfate (Cat. Nr. 5956.3, Roth, Karlsruhe, Germany), 1% 
sodium dodecyl sulfate (SDS) (Cat. Nr. 2326.1, Roth, Karlsruhe, Germany) and 250 µg/ml 
herring sperm single-stranded DNA. Probe was hybridized rotating overnight at 65 °C. Probe 
was washed off with 2x SSC / 0.5% SDS (preincubated at 65 °C) at 65 °C. Membranes were 
constantly measured and cleared for exposure to Kodak BioMax MS films (Cat. Nr. z363057, 
Sigma-Aldrich, Taufkirchen, Germany) if beta radiation was between 30 – 50 counts per 
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second measured on contamination monitor (Cat. Nr. LB 122, Berthold Technologies, Bad 
Wildbad, Germany). Membranes were wrapped in plastic foil and exposed in a film cassette 
at – 80 °C for at least 3 days.  X-ray films were processed using an AGFA Curix 60 developer 
machine (Cat. Nr. 09712043, Siemens, Munich, Germany). 
 
7.1.18 Genotyping 
 
PU.1eYFP   mice   were   genotyped   using   the   primers   5’-TGCGCAACTACGGCAAGAC-3’  
(forward),   5’-GGGCGACGGGTTAATGCTATG-3’   (wildtype   allele   reverse)   and   5’-
TCAGCTCGATGCGGTTCAC-3’   (knock-in allele reverse) leading to a 176 bp band 
(wildtype) or a 546 bp and 947 bp bands (knock-in), respectively.  
Gata1mCHERRY  mice  were  genotyped  using  the  primers  5’-AGGTACTGCCCACCTCTAT 
C-3’  (wildtype  forward),  5’-GCATGGACGAGCTGTACAAG-3’  (knock-in  forward)  and  5’-
GCAGGAGAATGGGAAATGTG-3’   (reverse)   leading   to   a   297   bp   (wildtype)   or   a   223   bp  
(and a 1101 bp band) (knock-in), respectively.  
Successful removal of the neomycin resistance cassette was verified   by   the   primers   5’-
GCATGGACGAGCTGTACAAG-3’   (forward),   5’-CTGCACGAGACTAGTGAGAC-3’  
(neomycin   reverse)   and   5’-GCAGGAGAATGGGAAATGTG-3’   (Gata1   3’-UTR reverse), 
leading to 387 bp band (and a 2020 bp band) in the case of non-removal and a band of 223 bp 
band in the case of Flp-e mediated recombination.  
 
7.1.19 Sequencing 
 
Capillary sequencing was performed in the in-house sequencing facility using the BigDye 
Terminator v3.1 Cycle Sequencing Kit (Cat. Nr. 4337455) on a 3730 DNA Analyzer (both 
Applied Biosystem, Foster City, USA). 
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7.2 Generation of Lentivirus 
7.2.1 Virus Production 
 
Vesicular stomatitis virus glycoprotein (VSV-g) pseudotyped lentivirus was produced in 
human embryonic kidney (HEK) 293T cells. In comparison to vectors pseudotyped with 
murine ecotropic envelope, VSV-g lentivirus always resulted in higher titers (Schambach et 
al., 2006) and better transduction rates of primary cells (data not shown). HEK cells were kept 
in Dulbecco's modified Eagle medium (DMEM) (Cat. Nr. 41966-029, Invitrogen, Karlsruhe, 
Germany) with 10% fetal calf serum (FCS) (Cat. Nr. S1900-500, Lot Nr. S05130S1900, 
Biowest SAS, Nuaillé, France). For each virus cells were seeded at a density of 5 · 106 cells / 
60 cm2 in 4 dishes (Cat. Nr. 150350, Thermo Scientific, Waltham, USA). The next day each 
plate was cotransfected with 4 different plasmids in 0.5 ml 250 mM calcium chloride (CaCl2) 
HEPES buffered saline (HBS) (Cat. Nr. CAPHOS, Sigma-Aldrich, Taufkirchen, Germany). 
The plasmids added were 2,5 µg pRSV_rev (containing rev, regulator of expression of virion 
proteins), 5 µg pMDLg_pRRE (containing gag = structural protein and pol = lentivirus-
specific enzymes and a rev responsive element), 1 µg pMD2.VSV-g (containing envelope 
protein) and 10 µg of the plasmid with the gene of interest derived from 
pRRL.PPT.SFFV.GFP.PRE (Schambach et al., 2006). Prior to transfection, the medium was 
replaced by 10 ml of transfection medium which contained DMEM, 10% FCS, 0.1 mM non-
essential amino-acids (NEAA) (Cat. Nr. 11140-035, Invitrogen, Karlsruhe, Germany), 1 mM 
sodium pyruvate (Cat. Nr. S8636, Sigma-Aldrich, Taufkirchen, Germany), 20 mM HEPES 
(Cat. Nr. 15630-056, Invitrogen, Karlsruhe, Germany) and 100 U/ml and 100 µg/ml 
penicillin/streptomycin (Cat. Nr. 15140122, Invitrogen, Karlsruhe, Germany). Cells were 
incubated at least 6 hs before medium was changed. 2 days after transfection, the virus 
containing medium from 4 dishes was collected, centrifuged at 240 rcf at 4 °C and the 
supernatant was filtered through a 0.2 µm filter (Cat. Nr. 17805, Sartorius, Göttingen, 
Germany). Supernatant was then centrifuged at 50000 rcf at 4°C for at least 1 h. The medium 
was exhausted and pellets were resuspended in 200 µl StemSpan serum free expansion 
medium (SFEM) (Cat. Nr. 09650, Stem Cell Technologies, Vancouver Canada), aliquoted in 
10 µl vials and frozen at – 80 °C.  
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7.2.2 Virus Titration 
 
Virus titer was determined by transducing NIH-3T3 (mouse embryonic fibroblasts) and 
quantifying infected cells with a fluorescent marker. NIH-3T3 cells were kept in DMEM/10% 
FCS and seeded at a density 1.5 · 104 cells per well of a 24-well plate (Cat. Nr. 131068, 
Thermo Scientific, Waltham, USA). The next day a 1:10 dilution series of lentivirus was 
prepared between 10-1 and 10-4 in DMEM/10% FCS. Cells were infected with each dilution in 
triplicates. 2 days later, medium was removed, cells were trypsinized (Cat. Nr. 25300-054, 
Invitrogen, Karlsruhe, Germany), counted and analyzed on a FACSCalibur or FACSAriaI 
(Beckton Dickinson, San Jose, USA). The amount of positive cells from dilutions which 
resulted in 3% - 30% positive cells was used for titer calculation. 
 
7.2.3 Virus Infection 
 
Cells were sorted, counted and cultured in 100 µl SFEM containing 100 ng/ml SCF (Cat. Nr. 
250-03), 10 ng/ml IL-3 (Cat. Nr. 213-13) and 10 ng/ml IL-6 (Cat. Nr. 200-06, all PeproTech, 
Hamburg, Germany) in a well of a 96-well plate. Lentivirus was added at a multiplicity of 
infection (MOI) of 60 – 100. Cells were incubated at 37 °C for 24 h before further usage.  
 
7.3 Isolation of Primary Cells 
7.3.1 Mouse Lines 
 
Mouse lines used for experiments included C57BL/6J wildtype mice from an in-house 
breeding facility, PU.1eYFP knock-in mice (Kirstetter et al., 2006) and self-generated 
Gata1mCHERRY knock-in mice made from JM8.N4 (C57BL/6N) ES cells (Pettitt et al., 
2009). PU.1eYFP and Gata1mCHERRY mice were crossed in order to generate double 
knock-in mice. 
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7.3.2 Fetal Liver Preparation 
 
Fetal livers from C57BL/6 and Gata1mCHERRY E14.5 day embryos were isolated, pooled 
and singularized by vigorous pipetting of the cell suspension. Cells were washed with DPBS, 
centrifuged at 300 rcf for 5 min at 4 °C and resuspended in 50 µl (per fetal liver) FACS buffer 
containing DPBS, 10% FCS, 0.1% sodium azide (NaN3) (Cat. Nr. S2002, Sigma-Aldrich, 
Taufkirchen, Germany) and 10 mM EDTA. 
 
7.3.3 Bone Marrow Preparation 
 
For analysis and sorting of mononuclear cells from murine bone marrow, femurs and tibiae of 
adult mice were isolated, flushed with 6 ml DPBS and isolated from the interphase of a 
Histopaque-1083 Ficoll gradient (Cat. Nr., 10831, Sigma-Aldrich, Taufkirchen, Germany) 
after centrifugation for 15 min at 490 rcf at room temperature with minimal acceleration and 
no brake. 
Alternatively, femurs, tibiae, humeri, hip bones and vertebrae from adult mice were isolated 
and muscle tissue was removed with a scalpel. Bones were crushed in cold 2% FCS in DPBS 
and filtered through a 40 µm filter (Cat. Nr. 352340, Becton Dickinson, Heidelberg, 
Germany) in a total volume of 50 ml. The cell suspension was centrifuged at 300 rcf for 5 min 
at 4 °C. If cells were prepared for sorting, the pellet was resuspended in twice the volume of 
ACK lysis buffer (Cat. Nr. 10-548E, Lonza, Basel, Switzerland) and incubated for 2 min at 
room temperature. The volume was increased to 50 ml with DPBS and cells were counted in a 
hemocytometer. 
 
7.3.4 Staining of Primary Cells 
 
Isolated cells were centrifuged at 300 rcf for 5 min at 4 °C and resuspended in 200 µl (per 
mouse) FACS buffer. For analysis and sorting of HSPCs, 1 µl biotinylated lineage-antibody 
was added per 107 cells and incubated for 20 min on ice. Lineage-antibodies included CD3 
(Cat. Nr. 13-0031-85), CD19 (Cat. Nr. 13-0193-85), B220 (Cat. Nr. 13-0452-86), Gr1 (Cat. 
Nr. 13-5931-85), Mac-1 (Cat. Nr. 13-0112-85), Ter119 (Cat. Nr. 13-5921-85) and CD41 (Cat. 
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Nr. 13-0411-85, all eBioscience, San Diego, USA). If lineage-specific antigens were stained 
with a color, they were omitted in the lineage-mix. CD41 was omitted when MegE progenitor 
cells were sorted. If cells were prepared for sorting, a magnetic depletion of lineage positive 
cells was performed: Cells were washed, centrifuged and resuspended in 200 µl (per mouse) 
FACS buffer. Streptavidin-coated magnetic beads (Cat. Nr. HP57.1, Roth, Karlsruhe, 
Germany) were added to the cells (1 µl per 107 cells) and incubated for 7 min on ice. Cells 
were then incubated for 7 min on an EasySep magnet (Cat. Nr. 18001, Stem Cell 
Technologies, Vancouver, Canada) and lineage-negative cells were decanted. Cells were 
washed, counted, centrifuged and resuspended in 100 µl (per mouse) FACS buffer. 
Fluorescence labeled antibodies and fluorescence labeled streptavidin (2-3 µl per 107 cells) 
were added to the cells and incubated for at least 30 min on ice. Antibodies used for staining 
included CD16/32-AlexaFluor 700 (Cat. Nr. 56-0161-82), CD19-APC (Cat. Nr. 17-0191-81), 
CD34-eFluor660 (Cat. Nr. 50-0341-82), CD41-PerCP-eFluor710 (Cat. Nr. 46-0411-82), 
CD48-PerCP-eFluor710 (Cat. Nr. 46-0481-82), CD71-PE (Cat. Nr. 12-0711-81), CD71-
PerCP-eFluor710 (Cat. Nr. 46-0711-82), B220-PE (Cat. Nr. 12-0452-83), Flt3-PE (Cat. Nr. 
12-1351-83), c-Kit-PE-Cy7 (Cat. Nr. 25-1171-82), c-Kit-APC-eFluor780 (Cat. Nr. 47-1172-
82), Gr-1-PE-Cy7 (Cat. Nr. 25-5931-81), Mac1-PE-Cy7 (Cat. Nr. 25-0112-81), Sca-1-PerCP-
Cy5.5 (Cat. Nr. 45-5981-82), Ter119-PE (Cat. Nr. 12-5921-81), Ter119-APC-eFluor780 (Cat. 
Nr. 47-5921-82, all eBiocience, San Diego, USA), CD3-Biotin, CD16/32-APC (Cat. Nr. 
101326), CD105-APC (Cat. Nr. 120414,), CD150-PE (Cat. Nr. 115904) and Sca-1-PB (Cat. 
Nr. 108120, all Biolegend, San Diego, USA). Streptavidin for staining biotin-labeled lineage 
mix was either APC-eFluor780 (Cat. Nr. 47-4317-82, eBioscience, San Diego, USA), PB 
(Cat. Nr. S-11222) or AlexaFluor 430 (Cat. Nr. S-11237, both Invitrogen, Karlsruhe, 
Germany). After staining, cells were washed, centrifuged, resuspended in FACS Buffer (200 
µl per mouse) and filtered through a 35 µm filter (Cat. Nr. 352235, Becton Dickinson, 
Heidelberg, Germany) into polypropylene round-bottom tubes (Cat. Nr. 352063, Becton 
Dickinson, Heidelberg, Germany).  
 
7.3.5 Flow Cytometric Analysis and Sorting of Primary Cells 
 
All flow cytometric analysis and sorting was performed on a FACSAriaI or FACSAriaIII 
(Becton Dickinson, Heidelberg, Germany) equipped with a 405 nm, 488 nm and 633 nm 
Laser (both machines) and a 561 nm laser (only FACSAriaIII) using a 70 µm nozzle and 
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manually adjusted compensations necessary for multi-color staining. Filters for detection of 
fluorescent colors with the 405 nm laser were 450/40 (PB) and 530/30 (AlexaFluor 430). 
Filters for the 488 nm laser were 530/30 (eYFP), 576/15 (PE), 695/40 (PE-Cy5.5) and 780/60 
(PE-Cy7). Filters for the 561 nm laser were 582/15 (PE), 610/20 (mCHERRY), 670/14 (PE-
Cy5) and 780/60 (PE-Cy7). Filters for the 633 nm laser were 660/20 (APC, AlexaFluor 647, 
eFluor660), 730/45 (AlexaFluor 700) and 780/60 (APC-Cy7, APC-eFluor780). Cells were 
sorted  in  ‘purity’  or  ‘4-way-sort’  mode  into  4  °C  cold  SFEM  or  Iscove’s  Modified  Dulbecco’s  
Medium (IMDM) (Cat. Nr. P04-20451S1, PAN Biotech, Aidenbach, Germany) containing 
100 ng/ml SCF and additionally 5 U/ml EPO (Cat. Nr. C-60023, Promokine, Heidelberg, 
Germany) for sorting of erythroid cells.  A sorting purity of at least 95% was always 
confirmed by reanalysis of sorted populations. Flow cytometric was analyzed using 
FACSDiva software version 6.1.3 (Becton Dickinson, Heidelberg, Germany). 
 
7.3.6 Blood Counts 
 
Peripheral blood was collected by cardiac puncture immediately after sacrifice of mice and 
transferred to EDTA-coated tubes (Cat. Nr. 078035, Kabe Labortechnik, Nümbrecht-
Elsenroth, Germany). Blood counts were quantified by Sebastian Kaidel (Institute of 
Experimental Genetics, Helmholtz Center Munich) on an Abc Animal Blood Counter (scil 
animal care company, Viernheim, Germany). 
 
7.4 Cell Culture 
7.4.1 Liquid Culture 
 
Freshly sorted cells were cultured in SFEM containing 100 ng/ml SCF, 10 ng/ml IL-3, 10 
ng/ml IL-6, 5 U/ml EPO, 100 ng/ml TPO (Cat. Nr.  315-14, PeproTech, Hamburg, Germany) 
and 100 U/ml and 100 µg/ml penicillin/streptomycin, respectively. Cell culture dishes for 
population culture were 24-well plates and 1536-well glass bottom dishes (Cat. Nr. 783892, 
Greiner Bio-One, Frickenhausen, Germany) for single-cell cultures. For time-lapse movies, 
cells were cultured in fibronectin-coated (Cat. Nr IHMFBN, Innovative Research, Novi, 
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USA) ibidi µ-slides VI0.4 (Cat. Nr. 80606, Ibidi, Martinsried, Germany). Cells were incubated 
at 37 °C and 5% CO2.  
 
7.4.2 Live Continuous In Culture Antibody Staining 
 
CD16/32 antibody (Cat. Nr. 553142, BD Pharmingen, Heidelberg, Germany) was self-labeled 
with AlexaFluor 647 Labeling Kit (Cat. Nr.  A-20186, Invitrogen, Karlsruhe, Germany) 
according to manufacturer’s   protocol.  CD16/32-AlexaFluor 647 antibody was added to cell 
cultures at a final concentration of 10 – 50 ng/ml.  
 
7.4.3 Colony Assay 
 
Freshly isolated bone marrow or freshly sorted cells were sorted, counted and seeded at 
suitable densities in 35 mm dishes (Cat. Nr. 430165, Corning, Amsterdam, Netherlands) with 
MethoCult GF M3434 colony assay medium (Stem Cell Technologies, Vancouver, Canada) 
containing 100 U/ml and 100 µg/m penicillin/streptomycin. Colonies with at least 30 cells (or 
at least 1 megakaryocyte) were scored after 4 – 14 days according to cell morphology and 
colony morphology. For staining of erythroid colonies, a benzidine staining was performed: 
Stock solution was prepared by dissolving 0.1 g dibenzidine hydrochloride (Cat. Nr. B3383, 
Sigma-Aldrich, Taufkirchen, Germany) in 1.46 ml glacial acetic acid (Cat. Nr. 1.00063.1000, 
Merck, Darmstadt, Germany) and 48.54 ml H2O bidest. In order to prepare the working 
solution 1 ml stock solution were mixed with 20 µl 30% hydrogen peroxide (H2O2) (Cat. Nr. 
216763, Sigma-Aldrich, Taufkirchen, Germany). A few drops of the working solution were 
added on top of the colony assay medium. The hemoglobin of erythroid colonies stained blue 
after 2 – 3 minutes.  
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7.5 Cytospin 
7.5.1 Spinning 
 
Cells were spun down on object slides using Hettich cytospin equipment (Cat. Nr 1662, 1668, 
5280, Hettich, Tuttlingen, Germany) and a Rotanta 460 R centrifuge (Cat. Nr. 5660, Hettich, 
Tuttlingen, Germany). Up to 1 ml of cell suspension were centrifuged at 270 rcf for 3 min at 
room temperature. Medium was exhausted until 100 µl were left and the cyto-chamber was 
removed. Remaining medium was removed by centrifugation at 1100 rcf for 1 min. Cells 
were air-dried before staining. 
 
7.5.2 Staining and Analysis 
 
Cytoplasm and granulae of spun cells were stained for 4 min with May-Gruenwald-Solution 
(Cat. Nr. T863.1, Roth, Karlsruhe, Germany). Cells were washed twice with H2O bidest and 
nuclei were stained for 16 min with a 5% Giemsa-Solution (Cat. Nr. 1.09204.0500, Merck, 
Darmstadt, Germany). Cells were washed three times with H2O bidest, air-dried and covered 
with Pertex mounting medium (Cat. Nr. PER20000, Medite, Burgdorf, Germany). Cytospins 
were analyzed using a 63x oil-immersion objective and an Axiovert 200M inverted 
microscope. Pictures were taken using the RGB camera AxioCam MRc5 and a 1x TV-adapter 
(all Zeiss, Hallbergmoos, Germany).  
 
7.6 Western Blot 
7.6.1 Cycloheximide Treatment 
 
For comparison of biochemical stability of wildtype transcription factors and transcription 
factor fusions with fluorescent proteins cells were subjected to cycloheximide treatment 
which blocks proteinbiosynthesis. For comparison of PU.1/PU.1eYFP stability, PU.1eYFP+ 
progenitor cells from PU.1/PU.1eYFP heterozygous mice were sorted, cultured in IMDM 
containing 100 ng/ml SCF, 10 ng/ml IL-3, 10 ng/ml IL-6 and 50 µM cycloheximide (Cat. Nr. 
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C4859-1ML, Sigma-Aldrich, Taufkirchen, Germany) and distributed into equal aliquots. For 
comparison of Gata1/Gata1mCHERRY stability, equal numbers of E14.5 fetal liver cells 
from wildtype C57BL/6 and Gata1mCHERRY embryos were mixed and cultured in IMDM 
containing 100 ng/ml SCF, 10 ng/ml IL-3, 10 ng/ml IL-6, 5 U/ml EPO and 50 µM 
cycloheximide. At designated time points, cells were washed, spun down at 300 rcf for 5 min 
at 4 °C and resuspended in 30 µl Laemmli-buffer (Laemmli, 1970). Cell lysates were boiled at 
100 °C for 5 minutes and stored at – 20 °C until further usage.  
 
7.6.2 SDS-Polyacrylamidgelectrophoresis 
 
Proteins from cell lysates and recombinant GFP (Cat. Nr. 632373, Clontech, Mountain View, 
USA) or mCHERRY (Cat. Nr. ABIN412973, antibodies-online.com, Aachen, Germany) were 
separated by SDS-polyacrylamidgelectrophoresis. Gels were prepared and mounted according 
to  manufacturer’s   instructions   (Cat.  Nr.   165-8001, Bio-Rad, Munich, Germany). Collecting 
gel buffer was 0.5 M TRIS (pH = 6.8) with 0.4% SDS. Resolving gel buffer was 1.3 M TRIS 
(pH = 8.8) with 1.0% SDS. The resolving gel was prepared by mixing 3 ml of resolving gel 
buffer with 5 ml H2O and 4 ml 30% bisacrylamid (Cat. Nr. 3029.3, Roth, Karlsruhe, 
Germany). Polymerisation was started by adding 16 µl tetramethylethylendiamin (TEMED) 
(Cat. Nr. 2367.3, Roth, Karlsruhe, Germany) and 52 µl 25% ammonium persulfate (APS) 
(Cat. Nr. GENOP011-B, VWR, Darmstadt, Germany). Gel was poured and layered with 
100% isopropanol. After polymerisation of the resolving gel, the 5% collecting gel was 
prepared: 1.25 ml collecting gel buffer were mixed with 2.92 ml H2O bidest and 0.83 ml 30% 
bisacrylamid. At last, 10 µl TEMED and 25 µl APS were added. After removal of 
isopropanol, the collecting gel was poured and supplied with a comb generating 10 wells. 
Gels were run in buffer consisting of 25 mM TRIS, 19.2 mM glycine (Cat. Nr. T873.2, Roth, 
Karlsruhe, Germany) and 0.5% SDS. Gels were run at 80 V until proteins reached the 
resolving gel and voltage was increased to 100 V. PAGERuler (Cat. Nr. 10398469, Thermo 
Scientific, Waltham, USA) was used as a protein standard.  
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7.6.3 Western Blotting 
 
After separation of proteins, gels were blotted by wet blotting onto a PVDF membrane 
according   to  manufacturer’s   instructions   (Cat.   Nr.   162-0177, Bio-Rad, Munich, Germany). 
Transfer buffer was 0.16 M glycine and 25 mM TRIS. PVDF membrane was wetted in 
methanol (Cat. Nr. 1.06009.2500, Merck, Darmstadt, Germany) prior to blotting. Gel, 
membrane, sponges and filter papers were preincubated in transfer buffer for 10 minutes. 
Blotting was performed at 100V for 2 hours or at 30V overnight with a – 20 °C thermal pack 
or at 4 °C.  
 
7.6.4 Protein Detection and Processing 
 
All protein detection was performed in TRIS-buffered saline (TBS) consisting of 20 mM 
TRIS and 0.14 M NaCl (pH = 7.5) under light shaking. PVDF membranes were blocked with 
5% milk powder (Cat. Nr. T145.1, Roth, Karlsruhe, Germany) in TBS for 1 h at room 
temperature.   The   following   primary   antibodies   were   used:   α-PU.1 (Cat. Nr. 2258, Cell 
Signaling,  Frankfurt  am  Main,  Germany),  α-Gata1 (Cat. Nr. sc-265, Santa Cruz, Heidelberg, 
Germany),   α-GFP (Cat. Nr. 11814460001,   Roche,   Penzberg,   Germany)   and   α-mCHERRY 
(Cat. Nr. ab125096, Abcam, Cambridge, United Kingdom). Primary antibodies were 
incubated overnight at 4 °C in a dilution of 1:1000 in 5% milk (Cat. Nr. T145.2, Roth, 
Karlsruhe, Germany) in TBS. Membranes were washed 3 times for 5 min in 0.1% Tween-20 
(Cat. Nr. 9127.1, Roth, Karlsruhe, Germany) in TBS (TBS-T). The following horseradish 
peroxidase  linked  secondary  antibodies  were  used:  α-mouse IgG (Cat. Nr. NA931-1ML),  α-
rat   IgG   (Cat.  Nr.  NA935)   and  α-rabbit IgG (Cat. Nr. NA934-1ML, all GE Healthcare Life 
Sciences, Freiburg, Germany). Secondary antibodies were incubated for 1 h at room 
temperature at a dilution of 1:10000 – 1:15000 in 5% milk in TBS and excess antibodies were 
removed by washing 6 times for 5 min in TBS-T. Specific proteins were detected by 
chemiluminescent signals provided by an enzymatic reaction. Substrate was provided by the 
ECL+ Kit (Cat. Nr. RPN2132, GE Healthcare, Freiburg, Germany) and used according to 
manufacturer’s   instructions.  Signals  were detected using Fuji medical X-ray films (Cat. Nr. 
RF11, A. Hartenstein, Würzburg, Germany). Films were processed on an AGFA Curix 60 
Developer Machine. Films were scanned and signals were quantified using ImageJ 
(http://rsbweb.nih.gov/ij/) software drawing manual gates around bands and subtracting the 
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average of the same background area above and below the bands. The mean out of three 
manual drawings was used for further calculations. 
 
7.6.5 Calculation of PU.1eYFP and Gata1mCHERRY Protein Numbers 
 
Calculation of PU.1eYFP and Gata1mCHERRY protein numbers will be described elsewhere 
(Schwarzfischer et al., manuscript in preparation) and was not part of this thesis. Briefly, 
calculated protein data from Western blot analysis of defined amount of PU.1eYFP+ or 
Gata1mCHERRY+ cells were assigned to other defined HSPC populations by their average 
fold-changes in flow cytometry. Error estimates were derived using propagation of 
uncertainty. Average HSC protein numbers for PU.1eYFP in movies were mapped to the 
signal intensities of HSCs in the first three timepoints of the movies. Protein numbers for 
Gata1mCHERRY were estimated by mapping the average protein number of 
Gata1mCHERRYmid cells to the average intensity of cells which have been marked as 
Gata1mCHERRY-positive in the time-lapse movies. A cell was marked as Gata1mCHERRY 
positive if its expression exceeded twice the negative gate for more than 5 consecutive time 
points. 
 
7.7 Time-Lapse Imaging 
7.7.1 Movie Acquisition 
 
Time-lapse movies were acquired on the inverted epifluorescence microscope Zeiss Axio 
Observer (Zeiss, Hallbergmoos, Germany) equipped with AxioVision Software 4.9. A self-
written macro was used to control hardware equipment. Cells were constantly kept at 37 °C in 
a custom-made Plexiglas housing by the Heating Unit XL S (Cat. Nr. 411857-9030-000, 
Zeiss, Hallbergmoos, Germany) and directly supplied with pre-mixed gas consisting of 5% 
CO2, 5% O2 and 90% N2 (Praxair, Düsseldorf, Germany). Images were acquired with a 10x 
Fluar objective (Cat. Nr. 440135-0000-000, Zeiss, Hallbergmoos, Germany) and a 0.63x TV-
Adapter (Cat. Nr., 426113-0000-000 Zeiss, Hallbergmoos, Germany). The brightfield 
lightsource was a halogen lamp and images were acquired every 1.5 min with an Axiocam 
HRm (Cat. Nr. 426511-9901-000, Zeiss, Hallbergmoos, Germany) camera at a resolution of 
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1388 x 1040 pixels in lossless TIF or PNG-format. Fluorescent light was provided by a HXP 
120 light source (Cat. Nr. 423013-9010-000, Zeiss, Hallbergmoos, Germany) with a Osram 
HXP-R 120W/45C VIS bulb (Cat. Nr. 882772, Osram, Munich, Germany). Filters for 
excitation/emission of different fluorophores were 46 HE (Cat. Nr. 489046-9901-000, Zeiss, 
Hallbergmoos, Germany) for eYFP, 43 HE (Cat. Nr. 489043-9901-000, Zeiss, Hallbergmoos, 
Germany) for mCHERRY and AHF Cy5 (Cat. Nr. F46-006, AHF Analysentechnik, 
Tübingen, Germany) for AlexaFluor 647. Excitation times were 1.5 s for eYFP, 0.8 s for 
mCHERRY and 0.6 s for AlexaFluor 647. Hardware autofocus (Cat. Nr. 410133-0506-000, 
Zeiss, Hallbergmoos, Germany) was applied just prior to eYFP image acquisition. EYFP and 
mCHERRY images were acquired every 30 min and AlexaFluor 647 images were acquired 
every 4 hours.  
 
7.7.2 Tracking Software 
 
Time-lapse data was analysed using self-written   tracking   software   (TTT,  Timm’s Tracking 
Tool) (Eilken et al., 2009; Rieger et al., 2009) on Fujitsu Siemens (Munich, Germany) 
workstations with up to 96 GB RAM. Briefly, the software allows manual tracking of 
individual colonies at the single-cell level which results in cell genealogies with exact 
information about many parameters, e.g. division, cell cycle length, apoptosis or cell 
movement. Onsets of Gata1mCHERRY and CD16/32 expression as well as appearance of 
morphological distinct megakaryocytes were manually annotated. Any cell with insecure 
identity (loss of single cell data) was excluded from analysis. 
 
7.7.3 Image Quantification Software 
 
Background and position-dependent gain from every acquired fluorescent picture was 
quantified using a recently developed algorithm (Schwarzfischer et al., 2011). Based on 
corrected backgrounds, fluorescent signals were quantified using new interactive software 
(QTF) which allows inspection and manual correction of every single fluorescent data point 
(developed in collaboration with Prof. Fabian Theis Group, Institute of Computational 
Biology Helmholtz Center Munich, manuscript in preparation). Only data points that were 
manually inspected were used for further analysis.  
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7.8 Statistical Analysis 
 
A one-way multivariate analysis of variance (MANOVA) was used for comparing C57BL/6 
and PU.1eYFP/Gata1mCHERRY bone marrow composition and blood counts. A Wilcoxon 
rank sum test was used for comparing in vitro colony forming potential of C57BL/6 and 
PU.1eYFP/Gata1mCHERRY bulk bone marrow. A statistical test for differences between 
paired time-resolved observations was used for comparing biochemical stability of wildtype 
PU.1/Gata1 and PU.1eYFP/Gata1mCHERRY, respectively (Brand et al., 2013). A 
significance level of 5% was used for every test. 
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9 Abbreviations 
 
°C  degrees Celsius 
µ  micro 
Ω  Ohm 
AGM   aorta-gonads-mesonephros 
AML  acute myeloid leukemia 
APC  allophycocyanin  
BAC  bacterial artificial chromosome 
BFP  blue fluorescent protein 
bp  base pair 
Cat Nr  catalogue number 
CD  cluster of differentiation 
CFP  cyan fluorescent protein 
CFU  colony-forming unit 
CLP  common lymphoid progenitor 
CMP  common myeloid progenitor 
CSF  colony-stimulating factor 
d  day 
DMEM Dulbecco’s  modified  Eagle’s  medium 
DNA  deoxyribonucleic acid 
DPBS  Dulbecco’s  phosphate-buffered saline 
E  embryonic day 
E  erythrocyte 
e.g.  exempli gratia 
EDTA  ethylenediaminetetraacetic acid 
EMSA  electrophoresis mobility shift assay 
EPO  erythropoietin 
ER  estrogen receptor 
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ES  embryonic stem  
F  Farad 
FACS  fluorescence-activated cell sorting 
FCS  fetal calf serum 
FL  fetal liver 
FLP-e  enhanced FLP recombinase 
Flt3  fms-related tyrosine kinase 3 
FSC  forward scatter 
g  gram 
G  granulocyte 
GB  gigabyte 
G-CSF  granulocyte colony-stimulating factor 
GEMMeg granulocytic, erythroid, monocytic, megakaryocytic 
GFP  green fluorescent protein 
GM  granulocytic-monocytic  
GM-CSF granulocyte macrophage colony-stimulating factor 
GMP  granulocyte-macrophage progenitor 
h  hour 
HEK  human embryonic kidney 
HSC  hematopoietic stem cell 
HSPC  hematopoietic stem and progenitor cell 
IL  interleukin 
IRES  internal ribosomal entry site 
l  liter 
LB  Luria broth 
Lin  Lineage 
LMPP  lymphoid-primed multipotent progenitor 
LSK  Lineage-Sca-1+c-Kit+ 
M  macrophage 
m  meter 
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M  molar 
M-CSF macrophage colony-stimulating factor 
Meg  megakaryocytic 
MegE  megakaryocytic-erythroid 
MEP  megakaryocyte-erythrocyte progenitor 
min  minute 
miRNA microRNA 
MkP  megakaryocytic progenitors 
ml  milliliter 
mM  millimolar 
MOI  multiplicity of infection 
MPO   myeloperoxidase 
MPP  multipotent progenitor 
mRNA messenger RNA 
ms   millisecond 
NaCl  sodium chloride 
NaOH  sodium hydroxide  
ng  nanogram  
NK  natural killer cell 
nm  nanometer 
OD  optical density 
PAGE  polyacrylamide gelelectrophoresis 
PB  Pacific Blue 
PBS  phosphate-buffered saline  
PCR  polymerase chain reaction 
PE  phycoerythrin 
rcf  radial centrifugal force 
RFLP  restriction fragment length polymorphism  
RNA  ribonucleic acid 
RT  room temperature 
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RT-PCR reverse transcriptase polymerase chain reaction 
s  second 
Sca-1  stem cell antigen 1 
SCF  stem cell factor 
SDS  sodium dodecyl sulfate 
SFEM  serum-free expansion medium 
SFFV  spleen focus forming virus 
SSC  saline sodium citrate  
SSC  side scatter 
TAE  TRIS acetate EDTA  
TBS  TRIS-buffered saline 
TBS-T  TRIS-buffered saline, Tween 
TPO  thrombopoietin 
TRIS  tris-(hydroxymethyl)-aminomethane 
URE  upstream regulatory element 
UTR  untranslated region 
V  Volt  
VSV-g  vesicular stomatitis virus G protein 
WT  wildtype 
YFP  yellow fluorescent protein 
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